Journal Article
. 2005 May;365(9472).
doi: 10.1016/S0140-6736(05)66544-0.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)  
  • PMID: 15894097
  •     2125 citations

Abstract

Background: Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year effects.

Methods: Collaborative meta-analyses were undertaken of 194 unconfounded randomised trials of adjuvant chemotherapy or hormonal therapy that began by 1995. Many trials involved CMF (cyclophosphamide, methotrexate, fluorouracil), anthracycline-based combinations such as FAC (fluorouracil, doxorubicin, cyclophosphamide) or FEC (fluorouracil, epirubicin, cyclophosphamide), tamoxifen, or ovarian suppression: none involved taxanes, trastuzumab, raloxifene, or modern aromatase inhibitors.

Findings: Allocation to about 6 months of anthracycline-based polychemotherapy (eg, with FAC or FEC) reduces the annual breast cancer death rate by about 38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4) for those of age 50-69 years when diagnosed, largely irrespective of the use of tamoxifen and of oestrogen receptor (ER) status, nodal status, or other tumour characteristics. Such regimens are significantly (2p=0.0001 for recurrence, 2p<0.00001 for breast cancer mortality) more effective than CMF chemotherapy. Few women of age 70 years or older entered these chemotherapy trials. For ER-positive disease only, allocation to about 5 years of adjuvant tamoxifen reduces the annual breast cancer death rate by 31% (SE 3), largely irrespective of the use of chemotherapy and of age (<50, 50-69, > or =70 years), progesterone receptor status, or other tumour characteristics. 5 years is significantly (2p<0.00001 for recurrence, 2p=0.01 for breast cancer mortality) more effective than just 1-2 years of tamoxifen. For ER-positive tumours, the annual breast cancer mortality rates are similar during years 0-4 and 5-14, as are the proportional reductions in them by 5 years of tamoxifen, so the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis. These results combine six meta-analyses: anthracycline-based versus no chemotherapy (8000 women); CMF-based versus no chemotherapy (14,000); anthracycline-based versus CMF-based chemotherapy (14,000); about 5 years of tamoxifen versus none (15,000); about 1-2 years of tamoxifen versus none (33,000); and about 5 years versus 1-2 years of tamoxifen (18,000). Finally, allocation to ovarian ablation or suppression (8000 women) also significantly reduces breast cancer mortality, but appears to do so only in the absence of other systemic treatments. For middle-aged women with ER-positive disease (the commonest type of breast cancer), the breast cancer mortality rate throughout the next 15 years would be approximately halved by 6 months of anthracycline-based chemotherapy (with a combination such as FAC or FEC) followed by 5 years of adjuvant tamoxifen. For, if mortality reductions of 38% (age <50 years) and 20% (age 50-69 years) from such chemotherapy were followed by a further reduction of 31% from tamoxifen in the risks that remain, the final mortality reductions would be 57% and 45%, respectively (and, the trial results could well have been somewhat stronger if there had been full compliance with the allocated treatments). Overall survival would be comparably improved, since these treatments have relatively small effects on mortality from the aggregate of all other causes.

Interpretation: Some of the widely practicable adjuvant drug treatments that were being tested in the 1980s, which substantially reduced 5-year recurrence rates (but had somewhat less effect on 5-year mortality rates), also substantially reduce 15-year mortality rates. Further improvements in long-term survival could well be available from newer drugs, or better use of older drugs.

Menopausal hormone therapy after breast cancer.
Graham A Colditz.
Breast Cancer Res, 2005 Jul 01; 7(4). PMID: 15987471    Free PMC article.
Clinical trial update: International Breast Cancer Study Group.
Karen N Price, Aron Goldhirsch, International Breast Cancer Study Group.
Breast Cancer Res, 2005 Nov 11; 7(6). PMID: 16280051    Free PMC article.
Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group.
Ambuj Kumar, Heloisa Soares, +7 authors, Children's Oncology Group.
BMJ, 2005 Nov 22; 331(7528). PMID: 16299015    Free PMC article.
Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
V M Duric, L J Fallowfield, +3 authors, M R Stockler.
Br J Cancer, 2005 Dec 08; 93(12). PMID: 16333242    Free PMC article.
Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.
Susan M Cheer, Greg L Plosker, Dene Simpson, Antona J Wagstaff.
Drugs, 2006 Jan 06; 65(18). PMID: 16392882
Review.
Medical treatment of early breast cancer. I: adjuvant treatment.
Ian Smith, Susan Chua.
BMJ, 2006 Jan 10; 332(7532). PMID: 16399737    Free PMC article.
Review.
Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer.
V Craig Jordan.
Br J Pharmacol, 2006 Jan 13; 147 Suppl 1. PMID: 16402113    Free PMC article.
Review.
Medical treatment of early breast cancer. II: endocrine therapy.
Ian Smith, Susan Chua.
BMJ, 2006 Jan 18; 332(7533). PMID: 16410586    Free PMC article.
Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).
David A Clark, Carolyn B Coulam, Raphael B Stricker.
J Assist Reprod Genet, 2006 Jan 20; 23(1). PMID: 16421767    Free PMC article.
Review.
Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
J Cuzick, P Sasieni, A Howell.
Br J Cancer, 2006 Jan 26; 94(4). PMID: 16434989    Free PMC article.
Review.
Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects.
Walter Jonat, Felix Hilpert.
J Cancer Res Clin Oncol, 2006 Feb 02; 132(6). PMID: 16450161
Review.
Gene expression in breast cancer.
Virginia G Kaklamani, William J Gradishar.
Curr Treat Options Oncol, 2006 Feb 04; 7(2). PMID: 16455023
Review.
Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.
Ahmad Al-Hajj, Ruth O'Regan.
Curr Treat Options Oncol, 2006 Feb 04; 7(2). PMID: 16455026
Review.
Harmful impact of EU clinical trials directive.
Akseli Hemminki, Pirkko-Liisa Kellokumpu-Lehtinen.
BMJ, 2006 Mar 04; 332(7540). PMID: 16513690    Free PMC article.
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?
C Alliot.
Br J Cancer, 2006 Mar 09; 94(6). PMID: 16523197    Free PMC article.
Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.
A Rocchi, S Verma.
Support Care Cancer, 2006 Apr 06; 14(9). PMID: 16596419
Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients.
H E Innes, D Liu, +6 authors, P S Rudland.
Br J Cancer, 2006 Apr 07; 94(7). PMID: 16598187    Free PMC article.
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
Donald A Berry, Constance Cirrincione, +9 authors, Eric P Winer.
JAMA, 2006 Apr 13; 295(14). PMID: 16609087    Free PMC article.
Highly Cited.
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.
C Pacilio, A Morabito, +14 authors, NCI-Naples Breast Cancer Group.
Br J Cancer, 2006 Apr 20; 94(9). PMID: 16622454    Free PMC article.
Early breast cancer.
Tomoyoshi Suzuki, Masakazu Toi, +7 authors, Noriko Kamata.
Int J Clin Oncol, 2006 Apr 20; 11(2). PMID: 16622745
Review.
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.
K Aaltonen, C Ahlin, +5 authors, C Blomqvist.
Br J Cancer, 2006 May 04; 94(11). PMID: 16670718    Free PMC article.
Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
Christopher Dunn, Susan J Keam.
Pharmacoeconomics, 2006 May 19; 24(5). PMID: 16706574
Review.
The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.
Zsolt Hodi, Jayeta Chakrabarti, +5 authors, Ian O Ellis.
J Clin Pathol, 2006 May 30; 60(3). PMID: 16731591    Free PMC article.
Review.
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.
J M Gil, C Rubio-Terrés, +2 authors, F Canorea.
Clin Transl Oncol, 2006 Jun 09; 8(5). PMID: 16760009
Meta-analyses in cancer clinical trials: principles and pitfalls.
J R Benson, K Saeb-Parsy.
World J Surg, 2006 Jun 24; 30(7). PMID: 16794898
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.
I Radke, M Götte, +3 authors, P Wülfing.
Br J Cancer, 2006 Jul 13; 95(3). PMID: 16832410    Free PMC article.
Heterogeneity of breast cancer among patients and implications for patient selection for adjuvant chemotherapy.
Fabrice Andre, Lajos Pusztai.
Pharm Res, 2006 Aug 15; 23(9). PMID: 16906452
Review.
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.
Philippe Leissner, Thibault Verjat, +4 authors, Bruno Mougin.
BMC Cancer, 2006 Sep 02; 6. PMID: 16945123    Free PMC article.
Can differences in breast cancer utilities explain disparities in breast cancer care?
Mark D Schleinitz, Dina DePalo, Jeffrey Blume, Michael Stein.
J Gen Intern Med, 2006 Sep 12; 21(12). PMID: 16961753    Free PMC article.
Cardiovascular health and aromatase inhibitors.
Kathleen I Pritchard, Beth L Abramson.
Drugs, 2006 Sep 19; 66(13). PMID: 16978036
Review.
Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study.
M Prochazka, P Hall, F Granath, K Czene.
Br J Cancer, 2006 Oct 07; 95(9). PMID: 17024122    Free PMC article.
[Treatment of breast cancer: from hormones to antibodies].
J Eucker, A Emde, K Possinger.
Internist (Berl), 2006 Oct 26; 47(12). PMID: 17063333
Review.
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.
Eric A Ariazi, Joan S Lewis-Wambi, +8 authors, V Craig Jordan.
J Steroid Biochem Mol Biol, 2006 Nov 07; 102(1-5). PMID: 17085047    Free PMC article.
The war on cancer: a report from the front lines.
Gavin Melmed.
Proc (Bayl Univ Med Cent), 2006 Nov 16; 19(4). PMID: 17106493    Free PMC article.
Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer.
K M Malinovszky, A Gould, +5 authors, Anglo Celtic Co-operative Oncology Group.
Br J Cancer, 2006 Dec 13; 95(12). PMID: 17160080    Free PMC article.
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
V Craig Jordan, Angela M H Brodie.
Steroids, 2006 Dec 16; 72(1). PMID: 17169390    Free PMC article.
Review.
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence.
A Neri, D Marrelli, +8 authors, F Roviello.
World J Surg, 2006 Dec 21; 31(1). PMID: 17180474
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
A Raymond Frackelton, Li Lu, +3 authors, Dennis C Sgroi.
Breast Cancer Res, 2007 Jan 02; 8(6). PMID: 17196107    Free PMC article.
Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.
Emin Yildirim, Ugur Berberoglu.
World J Surg, 2007 Jan 16; 31(2). PMID: 17219275
Continuing with letrozole offers greater benefits.
Fritz Jänicke.
J Cancer Res Clin Oncol, 2007 Jan 18; 133(7). PMID: 17226047
Review.
Tamoxifen-associated vasculitis in a breast cancer patient.
Myrna Candelaria, Rafael Hurtado-Monroy, +2 authors, Alfonso Duenas-Gonzalez.
World J Surg Oncol, 2007 Jan 25; 5. PMID: 17244373    Free PMC article.
Pregnancy in women with a history of breast cancer.
Emily Banks, Gillian Reeves.
BMJ, 2007 Jan 27; 334(7586). PMID: 17255571    Free PMC article.
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Paul E Goss, Kathrin Strasser-Weippl, Shangle Qi, Haiqing Hu.
BMC Cancer, 2007 Feb 03; 7. PMID: 17266767    Free PMC article.
Factors affecting health-related quality of life in women with recurrent breast cancer in Korea.
Myung Kyung Lee, Byung Ho Son, +4 authors, Young Ho Yun.
Qual Life Res, 2007 Feb 07; 16(4). PMID: 17279443
Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
A R Hinnis, J C A Luckett, R A Walker.
Br J Cancer, 2007 Feb 08; 96(4). PMID: 17285125    Free PMC article.
Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.
A J Swerdlow, M E Jones.
Br J Cancer, 2007 Feb 08; 96(5). PMID: 17285129    Free PMC article.
Managing high-risk breast cancer.
Frances M Palmieri, Edith A Perez.
Semin Oncol Nurs, 2007 Feb 17; 23(1). PMID: 17303514    Free PMC article.
Review.
An overview of prognostic factors for long-term survivors of breast cancer.
Isabelle Soerjomataram, Marieke W J Louwman, +2 authors, Jan Willem W Coebergh.
Breast Cancer Res Treat, 2007 Mar 23; 107(3). PMID: 17377838    Free PMC article.
Highly Cited. Review.
SERMs for the treatment and prevention of breast cancer.
Ramona F Swaby, Catherine G N Sharma, V Craig Jordan.
Rev Endocr Metab Disord, 2007 Apr 19; 8(3). PMID: 17440819
Review.
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
E de Azambuja, F Cardoso, +7 authors, M Paesmans.
Br J Cancer, 2007 Apr 25; 96(10). PMID: 17453008    Free PMC article.
Highly Cited.
Aromatase inhibitors for breast cancer.
Susanne Briest, Nancy E Davidson.
Rev Endocr Metab Disord, 2007 May 09; 8(3). PMID: 17486453
Review.
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.
P Kerbrat, H Roché, +16 authors, French adjuvant Study Group.
Br J Cancer, 2007 May 17; 96(11). PMID: 17505516    Free PMC article.
Breast cancer clinical and translational research: analogies and implications for prostate cancer.
Lea Baer, Silvia C Formenti.
Rev Urol, 2007 Jun 08; 9 Suppl 2. PMID: 17554404    Free PMC article.
Molecular response to aromatase inhibitor treatment in primary breast cancer.
Alan Mackay, Ander Urruticoechea, +10 authors, Mitch Dowsett.
Breast Cancer Res, 2007 Jun 09; 9(3). PMID: 17555561    Free PMC article.
Tumour dormancy in breast cancer: an update.
Muriel Brackstone, Jason L Townson, Ann F Chambers.
Breast Cancer Res, 2007 Jun 15; 9(3). PMID: 17561992    Free PMC article.
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Stephan Duss, Sylvie André, +4 authors, Richard D Iggo.
Breast Cancer Res, 2007 Jun 19; 9(3). PMID: 17573968    Free PMC article.
Adjuvant endocrine therapies for premenopausal women.
C A Rodríguez Sánchez.
Clin Transl Oncol, 2007 Jun 28; 9(6). PMID: 17594951
Review.
Current controversies in the management of early breast cancer.
L G Estévez, M Martín, +13 authors, I Tusquets.
Clin Transl Oncol, 2007 Jun 28; 9(6). PMID: 17594952
Review.
Is breast cancer prognosis inherited?
Mikael Hartman, Linda Lindström, +3 authors, Kamila Czene.
Breast Cancer Res, 2007 Jun 30; 9(3). PMID: 17598882    Free PMC article.
Treatment of premenopausal women with early breast cancer: old challenges and new opportunities.
Stefan Aebi, Olivia Pagani.
Drugs, 2007 Jun 30; 67(10). PMID: 17600388
Review.
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.
R Mansel, G Locker, +2 authors, D Jones.
Br J Cancer, 2007 Jul 12; 97(2). PMID: 17622238    Free PMC article.
Integrating circulating tumor cell assays into the management of breast cancer.
Shaheenah Dawood, Massimo Cristofanilli.
Curr Treat Options Oncol, 2007 Jul 20; 8(1). PMID: 17634836
Review.
The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
Amy Lin, Hope S Rugo.
Curr Treat Options Oncol, 2007 Jul 31; 8(1). PMID: 17660958
Review.
Using clinical trial data to tailor adjuvant treatments for individual patients.
Meredith M Regan, Richard D Gelber, International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG).
Breast, 2007 Aug 28; 16 Suppl 2. PMID: 17719227    Free PMC article.
Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.
V Craig Jordan, Joan Lewis-Wambi, +5 authors, Ramona Swaby.
Breast, 2007 Aug 28; 16 Suppl 2. PMID: 17719781    Free PMC article.
Review.
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.
V Craig Jordan.
Steroids, 2007 Sep 04; 72(13). PMID: 17765940    Free PMC article.
Review.
Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching.
Stefan Paepke, Volker R Jacobs, +5 authors, Marion Kiechle-Bahat.
J Cancer Res Clin Oncol, 2007 Sep 07; 133(12). PMID: 17805570
Review.
Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.
M P Goetz, A Kamal, M M Ames.
Clin Pharmacol Ther, 2007 Sep 21; 83(1). PMID: 17882159    Free PMC article.
Review.
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
C J Fabian.
Int J Clin Pract, 2007 Sep 26; 61(12). PMID: 17892469    Free PMC article.
Review.
Letrozole in the extended adjuvant setting: MA.17.
Paul E Goss.
Breast Cancer Res Treat, 2007 Nov 21; 105 Suppl 1. PMID: 17912635    Free PMC article.
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98.
Dieter Koeberle, Beat Thuerlimann.
Breast Cancer Res Treat, 2007 Nov 21; 105 Suppl 1. PMID: 17912636    Free PMC article.
A decade of letrozole: FACE.
Joyce O'Shaughnessy.
Breast Cancer Res Treat, 2007 Nov 21; 105 Suppl 1. PMID: 17912637    Free PMC article.
Safety of aromatase inhibitors in the adjuvant setting.
Edith A Perez.
Breast Cancer Res Treat, 2007 Nov 21; 105 Suppl 1. PMID: 17912638    Free PMC article.
Review.
The patient experience.
Nadia Harbeck, Renate Haidinger.
Breast Cancer Res Treat, 2007 Nov 21; 105 Suppl 1. PMID: 17912639    Free PMC article.
Review.
Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis.
Jos A van der Hage, J Sven D Mieog, +2 authors, European Organization for Research and Treatment of Cancer.
Breast Cancer Res, 2007 Oct 13; 9(5). PMID: 17931406    Free PMC article.
Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials.
Carsten Rose.
J Cancer Res Clin Oncol, 2007 Oct 17; 134(1). PMID: 17938958
Review.
UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
Fumihiro Tanaka.
Surg Today, 2007 Oct 24; 37(11). PMID: 17952521
Review.
Postoperative wound complications and systemic recurrence in breast cancer.
B L Murthy, C S Thomson, +4 authors, K Horgan.
Br J Cancer, 2007 Oct 31; 97(9). PMID: 17968426    Free PMC article.
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.
M Debled, N Houédé, +4 authors, Louis Mauriac.
Br J Cancer, 2007 Nov 15; 97(12). PMID: 18000502    Free PMC article.
Under utilization of surveillance mammography among older breast cancer survivors.
Terry S Field, Chyke Doubeni, +9 authors, Rebecca A Silliman.
J Gen Intern Med, 2007 Dec 07; 23(2). PMID: 18060463    Free PMC article.
Tamoxifen: catalyst for the change to targeted therapy.
V Craig Jordan.
Eur J Cancer, 2007 Dec 11; 44(1). PMID: 18068350    Free PMC article.
Review.
Understanding and management of male breast cancer: a critical review.
Kartikeya Pant, Udayan Dutta.
Med Oncol, 2007 Dec 13; 25(3). PMID: 18074245
Review.
Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.
Alison K Conlin, Andrew D Seidman.
Mol Diagn Ther, 2007 Dec 15; 11(6). PMID: 18078353
Review.
Aromatase inhibitors in early hormone receptor-positive breast cancer : what is the optimal initiation time for the maximum benefit?
Sarah J Needleman, Jeffrey S Tobias.
Drugs, 2007 Dec 18; 68(1). PMID: 18081369
Review.
Early breast cancer in the elderly: assessment and management considerations.
Gilles Albrand, Catherine Terret.
Drugs Aging, 2008 Jan 11; 25(1). PMID: 18184027
Review.
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Ting Bao, Nancy E Davidson.
Breast Cancer Res, 2008 Jan 15; 9(6). PMID: 18190722    Free PMC article.
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.
Grazia Arpino, Lisa Wiechmann, C Kent Osborne, Rachel Schiff.
Endocr Rev, 2008 Jan 25; 29(2). PMID: 18216219    Free PMC article.
Highly Cited. Review.
Ambulatory care for cancer in the United States: results from two national surveys comparing visits to physicians' offices and hospital outpatient departments.
Lisa C Richardson, Florence K Tangka.
J Natl Med Assoc, 2008 Jan 31; 99(12). PMID: 18229771    Free PMC article.
A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival.
Jianjun Yu, Jindan Yu, +5 authors, Marc E Lippman.
Neoplasia, 2008 Jan 31; 10(1). PMID: 18231641    Free PMC article.
Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer.
K Towns, P L Bedard, S Verma.
Curr Oncol, 2008 Jan 31; 15(Suppl 1). PMID: 18231644    Free PMC article.
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
Beat Thürlimann, Karen N Price, +9 authors, International Breast Cancer Study Group.
Breast Cancer Res Treat, 2008 Feb 09; 113(1). PMID: 18259856    Free PMC article.
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.
Judith-Anne W Chapman, Daniel Meng, +6 authors, Paul E Goss.
J Natl Cancer Inst, 2008 Feb 14; 100(4). PMID: 18270335    Free PMC article.
Prognostic significance of HER-2 status in women with inflammatory breast cancer.
Shaheenah Dawood, Kristine Broglio, +8 authors, Inflammatory Breast Cancer Research Group.
Cancer, 2008 Feb 27; 112(9). PMID: 18300243    Free PMC article.
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
Sandra M Swain, Stephanie R Land, +5 authors, Patricia A Ganz.
Breast Cancer Res Treat, 2008 Feb 28; 113(2). PMID: 18302020    Free PMC article.
Update of evidence in chemotherapy for breast cancer.
Hiroyasu Yamashiro, Masakazu Toi.
Int J Clin Oncol, 2008 Mar 01; 13(1). PMID: 18307012
Review.
Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Karen S Anderson, Niroshan Ramachandran, +9 authors, Joshua LaBaer.
J Proteome Res, 2008 Mar 04; 7(4). PMID: 18311903    Free PMC article.
The role of ovarian ablation in the adjuvant therapy of breast cancer.
Sing-Huang Tan, Antonio C Wolff.
Curr Oncol Rep, 2008 Mar 28; 10(1). PMID: 18366958
Review.
Breast cancer follow-up in the adjuvant setting.
James Khatcheressian, Craig Swainey.
Curr Oncol Rep, 2008 Mar 28; 10(1). PMID: 18366959
Review.
Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.
Melinda E Sanders, Eduardo C Dias, +7 authors, Richard M Caprioli.
J Proteome Res, 2008 Apr 05; 7(4). PMID: 18386930    Free PMC article.
Competing causes of death for women with breast cancer and change over time from 1975 to 2003.
Xianglin L Du, Erin E Fox, Dejian Lai.
Am J Clin Oncol, 2008 Apr 09; 31(2). PMID: 18391593    Free PMC article.
Weekly paclitaxel in the adjuvant treatment of breast cancer.
Joseph A Sparano, Molin Wang, +7 authors, Nancy E Davidson.
N Engl J Med, 2008 Apr 19; 358(16). PMID: 18420499    Free PMC article.
Highly Cited.
Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.
Susan L Greenspan, Adam Brufsky, +5 authors, Victor G Vogel.
J Clin Oncol, 2008 Apr 23; 26(16). PMID: 18427147    Free PMC article.
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making.
Lieven Annemans.
Pharmacoeconomics, 2008 Apr 24; 26(5). PMID: 18429657
Review.
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
Emma Niméus-Malmström, Morten Krogh, +8 authors, Mårten Fernö.
Breast Cancer Res, 2008 Apr 24; 10(2). PMID: 18430221    Free PMC article.
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?
Daniel F Hayes, Vered Stearns, +2 authors, Consortium on Breast Cancer Pharmacogenomics.
J Natl Cancer Inst, 2008 May 01; 100(9). PMID: 18445818    Free PMC article.
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Rinaa S Punglia, Harold J Burstein, Eric P Winer, Jane C Weeks.
J Natl Cancer Inst, 2008 May 01; 100(9). PMID: 18445827    Free PMC article.
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
Britta Weigelt, Mina J Bissell.
Semin Cancer Biol, 2008 May 06; 18(5). PMID: 18455428    Free PMC article.
Highly Cited. Review.
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Lidia Albanito, Diego Sisci, +9 authors, Marcello Maggiolini.
Endocrinology, 2008 May 10; 149(8). PMID: 18467441    Free PMC article.
A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer.
Michael H Nelson, Christian R Dolder.
Ther Clin Risk Manag, 2008 May 14; 3(4). PMID: 18472989    Free PMC article.
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.
Ben S Wittner, Dennis C Sgroi, +9 authors, Sridhar Ramaswamy.
Clin Cancer Res, 2008 May 17; 14(10). PMID: 18483364    Free PMC article.
Competing risk and heterogeneity of treatment effect in clinical trials.
David M Kent, Alawi Alsheikh-Ali, Rodney A Hayward.
Trials, 2008 May 24; 9. PMID: 18498644    Free PMC article.
Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women.
G J van Londen, S Perera, +3 authors, S L Greenspan.
Bone, 2008 Jun 04; 43(2). PMID: 18519174    Free PMC article.
Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs.
Job Komen, Floor Wolbers, +3 authors, Albert van den Berg.
Biomed Microdevices, 2008 Jun 05; 10(5). PMID: 18523888    Free PMC article.
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.
Benjamin D Hedley, Kedar S Vaidya, +5 authors, Ann F Chambers.
Clin Exp Metastasis, 2008 Jun 11; 25(7). PMID: 18543067
Minireview: hormones and mammary cell fate--what will I become when I grow up?
Heather L LaMarca, Jeffrey M Rosen.
Endocrinology, 2008 Jun 17; 149(9). PMID: 18556345    Free PMC article.
Review.
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.
B C Pestalozzi, P Francis, +13 authors, BIG 02-98 Collaborative Group.
Ann Oncol, 2008 Jun 20; 19(11). PMID: 18562328    Free PMC article.
Management of breast cancer--Part II.
Nicholas C Turner, Alison L Jones.
BMJ, 2008 Jul 16; 337. PMID: 18621762    Free PMC article.
Review.
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.
Marjorie Zauderer, Sujata Patil, Arti Hurria.
Breast Cancer Res Treat, 2008 Jul 16; 117(1). PMID: 18622739    Free PMC article.
Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer.
Adnan Aydiner, Faruk Tas.
Trials, 2008 Jul 31; 9. PMID: 18664277    Free PMC article.
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
A M Wardley, L Hiller, +8 authors, tAnGo Trial Collaborators.
Br J Cancer, 2008 Jul 31; 99(4). PMID: 18665163    Free PMC article.
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.
T L Lash, L Pedersen, +8 authors, H T Sørensen.
Br J Cancer, 2008 Jul 31; 99(4). PMID: 18665165    Free PMC article.
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Lori J Goldstein, Robert Gray, +12 authors, Joseph A Sparano.
J Clin Oncol, 2008 Aug 06; 26(25). PMID: 18678838    Free PMC article.
Highly Cited.
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.
Tyler E Miller, Kalpana Ghoshal, +5 authors, Sarmila Majumder.
J Biol Chem, 2008 Aug 19; 283(44). PMID: 18708351    Free PMC article.
Highly Cited.
Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
Elizabeth A Musgrove, C Marcelo Sergio, +11 authors, Robert L Sutherland.
PLoS One, 2008 Aug 21; 3(8). PMID: 18714337    Free PMC article.
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.
Shaheenah Dawood, Kristine Broglio, +3 authors, Sharon H Giordano.
J Clin Oncol, 2008 Aug 30; 26(30). PMID: 18725649    Free PMC article.
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
Ranjan Chrisanthar, Stian Knappskog, +10 authors, Per Eystein Lønning.
PLoS One, 2008 Aug 30; 3(8). PMID: 18725978    Free PMC article.
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease.
M W Helms, D Kemming, +8 authors, B H Brandt.
Br J Cancer, 2008 Aug 30; 99(5). PMID: 18728668    Free PMC article.
Long-term safety of aromatase inhibitors in the treatment of breast cancer.
Jean-Marc A Nabholtz.
Ther Clin Risk Manag, 2008 Aug 30; 4(1). PMID: 18728707    Free PMC article.
Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.
Timothy L Lash, Thomas P Ahern, +3 authors, Henrik Toft Sørensen.
Cancer Sci, 2008 Aug 30; 99(8). PMID: 18754887    Free PMC article.
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
Matthew P Goetz, Vera J Suman, +12 authors, James N Ingle.
Clin Cancer Res, 2008 Sep 17; 14(18). PMID: 18794098    Free PMC article.
Cancer survival in England and Wales at the end of the 20th century.
B Rachet, L M Woods, +8 authors, M P Coleman.
Br J Cancer, 2008 Oct 01; 99 Suppl 1. PMID: 18813248    Free PMC article.
Survival from breast cancer in England and Wales up to 2001.
A Leary, I E Smith.
Br J Cancer, 2008 Oct 01; 99 Suppl 1. PMID: 18813261    Free PMC article.
Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer?
Michelle A Aranda, Marcia McGory, +3 authors, David S Zingmond.
Gynecol Oncol, 2008 Oct 03; 111(2). PMID: 18829086    Free PMC article.
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
N Lynn Henry, Vered Stearns, +2 authors, Michelle Riba.
Am J Psychiatry, 2008 Oct 03; 165(10). PMID: 18829880    Free PMC article.
Review.
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
James J Dignam, Vanja Dukic, +3 authors, Norman Wolmark.
Breast Cancer Res Treat, 2008 Oct 03; 116(3). PMID: 18830816    Free PMC article.
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Julie A Vendrell, Katherine E Robertson, +10 authors, Pascale A Cohen.
Breast Cancer Res, 2008 Oct 22; 10(5). PMID: 18928543    Free PMC article.
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Alfonso Sánchez-Muñoz, Ana María García-Tapiador, +11 authors, Pedro Sánchez-Rovira.
Clin Transl Oncol, 2008 Oct 23; 10(10). PMID: 18940745
Current research topics in endocrine therapy for breast cancer.
Hiroko Yamashita.
Int J Clin Oncol, 2008 Oct 24; 13(5). PMID: 18946747
Review.
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer.
Yutaka Yamamoto, Hirotaka Iwase.
Int J Clin Oncol, 2008 Oct 24; 13(5). PMID: 18946748
Review.
On the way to specifically targeting minimal residual disease?
Gerhard Gebauer.
Breast Cancer Res, 2008 Oct 25; 10(5). PMID: 18947365    Free PMC article.
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Elton Rexhepaj, Donal J Brennan, +6 authors, William M Gallagher.
Breast Cancer Res, 2008 Oct 25; 10(5). PMID: 18947395    Free PMC article.
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Tatsuya Toyama, Hiroko Yamashita, +6 authors, Yoshitaka Fujii.
BMC Cancer, 2008 Oct 28; 8. PMID: 18950515    Free PMC article.
National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures.
Karen M Freund, Tracy A Battaglia, +6 authors, Patient Navigation Research Program Group.
Cancer, 2008 Oct 28; 113(12). PMID: 18951521    Free PMC article.
Highly Cited.
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Olivia Pagani, Shari Gelber, +14 authors, International Breast Cancer Study Group.
Breast Cancer Res Treat, 2008 Oct 28; 116(3). PMID: 18953651    Free PMC article.
Adjuvant therapy of melanoma with interferon: lessons of the past decade.
Paolo A Ascierto, John M Kirkwood.
J Transl Med, 2008 Oct 29; 6. PMID: 18954464    Free PMC article.
Review.
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
Michael J Hassett, Melissa E Hughes, +7 authors, Jane C Weeks.
J Clin Oncol, 2008 Oct 29; 26(34). PMID: 18955448    Free PMC article.
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
A K Koutras, K T Kalogeras, +16 authors, Hellenic Cooperative Oncology Group (HeCOG).
Br J Cancer, 2008 Nov 06; 99(11). PMID: 18985033    Free PMC article.
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.
C McCowan, J Shearer, +4 authors, T P Fahey.
Br J Cancer, 2008 Nov 06; 99(11). PMID: 18985046    Free PMC article.
Highly Cited.
The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery.
Takayoshi Kiba, Takashi Inamoto, +6 authors, Masanori Fukushima.
BMC Cancer, 2008 Nov 08; 8. PMID: 18990247    Free PMC article.
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
Ralph R Weichselbaum, Hemant Ishwaran, +12 authors, Andy J Minn.
Proc Natl Acad Sci U S A, 2008 Nov 13; 105(47). PMID: 19001271    Free PMC article.
Highly Cited.
Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors.
Jill E Lavigne, Jennifer J Griggs, Xin M Tu, Debra J Lerner.
J Cancer Surviv, 2008 Nov 13; 2(4). PMID: 19003541
The UPS: a promising target for breast cancer treatment.
Ko Sato, Eeson Rajendra, Tomohiko Ohta.
BMC Biochem, 2008 Nov 26; 9 Suppl 1. PMID: 19007432    Free PMC article.
Review.
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
Fabien Reyal, Martin H van Vliet, +10 authors, Lodewyk F A Wessels.
Breast Cancer Res, 2008 Nov 19; 10(6). PMID: 19014521    Free PMC article.
Phase II study of dose-dense doxorubicin and docetaxel as neoadjunvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer.
Jesus García-Mata, Andres García-Palomo, +3 authors, Manuel Ramos.
Clin Transl Oncol, 2008 Nov 19; 10(11). PMID: 19015070
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Yan Jin, Daniel F Hayes, +10 authors, Vered Stearns.
J Clin Oncol, 2008 Nov 20; 26(36). PMID: 19018086    Free PMC article.
Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer.
E J Campbell, E McDuff, +4 authors, J Edwards.
Br J Cancer, 2008 Nov 20; 99(11). PMID: 19018258    Free PMC article.
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
Vered Stearns, James M Rae.
Expert Rev Mol Med, 2008 Nov 21; 10. PMID: 19019258    Free PMC article.
Review.
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
Shaheenah Dawood, Kristine Broglio, +9 authors, Ana Maria Gonzalez-Angulo.
J Clin Oncol, 2008 Dec 03; 27(2). PMID: 19047281    Free PMC article.
Should routine breast cancer staging include MRI?
Monica Morrow.
Nat Clin Pract Oncol, 2008 Dec 03; 6(2). PMID: 19048011
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
Annabel C Borley, Stephen Hiscox, +4 authors, Robert I Nicholson.
Breast Cancer Res, 2008 Dec 06; 10(6). PMID: 19055788    Free PMC article.
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
Lorenzo Gianni, Shari Gelber, +9 authors, Aron Goldhirsch.
Eur J Cancer, 2008 Dec 09; 45(4). PMID: 19062268    Free PMC article.
Rising incidence of breast cancer among female cancer survivors: implications for surveillance.
I Soerjomataram, W J Louwman, L E M Duijm, J W W Coebergh.
Br J Cancer, 2008 Dec 11; 100(1). PMID: 19066609    Free PMC article.
BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.
E K A Millar, L R Anderson, +9 authors, A J Butt.
Br J Cancer, 2008 Dec 11; 100(1). PMID: 19066611    Free PMC article.
Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
Mukaila A Raji, Lynsey P Tamborello, +5 authors, James S Goodwin.
Med Oncol, 2008 Dec 11; 26(4). PMID: 19067255    Free PMC article.
"New" molecular taxonomy in breast cancer.
Marta Hergueta-Redondo, José Palacios, Amparo Cano, Gema Moreno-Bueno.
Clin Transl Oncol, 2008 Dec 11; 10(12). PMID: 19068448
Review.
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?
Michaela J Higgins, Nancy E Davidson.
Curr Oncol Rep, 2008 Dec 17; 11(1). PMID: 19080741
Review.
Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.
Genet Med, 2009 Jan 07; 11(1). PMID: 19125125    Free PMC article.
By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy.
V Craig Jordan, Roshani Patel, Joan S Lewis-Wambi, Ramona F Swaby.
Breast Cancer Res, 2009 Jan 16; 10 Suppl 4. PMID: 19128429    Free PMC article.
Markers of endocrine sensitivity.
Daniel F Hayes.
Breast Cancer Res, 2009 Jan 16; 10 Suppl 4. PMID: 19128431    Free PMC article.
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Olivia Pagani, Karen N Price, +9 authors, International Breast Cancer Study Group (IBCSG).
Breast Cancer Res Treat, 2009 Jan 13; 117(2). PMID: 19137426    Free PMC article.
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Susan G Moore, Pareen J Shenoy, +2 authors, Christopher R Flowers.
BMC Health Serv Res, 2009 Jan 16; 9. PMID: 19144138    Free PMC article.
Pharmacogenetics and pharmacogenomics of anticancer agents.
R Stephanie Huang, Mark J Ratain.
CA Cancer J Clin, 2009 Jan 17; 59(1). PMID: 19147868    Free PMC article.
Review.
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.
A Barnadas, M Gil, +6 authors, A Moreno.
Br J Cancer, 2009 Jan 22; 100(3). PMID: 19156139    Free PMC article.
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients.
J G H van Nes, V T H B M Smit, +11 authors, C J H van de Velde.
Br J Cancer, 2009 Jan 22; 100(3). PMID: 19156146    Free PMC article.
A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.
R L Jones, G Walsh, +5 authors, I E Smith.
Br J Cancer, 2009 Jan 24; 100(2). PMID: 19165198    Free PMC article.
Breast cancer in young women and its impact on reproductive function.
M Hickey, M Peate, C M Saunders, M Friedlander.
Hum Reprod Update, 2009 Jan 29; 15(3). PMID: 19174449    Free PMC article.
Review.
Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women.
W-H Kuo, A M-F Yen, +5 authors, H-S Tsau.
Br J Cancer, 2009 Feb 05; 100(4). PMID: 19190627    Free PMC article.
Current indications for post-mastectomy radiation.
Maria Vilarino-Varela, Yaw Sinn Chin, Andreas Makris.
Int Semin Surg Oncol, 2009 Feb 11; 6. PMID: 19203387    Free PMC article.
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
Judith Hugh, John Hanson, +11 authors, Charles Vogel.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204205    Free PMC article.
Highly Cited.
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer.
M Loddo, S R Kingsbury, +10 authors, G H Williams.
Br J Cancer, 2009 Feb 26; 100(6). PMID: 19240714    Free PMC article.
Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
Allan Hackshaw, Michael Baum, +9 authors, Richard Sainsbury.
J Natl Cancer Inst, 2009 Feb 27; 101(5). PMID: 19244174    Free PMC article.
Adjuvant and preoperative therapy for localized gastric cancer.
Yixing Jiang, Alberto J Montero, Kevin F Staveley-O'Carroll.
Gastrointest Cancer Res, 2007 Jul 01; 1(4). PMID: 19262702    Free PMC article.
Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.
Andrew J Vickers, Elena B Elkin, +2 authors, Laura A Siminoff.
Med Decis Making, 2009 Mar 10; 29(4). PMID: 19270108    Free PMC article.
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
M Chehani Alles, Margaret Gardiner-Garden, +5 authors, Christopher J Ormandy.
PLoS One, 2009 Mar 10; 4(3). PMID: 19270750    Free PMC article.
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Marta Santisteban, Jennifer M Reiman, +10 authors, Keith L Knutson.
Cancer Res, 2009 Mar 12; 69(7). PMID: 19276366    Free PMC article.
Highly Cited.
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004.
Yu Shen, Wenli Dong, +3 authors, Sharon H Giordano.
Cancer, 2009 Mar 17; 115(10). PMID: 19288569    Free PMC article.
TLE3 as a candidate biomarker of response to taxane therapy.
Swati A Kulkarni, David G Hicks, +9 authors, Douglas T Ross.
Breast Cancer Res, 2009 Mar 25; 11(2). PMID: 19309506    Free PMC article.
The controversial clinicobiological role of breast cancer stem cells.
Claudia Casarsa, Saro Oriana, Danila Coradini.
J Oncol, 2008 Jan 01; 2008. PMID: 19325911    Free PMC article.
Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Arzu Umar, Hyuk Kang, +8 authors, Ljiljana Pasa-Tolić.
Mol Cell Proteomics, 2009 Mar 31; 8(6). PMID: 19329653    Free PMC article.
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
Richard C Zellars, Vered Stearns, +12 authors, Antonio C Wolff.
J Clin Oncol, 2009 Apr 01; 27(17). PMID: 19332718    Free PMC article.
Exemestane in early breast cancer: a review.
Michael Untch, Christian Jackisch.
Ther Clin Risk Manag, 2009 Apr 02; 4(6). PMID: 19337436    Free PMC article.
Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer.
Sara López-Tarruella, Miguel Martín.
Breast Cancer Res, 2009 Apr 07; 11(2). PMID: 19344489    Free PMC article.
Review.
Chemoprevention of lung cancer.
Robert L Keith.
Proc Am Thorac Soc, 2009 Apr 08; 6(2). PMID: 19349487    Free PMC article.
Review.
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Stewart J Anderson, Irene Wapnir, +7 authors, Norman Wolmark.
J Clin Oncol, 2009 Apr 08; 27(15). PMID: 19349544    Free PMC article.
Adjuvant chemotherapy for early breast cancer in the elderly.
Mary Leung, Iulianna Shapira, Thomas Bradley, Daniel R Budman.
Curr Treat Options Oncol, 2009 Apr 11; 10(3-4). PMID: 19360475
Review.
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
Robert J Crowder, Chanpheng Phommaly, +14 authors, Matthew J Ellis.
Cancer Res, 2009 Apr 16; 69(9). PMID: 19366795    Free PMC article.
Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.
H Irene Su, Mary D Sammel, +6 authors, Angela DeMichele.
Fertil Steril, 2009 Apr 21; 94(2). PMID: 19376514    Free PMC article.
Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healing.
William W Harless.
BMC Cancer, 2009 Apr 23; 9. PMID: 19383172    Free PMC article.
The MINDACT trial: the first prospective clinical validation of a genomic tool.
Fatima Cardoso, Martine Piccart-Gebhart, +2 authors, TRANSBIG Consortium.
Mol Oncol, 2007 Dec 01; 1(3). PMID: 19383299    Free PMC article.
Implementation and limitations of meta-analysis of randomized trials from the clinical biostatistician's point of view.
Junichi Sakamoto.
Int J Clin Oncol, 2009 Apr 25; 14(2). PMID: 19390936
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.
Jeffrey K Belkora, Hope S Rugo, +3 authors, Laura J Esserman.
BMC Cancer, 2009 Apr 30; 9. PMID: 19400938    Free PMC article.
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
Byoung Kwon Kim, Jong Won Lee, +11 authors, Chul Woo Kim.
Breast Cancer Res, 2009 Apr 30; 11(2). PMID: 19400944    Free PMC article.
Time-varying effects of prognostic factors associated with disease-free survival in breast cancer.
Loki Natarajan, Minya Pu, +9 authors, John P Pierce.
Am J Epidemiol, 2009 May 01; 169(12). PMID: 19403844    Free PMC article.
Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment.
Hirotaka Iwase, Yutaka Yamamoto, Teru Kawasoe, Mutsuko Ibusuki.
Surg Today, 2009 May 02; 39(5). PMID: 19408073
Review.
The silent estrogen receptor--can we make it speak?
Madhavi Billam, Abigail E Witt, Nancy E Davidson.
Cancer Biol Ther, 2009 May 05; 8(6). PMID: 19411863    Free PMC article.
Review.
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
J M Rae, M J Sikora, +11 authors, COBRA investigators.
Pharmacogenomics J, 2009 May 08; 9(4). PMID: 19421167    Free PMC article.
The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
Xinyi Liu, Maen Abdelrahim, +2 authors, Stephen Safe.
Mol Cancer Ther, 2009 May 14; 8(5). PMID: 19435870    Free PMC article.
A review of the use of exemestane in early breast cancer.
Andrew Robinson.
Ther Clin Risk Manag, 2009 May 14; 5(1). PMID: 19436613    Free PMC article.
Adjuvant chemotherapy in older women with early-stage breast cancer.
Hyman B Muss, Donald A Berry, +23 authors, CALGB Investigators.
N Engl J Med, 2009 May 15; 360(20). PMID: 19439741    Free PMC article.
Highly Cited.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Paul Ellis, Peter Barrett-Lee, +22 authors, TACT Trialists.
Lancet, 2009 May 19; 373(9676). PMID: 19447249    Free PMC article.
Adjuvant hormonal therapy use among insured, low-income women with breast cancer.
Gretchen Kimmick, Roger Anderson, +3 authors, Rajesh Balkrishnan.
J Clin Oncol, 2009 May 20; 27(21). PMID: 19451445    Free PMC article.
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.
Jaclyn L F Bosco, Rebecca A Silliman, +7 authors, Timothy L Lash.
J Clin Epidemiol, 2009 May 22; 63(1). PMID: 19457638    Free PMC article.
The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients.
Ho Sung Kim, Yong Tark Jeon, Yong Beom Kim.
J Gynecol Oncol, 2009 May 28; 19(4). PMID: 19471651    Free PMC article.
Autocrine human growth hormone expression leads to resistance of MCF-7 cells to tamoxifen.
Majid Mojarrad, Majid Momeny, +5 authors, Mohammad Hussein Modarressi.
Med Oncol, 2009 May 28; 27(2). PMID: 19472088
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
John A Olson, G Thomas Budd, +10 authors, Matthew J Ellis.
J Am Coll Surg, 2009 May 30; 208(5). PMID: 19476859    Free PMC article.
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.
Charlton Cooper, Jimin Guo, +6 authors, Etienne Leygue.
Nucleic Acids Res, 2009 Jun 02; 37(13). PMID: 19483093    Free PMC article.
Medical oncology: Endocrine-therapy-related symptoms and breast cancer.
Aman U Buzdar.
Nat Rev Clin Oncol, 2009 Jun 02; 6(6). PMID: 19483735
Treatment and survival in breast cancer in the Eastern Region of England.
G C Wishart, D C Greenberg, +3 authors, A D Purushotham.
Ann Oncol, 2009 Jun 09; 21(2). PMID: 19502647    Free PMC article.
Neoadjuvant chemotherapy for "triple negative" breast cancer: a review of current practice and future outlook.
Zeina Nahleh.
Med Oncol, 2009 Jun 11; 27(2). PMID: 19513864
Review.
Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women.
Dawn L Hershman, Donna Buono, +2 authors, Alfred I Neugut.
Cancer, 2009 Jun 12; 115(17). PMID: 19517470    Free PMC article.
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
Anita Giobbie-Hurder, Karen N Price, +2 authors, BIG 1-98 Collaborative Group.
Clin Trials, 2009 Jun 17; 6(3). PMID: 19528136    Free PMC article.
In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
Anne E Lykkesfeldt, Katrine L Henriksen, +5 authors, Henning T Mouridsen.
BMC Cancer, 2009 Jun 18; 9. PMID: 19531212    Free PMC article.
Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.
Christos Markopoulos, Urania Dafni, +8 authors, Helen Gogas.
Breast Cancer Res, 2009 Jun 18; 11(3). PMID: 19531217    Free PMC article.
Genomic predictors of outcome and treatment response in breast cancer.
Lara Dunn, Angela Demichele.
Mol Diagn Ther, 2009 Jun 23; 13(2). PMID: 19537843
Review.
Verification of a prolonged untreated natural history of breast cancer by the multigene assay.
Tadeja Urbas, Neal Agee, Marcia E Bouton, Ian K Komenaka.
Med Oncol, 2009 Jun 24; 27(3). PMID: 19548125
Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
Xiang H-F Zhang, Qiongqing Wang, +5 authors, Joan Massagué.
Cancer Cell, 2009 Jul 04; 16(1). PMID: 19573813    Free PMC article.
Highly Cited.
Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.
Mette Kalager, Tor Haldorsen, +3 authors, Hans-Olov Adami.
Breast Cancer Res, 2009 Jul 07; 11(4). PMID: 19575807    Free PMC article.
Systems pathology--taking molecular pathology into a new dimension.
Dana Faratian, Robert G Clyde, John W Crawford, David J Harrison.
Nat Rev Clin Oncol, 2009 Jul 08; 6(8). PMID: 19581910
Review.
Postoperative endocrine therapy for invasive breast cancer.
Leisha A Emens, Nancy E Davidson.
Cancer Treat Res, 2009 Jul 14; 151. PMID: 19593511    Free PMC article.
Review.
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
Raymond Tubbs, William E Barlow, +11 authors, Daniel F Hayes.
J Clin Oncol, 2009 Jul 22; 27(24). PMID: 19620488    Free PMC article.
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
A Daskalaki, S Agelaki, +7 authors, V Georgoulias.
Br J Cancer, 2009 Jul 23; 101(4). PMID: 19623181    Free PMC article.
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).
V H C Bramwell, K I Pritchard, +8 authors, L Shepherd.
Ann Oncol, 2009 Jul 25; 21(2). PMID: 19628570    Free PMC article.
CYP2D6 and tamoxifen: DNA matters in breast cancer.
Janelle M Hoskins, Lisa A Carey, Howard L McLeod.
Nat Rev Cancer, 2009 Jul 25; 9(8). PMID: 19629072
Highly Cited. Review.
Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.
Y Park, K Okamura, +16 authors, T Suzuki.
Br J Cancer, 2009 Jul 30; 101(4). PMID: 19638976    Free PMC article.
Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Christine L H Snozek, Dennis J O'Kane, Alicia Algeciras-Schimnich.
J Mol Diagn, 2009 Aug 01; 11(5). PMID: 19644023    Free PMC article.
Review.
Genotype-guided tamoxifen therapy: time to pause for reflection?
Timothy L Lash, Ernst A Lien, Henrik Toft Sørensen, Stephen Hamilton-Dutoit.
Lancet Oncol, 2009 Aug 04; 10(8). PMID: 19647203    Free PMC article.
Review.
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Fatima Cardoso, Philippe L Bedard, +8 authors, ESO-MBC Task Force.
J Natl Cancer Inst, 2009 Aug 07; 101(17). PMID: 19657108    Free PMC article.
Review.
Inference of Tamoxifen's Effects on Prevention of Breast Cancer from a Randomized Controlled Trial.
Yu Shen, Jing Qin, Joseph P Costantino.
J Am Stat Assoc, 2007 Dec 01; 102(480). PMID: 19662105    Free PMC article.
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
Ji-Yeob Choi, William E Barlow, +14 authors, Christine B Ambrosone.
Clin Cancer Res, 2009 Aug 13; 15(16). PMID: 19671875    Free PMC article.
Tamoxifen: the drug that came in from the cold.
L Hughes-Davies, C Caldas, G C Wishart.
Br J Cancer, 2009 Aug 13; 101(6). PMID: 19672259    Free PMC article.
Review.
An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
S Verma, S Sehdev, +3 authors, J A Roy.
Curr Oncol, 2009 Aug 13; 16 Suppl 2. PMID: 19672416    Free PMC article.
No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications.
Thomas P Ahern, Lars Pedersen, +2 authors, Timothy L Lash.
Cancer Epidemiol Biomarkers Prev, 2009 Aug 20; 18(9). PMID: 19690182    Free PMC article.
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
BIG 1-98 Collaborative Group, Henning Mouridsen, +10 authors, Alan S Coates.
N Engl J Med, 2009 Aug 21; 361(8). PMID: 19692688    Free PMC article.
Highly Cited.
Biological determinants of endocrine resistance in breast cancer.
Elizabeth A Musgrove, Robert L Sutherland.
Nat Rev Cancer, 2009 Aug 25; 9(9). PMID: 19701242
Highly Cited. Review.
Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.
G Bertelli, E Hall, +6 authors, J M Bliss.
Ann Oncol, 2009 Sep 01; 21(3). PMID: 19717534    Free PMC article.
Divide and conquer: progress in the molecular stratification of cancer.
Patrick Tan.
Yonsei Med J, 2009 Sep 01; 50(4). PMID: 19718393    Free PMC article.
Review.
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
H E Campbell, M A Taylor, A L Harris, A M Gray.
Br J Cancer, 2009 Sep 03; 101(7). PMID: 19724274    Free PMC article.
Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.
Anne-Sofie Schrohl, Maxime P Look, +2 authors, Nils Brünner.
BMC Cancer, 2009 Sep 12; 9. PMID: 19744322    Free PMC article.
G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.
Adele Vivacqua, Rosamaria Lappano, +6 authors, Marcello Maggiolini.
Mol Endocrinol, 2009 Sep 15; 23(11). PMID: 19749156    Free PMC article.
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women.
Sharath Gangadhara, Gianfilippo Bertelli.
Ther Clin Risk Manag, 2009 Sep 16; 5(4). PMID: 19753124    Free PMC article.
The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.
Muireann T Kelleher, Gilbert Fruhwirth, +10 authors, Tony Ng.
Target Oncol, 2009 Sep 17; 4(3). PMID: 19756916    Free PMC article.
Review.
Prospective meta-analysis using individual patient data in intensive care medicine.
Michael C Reade, Anthony Delaney, +6 authors, Derek C Angus.
Intensive Care Med, 2009 Sep 18; 36(1). PMID: 19760395    Free PMC article.
Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.
Monica Milani, Gautam Jha, David A Potter.
Clin Med Ther, 2009 Oct 02; 1. PMID: 19794821    Free PMC article.
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.
Werner Schroth, Matthew P Goetz, +19 authors, Hiltrud Brauch.
JAMA, 2009 Oct 08; 302(13). PMID: 19809024    Free PMC article.
Highly Cited.
The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.
Philipp Y Maximov, Joan S Lewis-Wambi, V Craig Jordan.
Curr Signal Transduct Ther, 2009 Oct 08; 4(2). PMID: 19809537    Free PMC article.
Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.
Philip Lazarus, Dongxiao Sun.
Drug Metab Rev, 2009 Oct 14; 42(1). PMID: 19821643    Free PMC article.
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
Tiffany A Traina, Hope S Rugo, +17 authors, Maura N Dickler.
J Clin Oncol, 2009 Oct 21; 28(4). PMID: 19841327    Free PMC article.
Breast cancer recurrence in older women five to ten years after diagnosis.
Jaclyn L F Bosco, Timothy L Lash, +6 authors, BOW Investigators.
Cancer Epidemiol Biomarkers Prev, 2009 Oct 22; 18(11). PMID: 19843686    Free PMC article.
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).
Marilyn L Slovak, Victoria Bedell, +8 authors, Wendy Stock.
Breast Cancer Res Treat, 2009 Oct 24; 119(2). PMID: 19851858    Free PMC article.
Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.
Ya-Chen Tina Shih, I-Wen Pan, Yi-Wen Tsai.
Pharmacoeconomics, 2009 Nov 06; 27(11). PMID: 19888794
Update on the use of aromatase inhibitors in early-stage breast cancer.
Georgios Kesisis, Andreas Makris, David Miles.
Breast Cancer Res, 2009 Nov 06; 11(5). PMID: 19889200    Free PMC article.
Review.
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
Patrick G Morris, Maura Dickler, +14 authors, Chau T Dang.
J Clin Oncol, 2009 Nov 11; 27(36). PMID: 19901120    Free PMC article.
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.
Hugo Arias-Pulido, Melanie Royce, +8 authors, Massimo Cristofanilli.
Breast Cancer Res Treat, 2009 Nov 11; 123(1). PMID: 19902352    Free PMC article.
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
T van Agthoven, A M Sieuwerts, +9 authors, L C J Dorssers.
Br J Cancer, 2009 Nov 12; 101(11). PMID: 19904269    Free PMC article.
New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.
V Craig Jordan, Joan S Lewis-Wambi, +2 authors, Eric A Ariazi.
Breast, 2009 Nov 17; 18 Suppl 3. PMID: 19914527    Free PMC article.
Adjuvant endocrine therapy for premenopausal women with breast cancer.
Shannon Puhalla, Adam Brufsky, Nancy Davidson.
Breast, 2009 Nov 17; 18 Suppl 3. PMID: 19914530    Free PMC article.
Review.
Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.
Jonna Frasor, Aisha Weaver, +4 authors, Adina Stanculescu.
Cancer Res, 2009 Nov 19; 69(23). PMID: 19920189    Free PMC article.
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Jeanne S Mandelblatt, Kathleen A Cronin, +17 authors, Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network.
Ann Intern Med, 2009 Nov 19; 151(10). PMID: 19920274    Free PMC article.
Highly Cited.
Relation of risk of contralateral breast cancer to the interval since the first primary tumour.
C Rubino, R Arriagada, S Delaloge, M G Lê.
Br J Cancer, 2009 Nov 19; 102(1). PMID: 19920826    Free PMC article.
CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.
H Jernström, E Bågeman, +2 authors, C Ingvar.
Br J Cancer, 2009 Nov 26; 101(11). PMID: 19935798    Free PMC article.
The size of the prize for earlier diagnosis of cancer in England.
M A Richards.
Br J Cancer, 2009 Dec 04; 101 Suppl 2. PMID: 19956156    Free PMC article.
Secondary malignancies across the age spectrum.
Andrea K Ng, Lisa B Kenney, Ethel S Gilbert, Lois B Travis.
Semin Radiat Oncol, 2009 Dec 05; 20(1). PMID: 19959033    Free PMC article.
Review.
Expectations, validity, and reality in pharmacogenetics.
Nita A Limdi, David L Veenstra.
J Clin Epidemiol, 2009 Dec 10; 63(9). PMID: 19995676    Free PMC article.
Review.
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis.
J Clin Oncol, 2009 Dec 10; 28(2). PMID: 19996031    Free PMC article.
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
Joseph A Sparano, Lori J Goldstein, +12 authors, Robert Gray.
Clin Cancer Res, 2009 Dec 10; 15(24). PMID: 19996222    Free PMC article.
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
Philippe L Bedard, Angelo Di Leo, Martine J Piccart-Gebhart.
Nat Rev Clin Oncol, 2009 Dec 10; 7(1). PMID: 19997076
Review.
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Kathy S Albain, William E Barlow, +18 authors, Breast Cancer Intergroup of North America.
Lancet, 2009 Dec 17; 374(9707). PMID: 20004966    Free PMC article.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Relative dose intensity delivered to patients with early breast cancer: Canadian experience.
S Raza, S Welch, J Younus.
Curr Oncol, 2009 Dec 18; 16(6). PMID: 20016741    Free PMC article.
Who would have thought a single Ki67 measurement would predict long-term outcome?
Mitch Dowsett, Roger A'Hern, +2 authors, Ian E Smith.
Breast Cancer Res, 2010 Jan 20; 11 Suppl 3. PMID: 20030866    Free PMC article.
Tailored targeted therapy for all: a realistic and worthwhile objective against.
Kathleen I Pritchard.
Breast Cancer Res, 2010 Jan 20; 11 Suppl 3. PMID: 20030883    Free PMC article.
Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradient liposomes in a multiple myeloma experimental model.
Giorgia Urbinati, Davide Audisio, +5 authors, Jack-Michel Renoir.
Pharm Res, 2009 Dec 25; 27(2). PMID: 20033476
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.
Marieke E Straver, Philip Meijnen, +11 authors, Emiel J T Rutgers.
J Clin Oncol, 2009 Dec 30; 28(5). PMID: 20038733    Free PMC article.
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy.
Ching-hung Lin, Huang-chun Lien, +7 authors, Chiun-sheng Huang.
J Zhejiang Univ Sci B, 2010 Jan 01; 11(1). PMID: 20043345    Free PMC article.
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer.
Jens Huober, Werner Fett, +7 authors, Andreas Rost.
BMC Cancer, 2010 Jan 06; 10. PMID: 20047698    Free PMC article.
Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.
Christian Schindlbeck, D Mayr, +7 authors, K Friese.
J Cancer Res Clin Oncol, 2010 Jan 07; 136(7). PMID: 20052594
Variations among experienced surgeons in cancer control after open radical prostatectomy.
Fernando J Bianco, Andrew J Vickers, +4 authors, Peter T Scardino.
J Urol, 2010 Jan 20; 183(3). PMID: 20083278    Free PMC article.
Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
P Hadji, M Ziller, U S Albert, M Kalder.
Br J Cancer, 2010 Jan 21; 102(4). PMID: 20087347    Free PMC article.
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.
Yang Li, Lihua Zou, +9 authors, Zhigang Charles Wang.
Nat Med, 2010 Jan 26; 16(2). PMID: 20098429    Free PMC article.
Highly Cited.
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer.
Ebru Sari, Gulnur Guler, +3 authors, Yavuz Ozisik.
Med Oncol, 2010 Jan 26; 28(1). PMID: 20099049
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Thushangi N Pathiraja, Vered Stearns, Steffi Oesterreich.
J Mammary Gland Biol Neoplasia, 2010 Jan 27; 15(1). PMID: 20101445    Free PMC article.
Review.
Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.
Amanda J Redig, Hidayatullah G Munshi.
Am J Med, 2010 Jan 28; 123(1). PMID: 20102997    Free PMC article.
Review.
Chemotherapy: dose-dense treatment for triple-negative breast cancer.
Eitan Amir, Alberto Ocana, +2 authors, Bostjan Seruga.
Nat Rev Clin Oncol, 2010 Feb 02; 7(2). PMID: 20118978
CYP2D6 testing in breast cancer: ready for prime time?
Nicole M Kuderer, Jeffrey Peppercorn.
Oncology (Williston Park), 2010 Feb 04; 23(14). PMID: 20120834    Free PMC article.
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.
Kazuma Kiyotani, Taisei Mushiroda, +16 authors, Hitoshi Zembutsu.
J Clin Oncol, 2010 Feb 04; 28(8). PMID: 20124171    Free PMC article.
Acute promyelocytic leukemia in a young patient with breast cancer.
Ozgur Kara, Evren Ozdemir, +2 authors, Kadri Altundag.
Med Oncol, 2010 Feb 09; 28(1). PMID: 20140540
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
Catherine M Kelly, David N Juurlink, +4 authors, Lawrence F Paszat.
BMJ, 2010 Feb 10; 340. PMID: 20142325    Free PMC article.
Highly Cited.
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
Zaida Garcia-Casado, Angel Guerrero-Zotano, +12 authors, Jose A Lopez-Guerrero.
BMC Cancer, 2010 Feb 11; 10. PMID: 20144226    Free PMC article.
Breast and prostate cancer: more similar than different.
Gail P Risbridger, Ian D Davis, Stephen N Birrell, Wayne D Tilley.
Nat Rev Cancer, 2010 Feb 12; 10(3). PMID: 20147902
Review.
Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
Timothy L Lash, Deirdre Cronin-Fenton, +8 authors, Lars Pedersen.
Acta Oncol, 2010 Feb 17; 49(3). PMID: 20156115    Free PMC article.
Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.
Ying Liu, Maria Pérez, +6 authors, Donna B Jeffe.
Cancer Epidemiol Biomarkers Prev, 2010 Feb 18; 19(3). PMID: 20160274    Free PMC article.
Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
Janie M Lee, Pamela M McMahon, +5 authors, G Scott Gazelle.
Radiology, 2010 Feb 24; 254(3). PMID: 20177093    Free PMC article.
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.
Robert J Paridaens, Shari Gelber, +7 authors, Aron Goldhirsch.
Breast Cancer Res Treat, 2010 Mar 03; 123(1). PMID: 20195744    Free PMC article.
Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate.
Fausto Petrelli, Sandro Barni.
Med Oncol, 2010 Mar 03; 28(2). PMID: 20195801
Review.
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis.
Rinaa S Punglia, Akiko M Saito, +2 authors, Jane C Weeks.
BMJ, 2010 Mar 04; 340. PMID: 20197326    Free PMC article.
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins.
Hideki Asakawa, Hirotaka Koizumi, +5 authors, Tomohiko Ohta.
Breast Cancer Res, 2010 Mar 09; 12(2). PMID: 20205718    Free PMC article.
Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Yin Li, Lutz Birnbaumer, Christina T Teng.
Mol Endocrinol, 2010 Mar 10; 24(5). PMID: 20211987    Free PMC article.
Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation.
Jeon-Hor Chen, Ke Nie, +6 authors, Min-Ying Su.
Radiology, 2010 Mar 24; 255(1). PMID: 20308443    Free PMC article.
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
Lee G Wilke, Karla V Ballman, +7 authors, Kelly K Hunt.
Ann Surg Oncol, 2010 Mar 24; 17(8). PMID: 20309640    Free PMC article.
Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen.
Philipp Y Maximov, Cynthia B Myers, +2 authors, V Craig Jordan.
J Med Chem, 2010 Mar 26; 53(8). PMID: 20334368    Free PMC article.
Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
Arash Naeim, F Lennie Wong, Sumanta K Pal, Arti Hurria.
Clin Breast Cancer, 2010 Apr 01; 10(2). PMID: 20353934    Free PMC article.
Plasma membrane proteomics and its application in clinical cancer biomarker discovery.
Rikke Leth-Larsen, Rikke R Lund, Henrik J Ditzel.
Mol Cell Proteomics, 2010 Apr 13; 9(7). PMID: 20382631    Free PMC article.
Review.
Control of mammary stem cell function by steroid hormone signalling.
Marie-Liesse Asselin-Labat, François Vaillant, +8 authors, Jane E Visvader.
Nature, 2010 Apr 13; 465(7299). PMID: 20383121
Highly Cited.
Risk of Parkinson's disease after tamoxifen treatment.
Jeanne C Latourelle, Merete Dybdahl, +2 authors, Timothy L Lash.
BMC Neurol, 2010 Apr 14; 10. PMID: 20385012    Free PMC article.
Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?
Gul Basaran, Cabuk Devrim, +9 authors, Serdar N Turhal.
Med Oncol, 2010 Apr 15; 28(3). PMID: 20390469
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, +18 authors, National Surgical Adjuvant Breast and Bowel Project.
Cancer Prev Res (Phila), 2010 Apr 21; 3(6). PMID: 20404000    Free PMC article.
Highly Cited.
Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer.
Daphne T Tsoi, Miho Inoue, +2 authors, Kathleen I Pritchard.
Oncologist, 2010 Apr 28; 15(5). PMID: 20421264    Free PMC article.
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance.
Michaela J Higgins, Vered Stearns.
Curr Oncol Rep, 2010 Apr 29; 12(1). PMID: 20425602
Review.
Coprescription of tamoxifen and medications that inhibit CYP2D6.
Kostandinos Sideras, James N Ingle, +7 authors, Matthew P Goetz.
J Clin Oncol, 2010 May 05; 28(16). PMID: 20439629    Free PMC article.
Review.
A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.
Ying Liu, Maria Pérez, +4 authors, Donna B Jeffe.
Breast Cancer Res Treat, 2010 May 07; 124(3). PMID: 20446031    Free PMC article.
Mechanisms of resistance to hormonal treatment in breast cancer.
P Eroles, A Bosch, B Bermejo, A Lluch.
Clin Transl Oncol, 2010 May 14; 12(4). PMID: 20462833
Review.
Current controversies in the management of breast cancer.
I Tusquets, L García-Estévez, +17 authors, A Lluch.
Clin Transl Oncol, 2010 May 14; 12(4). PMID: 20462837
Review.
CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.
Katrín A Gunnarsdóttir, Maj-Britt Jensen, +5 authors, Bent Ejlertsen.
Breast Cancer Res Treat, 2010 May 14; 123(1). PMID: 20464479    Free PMC article.
Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives.
Richard R Love.
Oncology (Williston Park), 2010 May 15; 24(4). PMID: 20464842    Free PMC article.
Review.
Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.
Andrea Veronesi, Gianmaria Miolo, +4 authors, Davide Lombardi.
BMC Cancer, 2010 May 18; 10. PMID: 20470379    Free PMC article.
Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview.
Michael Hubalek, Christine Brantner, Christian Marth.
Wien Med Wochenschr, 2010 May 18; 160(7-8). PMID: 20473727
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
Eunjung Lee, Peter Nichols, +2 authors, Amy S Lee.
Int J Cancer, 2010 May 18; 128(3). PMID: 20473863    Free PMC article.
Forecasting drug utilization and expenditure in a metropolitan health region.
Björn Wettermark, Marie E Persson, +7 authors, Regional Drug Expert Consortium in Stockholm County Council.
BMC Health Serv Res, 2010 May 19; 10. PMID: 20478043    Free PMC article.
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.
Sherry X Yang, Joseph P Costantino, +7 authors, Sandra M Swain.
J Clin Oncol, 2010 May 19; 28(18). PMID: 20479407    Free PMC article.
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.
Gina M Bernardo, Kristen L Lozada, +10 authors, Ruth A Keri.
Development, 2010 May 27; 137(12). PMID: 20501593    Free PMC article.
Highly Cited.
Managing aromatase inhibitors in breast cancer survivors: not just for oncologists.
Julia A Files, Marcia G Ko, Sandhya Pruthi.
Mayo Clin Proc, 2010 Jun 01; 85(6). PMID: 20511486    Free PMC article.
Review.
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
Jeanne S Mandelblatt, Vanessa B Sheppard, +17 authors, Cancer Leukemia Group B.
J Clin Oncol, 2010 Jun 03; 28(19). PMID: 20516438    Free PMC article.
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
Sandra M Swain, Jong-Hyeon Jeong, +14 authors, Norman Wolmark.
N Engl J Med, 2010 Jun 04; 362(22). PMID: 20519679    Free PMC article.
Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.
Patricia R Blank, Konstantin J Dedes, Thomas D Szucs.
Pharmacoeconomics, 2010 Jun 08; 28(8). PMID: 20524722
Systematic Review.
Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer.
Kenichi Sakurai, Katsuhisa Enomoto, Sadao Amano.
J Cancer Res Clin Oncol, 2010 Jun 10; 137(4). PMID: 20532911
Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.
Wen-Bin Zhou, Hong Yin, +8 authors, Shui Wang.
BMC Cancer, 2010 Jun 15; 10. PMID: 20540745    Free PMC article.
Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.
Charles Ferté, Fabrice André, Jean-Charles Soria.
Nat Rev Clin Oncol, 2010 Jun 17; 7(7). PMID: 20551944
Review.
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Judy E Garber, Susan Halabi, +16 authors, Cancer and Leukemia Group B.
J Natl Cancer Inst, 2010 Jun 18; 102(13). PMID: 20554945    Free PMC article.
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.
Karen J Taylor, Andrew H Sims, +8 authors, Simon P Langdon.
Breast Cancer Res, 2010 Jun 24; 12(3). PMID: 20569502    Free PMC article.
Underuse of anthracyclines in women with HER-2+ advanced breast cancer.
Filippo Montemurro, Valentina Rossi, +10 authors, Massimo Aglietta.
Oncologist, 2010 Jun 26; 15(7). PMID: 20576644    Free PMC article.
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, +7 authors, Alfred I Neugut.
J Clin Oncol, 2010 Jun 30; 28(27). PMID: 20585090    Free PMC article.
Highly Cited.
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
Edward B Garon, Richard S Finn, +10 authors, Dennis J Slamon.
Mol Cancer Ther, 2010 Jul 01; 9(7). PMID: 20587667    Free PMC article.
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.
Hege G Russnes, Hans Kristian Moen Vollan, +20 authors, Anne-Lise Børresen-Dale.
Sci Transl Med, 2010 Jul 02; 2(38). PMID: 20592421    Free PMC article.
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.
N L Henry, D Pchejetski, +9 authors, J Stebbing.
Br J Cancer, 2010 Jul 08; 103(3). PMID: 20606683    Free PMC article.
Lapatinib: in postmenopausal women with hormone receptor-positive, HER2-positive metastatic breast cancer.
Monique P Curran.
Drugs, 2010 Jul 10; 70(11). PMID: 20614948
Review.
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.
John M S Bartlett, Jeremy Thomas, +12 authors, Udi Chetty.
Breast Cancer Res, 2010 Jul 10; 12(4). PMID: 20615243    Free PMC article.
Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.
Yen Ling Low, Yuqing Li, +14 authors, Jianjun Liu.
PLoS Genet, 2010 Jul 10; 6(7). PMID: 20617168    Free PMC article.
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Harold J Burstein, Ann Alexis Prestrud, +16 authors, American Society of Clinical Oncology.
J Clin Oncol, 2010 Jul 14; 28(23). PMID: 20625130    Free PMC article.
Highly Cited. Systematic Review.
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome.
Shaheenah Dawood, Yun Gong, +7 authors, Massimo Cristofanilli.
Breast J, 2010 Jul 16; 16(5). PMID: 20626396    Free PMC article.
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.
Hazem Ghebeh, Cynthia Lehe, +9 authors, Said Dermime.
Breast Cancer Res, 2010 Jul 16; 12(4). PMID: 20626886    Free PMC article.
Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole.
William R Miller, Alexey Larionov.
Breast Cancer Res, 2010 Jul 22; 12(4). PMID: 20646288    Free PMC article.
Personalized tamoxifen: a step closer but miles to go.
Aditya Bardia, Vered Stearns.
Clin Cancer Res, 2010 Jul 24; 16(17). PMID: 20651057    Free PMC article.
Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival.
Colin S McArdle, Donald C McMillan, Nicola Greenlaw, David S Morrison.
BMC Cancer, 2010 Aug 03; 10. PMID: 20673353    Free PMC article.
Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.
Rinaa S Punglia, Michael J Hassett.
J Clin Oncol, 2010 Aug 11; 28(27). PMID: 20697089    Free PMC article.
Does race affect outcomes in triple negative breast cancer?
Jasgit C Sachdev, Saira Ahmed, +3 authors, Mohammad Jahanzeb.
Breast Cancer (Auckl), 2010 Aug 11; 4. PMID: 20697530    Free PMC article.
Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.
Y H Chia, M J Ellis, C X Ma.
Br J Cancer, 2010 Aug 12; 103(6). PMID: 20700118    Free PMC article.
Review.
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.
Diana S M Buist, Linn A Abraham, +7 authors, Breast Cancer Surveillance Consortium.
Breast Cancer Res Treat, 2010 Aug 12; 124(3). PMID: 20700648    Free PMC article.
Selectively targeting estrogen receptors for cancer treatment.
Erin K Shanle, Wei Xu.
Adv Drug Deliv Rev, 2010 Aug 17; 62(13). PMID: 20708050    Free PMC article.
Review.
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
Rowan T Chlebowski, Garnet L Anderson, +13 authors, Marcia L Stefanick.
J Natl Cancer Inst, 2010 Aug 17; 102(18). PMID: 20709992    Free PMC article.
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study.
Shaheenah Dawood, Rong Hu, +5 authors, Rulla M Tamimi.
Breast Cancer Res Treat, 2010 Aug 17; 126(1). PMID: 20711652    Free PMC article.
A model building exercise of mortality risk for Taiwanese women with breast cancer.
Tsai W Chang, Yao L Kuo.
BMC Med Inform Decis Mak, 2010 Aug 21; 10. PMID: 20723238    Free PMC article.
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.
Jean E Abraham, Mel J Maranian, +11 authors, Carlos Caldas.
Breast Cancer Res, 2010 Aug 25; 12(4). PMID: 20731819    Free PMC article.
Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy.
Fumikata Hara, Sachiko Kiyoto, +6 authors, Shigemitsu Takashima.
Case Rep Oncol, 2010 Aug 27; 3(2). PMID: 20740186    Free PMC article.
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, +6 authors, Alfred I Neugut.
Breast Cancer Res Treat, 2010 Aug 31; 126(2). PMID: 20803066    Free PMC article.
Highly Cited.
Rechallenging with anthracyclines and taxanes in metastatic breast cancer.
Carlo Palmieri, Jonathan Krell, +4 authors, David Miles.
Nat Rev Clin Oncol, 2010 Sep 03; 7(10). PMID: 20808300
Review.
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, +2 authors, Thomas Mognetti.
Int J Clin Oncol, 2010 Sep 03; 15(6). PMID: 20809217
Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
H E Campbell, A M Gray, +2 authors, M A Taylor.
Br J Cancer, 2010 Sep 09; 103(6). PMID: 20823886    Free PMC article.
Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer.
Hiltrud Brauch, Werner Schroth, +3 authors, in cooperation with the AGO TRAFO Comission.
Breast Care (Basel), 2008 Jan 01; 3(1). PMID: 20824020    Free PMC article.
Adjuvant Endocrine Therapy in Premenopausal Patients.
Michael Gnant.
Breast Care (Basel), 2008 Jan 01; 3(5). PMID: 20824025    Free PMC article.
Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer.
Christoph Mundhenke, Christian Schem, Walter Jonat.
Breast Care (Basel), 2008 Jan 01; 3(5). PMID: 20824026    Free PMC article.
Mammography Screening and Treatment of Breast Cancer in the Elderly.
Matti Aapro.
Breast Care (Basel), 2008 Jan 01; 3(3). PMID: 20824036    Free PMC article.
Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors.
Tina W F Yen, Linda K Czypinski, +4 authors, Ann B Nattinger.
Cancer, 2010 Sep 09; 117(2). PMID: 20824718    Free PMC article.
Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials.
Christos J Markopoulos.
Cancer Metastasis Rev, 2010 Sep 11; 29(4). PMID: 20830503    Free PMC article.
Review.
A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.
Suzanne J F Kaptein, Tine De Burghgraeve, +10 authors, Johan Neyts.
Antimicrob Agents Chemother, 2010 Sep 15; 54(12). PMID: 20837762    Free PMC article.
Targeted Therapy in Breast Cancer.
Andreas Schneeweiss.
Breast Care (Basel), 2010 Sep 18; 5(3). PMID: 20847825    Free PMC article.
The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.
Richard Greil.
Breast Care (Basel), 2009 Jan 01; 4(3). PMID: 20847873    Free PMC article.
Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?
Alfonso Sánchez-Muñoz, Nuria Ribelles, Emilio Alba.
Clin Transl Oncol, 2010 Sep 21; 12(9). PMID: 20851802
Review.
Editorial: gene expression profile assays as an aid in treatment decision making in early-stage breast cancer.
Gary H Lyman.
J Oncol Pract, 2007 Jul 01; 3(4). PMID: 20859408    Free PMC article.
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies.
Daniel J Toft, Vincent L Cryns.
Mol Endocrinol, 2010 Sep 24; 25(2). PMID: 20861225    Free PMC article.
Review.
Long-term prognostic role of functional limitations among women with breast cancer.
Dejana Braithwaite, William A Satariano, +11 authors, Bette J Caan.
J Natl Cancer Inst, 2010 Sep 24; 102(19). PMID: 20861456    Free PMC article.
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer.
Michael A Jacobs, Vered Stearns, +9 authors, Ronald Ouwerkerk.
Acad Radiol, 2010 Sep 25; 17(12). PMID: 20863721    Free PMC article.
CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic.
Issa Dahabreh, Teruhiko Terasawa, Peter Castaldi, Thomas A Trikalinos.
PLoS Curr, 2010 Sep 30; 2. PMID: 20877451    Free PMC article.
Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany.
Sebastian Braun, Thomas Mittendorf, +2 authors, Johann-Matthias von der Schulenburg.
Breast Care (Basel), 2009 Jan 01; 4(6). PMID: 20877674    Free PMC article.
Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors.
Nazmus Saquib, John P Pierce, +11 authors, Barbara A Parker.
Psychooncology, 2010 Sep 30; 20(3). PMID: 20878837    Free PMC article.
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.
Andre Mattar, Angela Flávia Logullo, +3 authors, Luiz Henrique Gebrim.
J Cancer Res Clin Oncol, 2010 Oct 05; 137(5). PMID: 20886231
Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution.
Nabil Ismaili, Sanaa Elmajjaoui, +10 authors, Hassan Errihani.
BMC Res Notes, 2010 Oct 06; 3. PMID: 20920323    Free PMC article.
Benefits and adverse effects of endocrine therapy.
M Colleoni, A Giobbie-Hurder.
Ann Oncol, 2010 Oct 15; 21 Suppl 7. PMID: 20943602    Free PMC article.
Review.
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C Correa, +8 authors, S Darby.
J Natl Cancer Inst Monogr, 2010 Oct 20; 2010(41). PMID: 20956824    Free PMC article.
Highly Cited. Review.
G protein-coupled receptor 30 in tumor development.
Dengfeng Wang, Lina Hu, +2 authors, Chen Chen.
Endocrine, 2010 Oct 21; 38(1). PMID: 20960099
Review.
Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.
Xianglin L Du, Rui Xia, Keith Burau, Chih-Chin Liu.
Med Oncol, 2010 Oct 23; 28 Suppl 1. PMID: 20967512
SEOM clinical guidelines for the treatment of early breast cancer.
Sonia del Barco Berrón, Eva Ciruelos Gil, +5 authors, SEOM (Spanish Society for Medical Oncology).
Clin Transl Oncol, 2010 Oct 27; 12(11). PMID: 20974561
Breast cancer assessment tools and optimizing adjuvant therapy.
Catherine Oakman, Libero Santarpia, Angelo Di Leo.
Nat Rev Clin Oncol, 2010 Oct 27; 7(12). PMID: 20975745
Review.
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.
S-E Al-Batran, M Güntner, +7 authors, E Jäger.
Br J Cancer, 2010 Oct 28; 103(10). PMID: 20978502    Free PMC article.
Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
José M A Moreira, Teresa Cabezón, +7 authors, Julio E Celis.
Mol Oncol, 2010 Nov 03; 4(6). PMID: 21036680    Free PMC article.
Breast cancer in the personal genomics era.
Rachel E Ellsworth, David J Decewicz, Craig D Shriver, Darrell L Ellsworth.
Curr Genomics, 2010 Nov 03; 11(3). PMID: 21037853    Free PMC article.
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider.
Pelagia G Tsoutsou, Yazid Belkacemi, +5 authors, Association of Radiotherapy and Oncology in the Mediterranean area (AROME).
Oncologist, 2010 Nov 03; 15(11). PMID: 21041378    Free PMC article.
Does tumour dormancy offer a therapeutic target?
Paul E Goss, Ann F Chambers.
Nat Rev Cancer, 2010 Nov 05; 10(12). PMID: 21048784
Highly Cited. Review.
The Future of Breast Cancer Management.
Nadia Harbeck, Raimund Jakesz, Christoph Thomssen.
Breast Care (Basel), 2008 Jan 01; 3(6). PMID: 21048905    Free PMC article.
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?
Mustafa Khasraw, Edi Brogi, Andrew D Seidman.
Curr Oncol Rep, 2010 Nov 06; 13(1). PMID: 21053108
Review.
Breast cancer in moroccan young women: a retrospective study.
Halima Abahssain, Issam Lalya, +8 authors, Hassan Errihani.
BMC Res Notes, 2010 Nov 10; 3. PMID: 21059204    Free PMC article.
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.
Kelly Graham, Xijin Ge, +2 authors, Carol L Rosenberg.
Clin Cancer Res, 2010 Nov 10; 17(2). PMID: 21059815    Free PMC article.
Breast cancer in young women.
Courtney A Gabriel, Susan M Domchek.
Breast Cancer Res, 2010 Nov 12; 12(5). PMID: 21067532    Free PMC article.
Review.
Characteristics of triple-negative breast cancer.
Tim C de Ruijter, Jürgen Veeck, +2 authors, Vivianne C Tjan-Heijnen.
J Cancer Res Clin Oncol, 2010 Nov 12; 137(2). PMID: 21069385    Free PMC article.
Review.
Node-Negative Breast Cancer: Which Patients Should Be Treated?
Marcus Schmidt.
Breast Care (Basel), 2008 Jan 01; 3(4). PMID: 21076603    Free PMC article.
Node-positive Breast Cancer: Which Are the Best Chemotherapy Regimens?
Wolfgang Janni, Brigitte Rack, +3 authors, Klaus Friese.
Breast Care (Basel), 2008 Jan 01; 3(4). PMID: 21076604    Free PMC article.
CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Xi-ru Li, Mei Liu, +5 authors, Xin Song.
Med Oncol, 2010 Nov 17; 28 Suppl 1. PMID: 21080107
Triple-negative breast cancer: epidemiology and management options.
Shaheenah Dawood.
Drugs, 2010 Nov 18; 70(17). PMID: 21080741
Review.
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Lyndsay V Rhodes, James W Antoon, +3 authors, Matthew E Burow.
Mol Cancer, 2010 Nov 23; 9. PMID: 21087507    Free PMC article.
Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Luisa Bonilla, Irit Ben-Aharon, +3 authors, Salomon M Stemmer.
J Natl Cancer Inst, 2010 Nov 26; 102(24). PMID: 21098761    Free PMC article.
Systematic Review.
Optimizing dose-dense regimens for early-stage breast cancer.
Patrick G Morris, Clifford A Hudis.
Nat Rev Clin Oncol, 2010 Dec 01; 7(12). PMID: 21116238
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
Henne Holstege, Hugo M Horlings, +5 authors, Jos Jonkers.
BMC Cancer, 2010 Dec 02; 10. PMID: 21118481    Free PMC article.
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
Nicolien T van Ravesteyn, Clyde B Schechter, +5 authors, Jeanne S Mandelblatt.
Cancer Epidemiol Biomarkers Prev, 2010 Dec 02; 20(1). PMID: 21119071    Free PMC article.
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.
Lyndsay V Rhodes, Sarah P Short, +26 authors, Matthew E Burow.
Cancer Res, 2010 Dec 03; 71(2). PMID: 21123450    Free PMC article.
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
M A Vollebergh, E H Lips, +15 authors, S C Linn.
Ann Oncol, 2010 Dec 08; 22(7). PMID: 21135055    Free PMC article.
Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.
Jonathan Karnon, Tazio Vanni.
Pharmacoeconomics, 2010 Dec 15; 29(1). PMID: 21142278
Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.
Paul D Gobardhan, Sjoerd G Elias, +11 authors, Thijs van Dalen.
Ann Surg Oncol, 2010 Dec 15; 18(6). PMID: 21153885    Free PMC article.
Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Song Yao, William E Barlow, +15 authors, Christine B Ambrosone.
Clin Cancer Res, 2010 Dec 21; 16(24). PMID: 21169260    Free PMC article.
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.
Diana M Cittelly, Partha M Das, +4 authors, Frank E Jones.
Mol Cancer, 2010 Dec 22; 9. PMID: 21172025    Free PMC article.
Highly Cited.
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
Kathleen I Pritchard.
Breast Cancer Res, 2011 Jan 05; 12 Suppl 4. PMID: 21172080    Free PMC article.
Are current development programs realising the full potential of new agents?
Per Eystein Lønning.
Breast Cancer Res, 2011 Jan 05; 12 Suppl 4. PMID: 21172086    Free PMC article.
High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
Beate C Litzenburger, Chad J Creighton, +10 authors, Adrian V Lee.
Clin Cancer Res, 2010 Dec 24; 17(8). PMID: 21177763    Free PMC article.
Tailoring adjuvant endocrine therapy for postmenopausal breast cancer: a CYP2D6 multiple-genotype-based modeling analysis and validation.
Ke-Da Yu, A-Ji Huang, Zhi-Ming Shao.
PLoS One, 2010 Dec 29; 5(12). PMID: 21187922    Free PMC article.
FACE: the barefaced facts of AI potency.
Alain Monnier.
Cancer Manag Res, 2010 Dec 29; 2. PMID: 21188118    Free PMC article.
Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.
Michael F Press, Guido Sauter, +17 authors, Dennis J Slamon.
J Clin Oncol, 2010 Dec 30; 29(7). PMID: 21189395    Free PMC article.
Menstruation recovery after chemotherapy and luteinizing hormone-releasing hormone agonist plus tamoxifen therapy for premenopausal patients with breast cancer.
Kenichi Sakurai, Sadanori Matsuo, +2 authors, Motomi Shiono.
Surg Today, 2010 Dec 31; 41(1). PMID: 21191690
Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.
H Irene Su, Karine Chung, +2 authors, Angela DeMichele.
Fertil Steril, 2011 Jan 05; 95(5). PMID: 21193192    Free PMC article.
Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results.
Arun Kumar Goel, Malay Nandy, Gopal Sharma.
Indian J Med Paediatr Oncol, 2011 Jan 06; 31(3). PMID: 21206711    Free PMC article.
Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.
C Kent Osborne, Patrick Neven, +10 authors, Mark Sellers.
Clin Cancer Res, 2011 Jan 12; 17(5). PMID: 21220480    Free PMC article.
Arzoxifene: the evidence for its development in the management of breast cancer.
Lee R Jackson, Kwok L Cheung, Aman U Buzdar, John F R Robertson.
Core Evid, 2008 Jan 01; 2(4). PMID: 21221190    Free PMC article.
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Gong Tang, Steven Shak, +6 authors, Norman Wolmark.
Breast Cancer Res Treat, 2011 Jan 12; 127(1). PMID: 21221771    Free PMC article.
The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients.
Yousri M Hussein, Amal F Gharib, +3 authors, Wael H Elsawy.
Mol Cell Biochem, 2011 Jan 26; 351(1-2). PMID: 21264495
Breast cancer and fertility preservation.
S Samuel Kim, Jennifer Klemp, Carol Fabian.
Fertil Steril, 2011 Jan 29; 95(5). PMID: 21272867    Free PMC article.
Review.
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Lisa M Arendt, Debra E Rugowski, +3 authors, Linda A Schuler.
Breast Cancer Res, 2011 Feb 01; 13(1). PMID: 21276249    Free PMC article.
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
Donal J Brennan, Henriette Laursen, +7 authors, Karin Jirström.
Breast Cancer Res, 2011 Feb 02; 13(1). PMID: 21281480    Free PMC article.
Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.
Lili Bao, Aliyya Haque, +4 authors, Srikanta Dash.
Am J Pathol, 2011 Feb 02; 178(2). PMID: 21281816    Free PMC article.
A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.
Sutapa Sinha, Sayantani Roy, +10 authors, Rajkumar Banerjee.
Mol Cancer Res, 2011 Feb 04; 9(3). PMID: 21289296    Free PMC article.
Measuring the performance of markers for guiding treatment decisions.
Holly Janes, Margaret S Pepe, Patrick M Bossuyt, William E Barlow.
Ann Intern Med, 2011 Feb 16; 154(4). PMID: 21320940    Free PMC article.
CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.
Timothy L Lash, Deirdre Cronin-Fenton, +9 authors, Stephen Hamilton-Dutoit.
J Natl Cancer Inst, 2011 Feb 18; 103(6). PMID: 21325141    Free PMC article.
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.
P Karlsson, Z Sun, +14 authors, A Goldhirsch.
Ann Oncol, 2011 Feb 18; 22(10). PMID: 21325445    Free PMC article.
The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.
Kemal Atahan, Hakan Küpeli, +6 authors, Ercüment Tarcan.
Int J Med Sci, 2011 Feb 18; 8(2). PMID: 21326957    Free PMC article.
Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.
Yong Wha Moon, Seho Park, +5 authors, Byeong-Woo Park.
J Cancer Res Clin Oncol, 2011 Feb 18; 137(7). PMID: 21327800
Increasingly strong reduction in breast cancer mortality due to screening.
G van Schoor, S M Moss, +6 authors, A L M Verbeek.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343930    Free PMC article.
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
J Rosell, B Nordenskjöld, +7 authors, J Carstensen.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343938    Free PMC article.
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer.
Heather L McArthur, Hope Rugo, +30 authors, Maura N Dickler.
Clin Cancer Res, 2011 Feb 26; 17(10). PMID: 21350003    Free PMC article.
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.
Cesar G Sanchez, Cynthia X Ma, +5 authors, Matthew J Ellis.
Breast Cancer Res, 2011 Mar 03; 13(2). PMID: 21362200    Free PMC article.
Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
Philippe L Bedard, Fatima Cardoso.
Nat Rev Clin Oncol, 2011 Mar 03; 8(5). PMID: 21364525
Review.
Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?
J Geisler.
Br J Cancer, 2011 Mar 03; 104(7). PMID: 21364577    Free PMC article.
Review.
Predictive markers in primary breast cancer compared with lymph node and bloodspread metastases.
Mohammad F El-Sibai, Cynthia Cohen, +2 authors, Momin T Siddiqui.
Int J Physiol Pathophysiol Pharmacol, 2009 Jan 01; 1(1). PMID: 21383878    Free PMC article.
Taming the dragon: genomic biomarkers to individualize the treatment of cancer.
Ian J Majewski, René Bernards.
Nat Med, 2011 Mar 10; 17(3). PMID: 21386834
Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.
Catherine Schairer, Linda M Brown, Phuong L Mai.
Breast Cancer Res Treat, 2011 Mar 11; 129(1). PMID: 21390499    Free PMC article.
ER-/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection.
Wei Ying, Sumeng Wang, Junfeng Shi, Yujie Sun.
Med Oncol, 2011 Mar 15; 29(2). PMID: 21399998
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Hazel B Nichols, Amy Berrington de González, +2 authors, William F Anderson.
J Clin Oncol, 2011 Mar 16; 29(12). PMID: 21402610    Free PMC article.
Lack of survival gain for elderly women with breast cancer.
Esther Bastiaannet, Johanneke E A Portielje, +8 authors, Gerrit-Jan Liefers.
Oncologist, 2011 Mar 17; 16(4). PMID: 21406470    Free PMC article.
Early breast cancer in the older woman.
Sonal Gandhi, Sunil Verma.
Oncologist, 2011 Mar 19; 16(4). PMID: 21415085    Free PMC article.
Review.
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
Jonas A de Souza, Olufunmilayo I Olopade.
Semin Oncol, 2011 Mar 23; 38(2). PMID: 21421116    Free PMC article.
Review.
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.
John M S Bartlett, Cassandra L Brookes, +15 authors, Daniel Rea.
J Clin Oncol, 2011 Mar 23; 29(12). PMID: 21422407    Free PMC article.
Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.
L Livi, I Meattini, +12 authors, G Biti.
Radiol Med, 2011 Mar 23; 116(7). PMID: 21424317
Socioeconomic status and survival after an invasive breast cancer diagnosis.
Brian L Sprague, Amy Trentham-Dietz, +5 authors, Polly A Newcomb.
Cancer, 2011 Mar 23; 117(7). PMID: 21425155    Free PMC article.
Genomics and drug response.
Liewei Wang, Howard L McLeod, Richard M Weinshilboum.
N Engl J Med, 2011 Mar 25; 364(12). PMID: 21428770    Free PMC article.
Highly Cited. Review.
The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
Mauro De Santi, Luca Galluzzi, +8 authors, Mauro Magnani.
Breast Cancer Res, 2011 Mar 26; 13(2). PMID: 21435243    Free PMC article.
Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care.
R Peto.
Br J Cancer, 2011 Mar 31; 104(7). PMID: 21448174    Free PMC article.
Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?
Rusen Cosar, Cem Uzal, +10 authors, Zafer Kocak.
Radiat Oncol, 2011 Apr 01; 6. PMID: 21450076    Free PMC article.
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.
Sang Woo Oh, Cheol-Young Park, +10 authors, Jungsil Ro.
Breast Cancer Res, 2011 Apr 01; 13(2). PMID: 21450081    Free PMC article.
Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.
Hideo Shigematsu, Hidetoshi Kawaguchi, +7 authors, Shinji Ohno.
BMC Cancer, 2011 Apr 02; 11. PMID: 21453503    Free PMC article.
Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis.
Sonja Eaker, Annette Wigertz, +4 authors, Uppsala/Örebro Breast Cancer Group.
PLoS One, 2011 Apr 12; 6(3). PMID: 21479209    Free PMC article.
Killer cell immunoglobulin-like receptor genes in patients with breast cancer.
Ozlem Goruroglu Ozturk, Faik Deniz Gun, Gurbuz Polat.
Med Oncol, 2011 Apr 12; 29(2). PMID: 21479698
Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.
Joanne S L Lim, Xiang A Chen, +6 authors, Balram Chowbay.
Br J Clin Pharmacol, 2011 Apr 13; 71(5). PMID: 21480951    Free PMC article.
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.
Eva J Kantelhardt, Martina Vetter, +12 authors, Nadia Harbeck.
BMC Cancer, 2011 Apr 19; 11. PMID: 21496284    Free PMC article.
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Tanya B Dorff, Thomas W Flaig, +10 authors, L Michael Glode.
J Clin Oncol, 2011 Apr 20; 29(15). PMID: 21502546    Free PMC article.
A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735.
L M Bernard, S Verma, +4 authors, S E Jones.
Curr Oncol, 2011 Apr 21; 18(2). PMID: 21505597    Free PMC article.
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
Julie Millour, Natalia de Olano, +5 authors, Eric W F Lam.
Mol Cancer Ther, 2011 Apr 27; 10(6). PMID: 21518729    Free PMC article.
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
L Huiart, S Dell'Aniello, S Suissa.
Br J Cancer, 2011 Apr 28; 104(10). PMID: 21522148    Free PMC article.
Growth of breast cancer recurrences assessed by consecutive MRI.
Ingrid Millet, Emmanuelle Bouic-Pages, +2 authors, Patrice Taourel.
BMC Cancer, 2011 Apr 30; 11. PMID: 21527002    Free PMC article.
Factors influencing treatment recommendations in node-negative breast cancer.
Elisabeth Edstrom Elder, Sally Baron Hay, Katrina Moore.
J Oncol Pract, 2011 May 03; 7(1). PMID: 21532807    Free PMC article.
Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
Ada Ao, Brian J Morrison, +3 authors, Jianrong Lu.
PLoS One, 2011 May 03; 6(4). PMID: 21533195    Free PMC article.
Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis.
Kelly E Mercer, Eugene O Apostolov, +7 authors, Susan A Kadlubar.
Int J Mol Epidemiol Genet, 2010 Jan 01; 1(2). PMID: 21537383    Free PMC article.
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection.
Carmen Criscitiello, Debora Fumagalli, Kamal S Saini, Sherene Loi.
Onco Targets Ther, 2011 May 10; 4. PMID: 21552410    Free PMC article.
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.
Ying Liu, Maria Pérez, +3 authors, Donna B Jeffe.
Breast Cancer Res Treat, 2011 May 10; 130(1). PMID: 21553295    Free PMC article.
Breast cancer adjuvant therapy: time to consider its time-dependent effects.
Ismail Jatoi, William F Anderson, Jong-Hyeon Jeong, Carol K Redmond.
J Clin Oncol, 2011 May 11; 29(17). PMID: 21555693    Free PMC article.
Preoperative chemotherapy for operable breast cancer improves surgical outcomes in the community hospital setting.
Ian K Komenaka, Michael L Hibbard, +4 authors, Chandra Jha.
Oncologist, 2011 May 12; 16(6). PMID: 21558133    Free PMC article.
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.
P N Munster, K T Thurn, +8 authors, S E Minton.
Br J Cancer, 2011 May 12; 104(12). PMID: 21559012    Free PMC article.
Highly Cited.
All nodes lead to chemo...
Lidia Schapira, Michaela J Higgins.
Oncologist, 2011 May 19; 16(5). PMID: 21586662    Free PMC article.
HER2 status in breast cancer: experience of a Spanish National Reference Centre.
Marta Cuadros, Carlos Cano, +4 authors, Ángel Concha.
Clin Transl Oncol, 2011 May 21; 13(5). PMID: 21596662
Biologic markers determine both the risk and the timing of recurrence in breast cancer.
Laura J Esserman, Dan H Moore, +11 authors, Christopher C Benz.
Breast Cancer Res Treat, 2011 May 21; 129(2). PMID: 21597921    Free PMC article.
Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.
Jennifer Y Wo, Kun Chen, +2 authors, Rinaa S Punglia.
J Clin Oncol, 2011 May 25; 29(19). PMID: 21606424    Free PMC article.
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Alfred I Neugut, Milayna Subar, +5 authors, Dawn L Hershman.
J Clin Oncol, 2011 May 25; 29(18). PMID: 21606426    Free PMC article.
Highly Cited.
Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
Philippe A Cassier, Isabelle Treilleux, +11 authors, Jean-Yves Blay.
BMC Cancer, 2011 Jun 01; 11. PMID: 21624121    Free PMC article.
Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making.
Gretchen Kimmick.
Curr Treat Options Oncol, 2011 Jun 04; 12(3). PMID: 21638199
Review.
Somatic variation and cancer: therapies lost in the mix.
Andrew V Biankin, Thomas J Hudson.
Hum Genet, 2011 Jun 07; 130(1). PMID: 21643984
Review.
The International Core Literature Consensus (ICLC): an alternative curriculum for Oncologists.
Shilpen Patel, Reshma Jagsi, +2 authors, Christine Parkinson.
J Cancer Educ, 2011 Jun 07; 26(3). PMID: 21644006
A CUE hints at tumor resistance.
Christoforos Thomas, Jan-Ake Gustafsson.
Nat Med, 2011 Jun 08; 17(6). PMID: 21647141
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres.
Y Madarnas, S F Dent, +5 authors, T Vandenberg.
Curr Oncol, 2011 Jun 10; 18(3). PMID: 21655158    Free PMC article.
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Solange Torchia Carvalho, Monica Maria Stiepcich, +3 authors, Fernando Augusto Soares.
Clinics (Sao Paulo), 2011 Jun 10; 66(4). PMID: 21655754    Free PMC article.
The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis.
Philipp Maximov, Surojeet Sengupta, +3 authors, V Craig Jordan.
Horm Mol Biol Clin Investig, 2011 Jun 11; 5(1). PMID: 21660224    Free PMC article.
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
Emmanouil Saloustros, Maria Perraki, +7 authors, Dimitris Mavroudis.
Breast Cancer Res, 2011 Jun 15; 13(3). PMID: 21663668    Free PMC article.
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.
A Bergamaschi, B S Katzenellenbogen.
Oncogene, 2011 Jun 15; 31(1). PMID: 21666713    Free PMC article.
Highly Cited.
The changing role of pathology in breast cancer diagnosis and treatment.
Anthony S-Y Leong, Zhengping Zhuang.
Pathobiology, 2011 Jun 17; 78(2). PMID: 21677473    Free PMC article.
Review.
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.
Jennifer S Haas, Su-Ying Liang, +3 authors, Kathryn A Phillips.
Breast Cancer Res Treat, 2011 Jun 18; 130(2). PMID: 21681446    Free PMC article.
Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy.
Alíz Nikolényi, Gabriella Uhercsák, +7 authors, Zsuzsanna Kahán.
Pathol Oncol Res, 2011 Jun 18; 18(1). PMID: 21681601
The treatment of early breast cancer in women over the age of 70.
A Ring, M Reed, +6 authors, R Coleman.
Br J Cancer, 2011 Jun 23; 105(2). PMID: 21694726    Free PMC article.
Review.
Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.
Wenjin Yin, Yiwei Jiang, +2 authors, Jinsong Lu.
PLoS One, 2011 Jun 23; 6(6). PMID: 21695277    Free PMC article.
Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.
Deirdre P Cronin-Fenton, Timothy L Lash.
Expert Rev Clin Pharmacol, 2011 Jun 29; 4(3). PMID: 21709817    Free PMC article.
Review.
The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics.
Sarah J Nechuta, Bette J Caan, +9 authors, Xiao Ou Shu.
Cancer Causes Control, 2011 Jun 29; 22(9). PMID: 21710192    Free PMC article.
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.
E K A Millar, P H Graham, +10 authors, R L Sutherland.
Br J Cancer, 2011 Jun 30; 105(2). PMID: 21712826    Free PMC article.
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.
Zhang-Zhi Hu, Benjamin L Kagan, +8 authors, Anton Wellstein.
PLoS One, 2011 Jul 09; 6(6). PMID: 21738574    Free PMC article.
Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.
Suellen J Pommier, Ariel Hernandez, +9 authors, Rodney F Pommier.
Ann Surg Oncol, 2011 Jul 13; 19(2). PMID: 21748247    Free PMC article.
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.
Thomas P Ahern, Mariann Christensen, +9 authors, Stephen Hamilton-Dutoit.
Cancer Epidemiol Biomarkers Prev, 2011 Jul 14; 20(9). PMID: 21750172    Free PMC article.
TP53 status and response to treatment in breast cancers.
Mariana Varna, Guilhem Bousquet, +2 authors, Anne Janin.
J Biomed Biotechnol, 2011 Jul 16; 2011. PMID: 21760703    Free PMC article.
Review.
Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials.
Jordi Ginés, Eliazar Sabater, +3 authors, Miguel A Casado.
Clin Transl Oncol, 2011 Jul 22; 13(7). PMID: 21775276
Review.
Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.
Mary Morrogh, Victor P Andrade, +7 authors, Tari A King.
J Surg Res, 2011 Jul 23; 176(1). PMID: 21777924    Free PMC article.
The different roles of ER subtypes in cancer biology and therapy.
Christoforos Thomas, Jan-Åke Gustafsson.
Nat Rev Cancer, 2011 Jul 23; 11(8). PMID: 21779010
Highly Cited. Review.
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients.
Michael Gnant.
Breast Care (Basel), 2010 Jan 01; 5(5). PMID: 21779211    Free PMC article.
Adjuvant Systemic Therapy of Breast Cancer.
Florian Schuetz.
Breast Care (Basel), 2011 Jul 23; 6(3). PMID: 21779222    Free PMC article.
Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer.
Elmar Stickeler.
Breast Care (Basel), 2011 Jul 23; 6(3). PMID: 21779224    Free PMC article.
Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Michael Gnant, Peter Blaha, +8 authors, Raimund Jakesz.
Ther Adv Med Oncol, 2009 Nov 01; 1(3). PMID: 21789117    Free PMC article.
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
Suleiman Massarweh, Yee L Tham, +9 authors, Richard Elledge.
Breast Cancer Res Treat, 2011 Jul 28; 129(3). PMID: 21792626    Free PMC article.
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C Davies, +11 authors, R Peto.
Lancet, 2011 Aug 02; 378(9793). PMID: 21802721    Free PMC article.
Highly Cited.
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers.
A M Brewster, C Etzel, +9 authors, R L Theriault.
Breast Cancer Res Treat, 2011 Aug 03; 130(3). PMID: 21809116    Free PMC article.
Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer.
Su Jin Lee, Silvia Park, +9 authors, Young-Hyuck Im.
Cancer Res Treat, 2011 Aug 04; 43(2). PMID: 21811424    Free PMC article.
Survival of women with breast cancer in central and northern Denmark, 1998-2009.
Lone Winther Lietzen, Gitte Vrelits Sørensen, +4 authors, Jacob Jacobsen.
Clin Epidemiol, 2011 Aug 05; 3 Suppl 1. PMID: 21814468    Free PMC article.
Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis.
Wen-Bin Zhou, Peng-Ling Zhang, +2 authors, Wei He.
J Exp Clin Cancer Res, 2011 Aug 06; 30. PMID: 21816036    Free PMC article.
SEOM clinical guidelines for using molecular markers in clinical practice.
Virginia Arrazubi, Roberto Pazo, Dolores Isla, José Luis Pérez Gracia.
Clin Transl Oncol, 2011 Aug 09; 13(8). PMID: 21821495
Psychotropic medication during endocrine treatment for breast cancer.
Geertruida H de Bock, Regina F Musters, +3 authors, Lolkje T W de Jong-van den Berg.
Support Care Cancer, 2011 Aug 09; 20(7). PMID: 21822636    Free PMC article.
In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4.
Jinghu Li, Tanja Gödecke, +6 authors, Dejan Nikolić.
Xenobiotica, 2011 Aug 11;. PMID: 21827327    Free PMC article.
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.
Kanwal P S Raghav, Leonel F Hernandez-Aya, +7 authors, Ana M Gonzalez-Angulo.
Cancer, 2011 Aug 13; 118(6). PMID: 21837669    Free PMC article.
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.
Anders Carlsson, Christer Wingren, +10 authors, Carl A K Borrebaeck.
Proc Natl Acad Sci U S A, 2011 Aug 17; 108(34). PMID: 21844363    Free PMC article.
The 70-gene prognostic signature for korean breast cancer patients.
Kuk Young Na, Ku Sang Kim, +7 authors, Yong Sik Jung.
J Breast Cancer, 2011 Aug 19; 14(1). PMID: 21847392    Free PMC article.
Association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment.
Hyung Seok Park, Ji-Yeob Choi, +5 authors, Byeong-Woo Park.
J Korean Med Sci, 2011 Aug 24; 26(8). PMID: 21860550    Free PMC article.
Estrogen receptor degradation: a CUE for endocrine resistance?
Elizabeth A Musgrove.
Breast Cancer Res, 2011 Aug 25; 13(4). PMID: 21861853    Free PMC article.
Review.
Management options in triple-negative breast cancer.
Christina A Minami, Debra U Chung, Helena R Chang.
Breast Cancer (Auckl), 2011 Aug 25; 5. PMID: 21863131    Free PMC article.
Younger age as a prognostic indicator in breast cancer: a cohort study.
Elrasheid H A Kheirelseid, Jennifer M E Boggs, +4 authors, Michael J Kerin.
BMC Cancer, 2011 Aug 30; 11. PMID: 21871129    Free PMC article.
Triple-negative breast cancers: an updated review on treatment options.
K B Reddy.
Curr Oncol, 2011 Aug 30; 18(4). PMID: 21874107    Free PMC article.
Challenges translating breast cancer gene signatures into the clinic.
Britta Weigelt, Lajos Pusztai, Alan Ashworth, Jorge S Reis-Filho.
Nat Rev Clin Oncol, 2011 Sep 01; 9(1). PMID: 21878891
Review.
Do all patients with breast cancer require systemic adjuvant therapy?
Jennifer J Griggs, Daniel F Hayes.
J Natl Cancer Inst, 2011 Sep 02; 103(18). PMID: 21881041    Free PMC article.
The breast screening programme and misinforming the public.
Peter C Gøtzsche, Karsten Juhl Jørgensen.
J R Soc Med, 2011 Sep 02; 104(9). PMID: 21881087    Free PMC article.
Review.
US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer.
John Hornberger, Rebecca Chien, Katie Krebs, Louis Hochheiser.
J Oncol Pract, 2011 Sep 03; 7(3 Suppl). PMID: 21886510    Free PMC article.
Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions.
Wendy Y Chen.
Endocrinol Metab Clin North Am, 2011 Sep 06; 40(3). PMID: 21889717    Free PMC article.
Review.
Review: mitochondrial defects in breast cancer.
Josefa Salgado, Beatriz Honorato, Jesús García-Foncillas.
Clin Med Oncol, 2008 Jan 01; 2. PMID: 21892280    Free PMC article.
Adjuvant hormonal therapy use among women with ductal carcinoma in situ.
Jennifer C Livaudais, E Shelley Hwang, +4 authors, Celia P Kaplan.
J Womens Health (Larchmt), 2011 Sep 10; 21(1). PMID: 21902542    Free PMC article.
ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study.
Fengyan Xu, Dalin Li, +6 authors, Dianjun Li.
BMC Cancer, 2011 Sep 16; 11. PMID: 21917182    Free PMC article.
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.
Davide Bedognetti, Mario Roberto Sertoli, +12 authors, Paolo Bruzzi.
J Natl Cancer Inst, 2011 Sep 17; 103(20). PMID: 21921285    Free PMC article.
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
Marieke A Vollebergh, Jos Jonkers, Sabine C Linn.
Cell Mol Life Sci, 2011 Sep 17; 69(2). PMID: 21922196
Review.
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.
Jennifer C Livaudais, Dawn L Hershman, +7 authors, Gloria D Coronado.
Breast Cancer Res Treat, 2011 Sep 17; 131(2). PMID: 21922245    Free PMC article.
NFIB is a potential target for estrogen receptor-negative breast cancers.
Hyeong-Gon Moon, Ki-Tae Hwang, +6 authors, Dong-Young Noh.
Mol Oncol, 2011 Sep 20; 5(6). PMID: 21925980    Free PMC article.
Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab.
Robert I Griffiths, Deepa Lalla, +3 authors, Mark D Danese.
Cancer Invest, 2011 Sep 21; 29(9). PMID: 21929325    Free PMC article.
Pharmacoeconomic considerations in the treatment of breast cancer.
Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, Nikos Maniadakis.
Clinicoecon Outcomes Res, 2010 Jan 01; 2. PMID: 21935314    Free PMC article.
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.
Kathryn P Lowry, Janie M Lee, +8 authors, G Scott Gazelle.
Cancer, 2011 Sep 22; 118(8). PMID: 21935911    Free PMC article.
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
Chungyeul Kim, Gong Tang, +18 authors, Soonmyung Paik.
J Clin Oncol, 2011 Sep 29; 29(31). PMID: 21947828    Free PMC article.
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
Soley Bayraktar, Ana M Gonzalez-Angulo, +7 authors, Funda Meric-Bernstam.
Cancer, 2011 Sep 29; 118(9). PMID: 21953213    Free PMC article.
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
Ann M Moyer, Vera J Suman, +7 authors, Matthew P Goetz.
Pharmacogenomics, 2011 Oct 04; 12(11). PMID: 21961651    Free PMC article.
Targeted therapies for breast cancer.
Michaela J Higgins, José Baselga.
J Clin Invest, 2011 Oct 04; 121(10). PMID: 21965336    Free PMC article.
Highly Cited. Review.
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
P Vici, M Brandi, +11 authors, M Lopez.
Ann Oncol, 2011 Oct 04; 23(5). PMID: 21965475    Free PMC article.
Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
Robert I Griffiths, Richard L Barron, +5 authors, Gary H Lyman.
Pharmacoeconomics, 2011 Oct 05; 30(2). PMID: 21967155
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
Wendy Lorizio, Hope Rugo, +7 authors, Elad Ziv.
Genome Med, 2011 Oct 06; 3(10). PMID: 21970596    Free PMC article.
Clinical trials: The silent minority--unpublished data on cancer care.
Daniel F Hayes.
Nat Rev Clin Oncol, 2011 Oct 06; 8(11). PMID: 21971591
A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Ji Hye Park, Mee Young Ahn, +7 authors, Hyung Sik Kim.
Invest New Drugs, 2011 Oct 11; 30(5). PMID: 21983700
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
B Ejlertsen, J Aldridge, +10 authors, Danish Breast Cancer Cooperative Group the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group.
Ann Oncol, 2011 Oct 12; 23(5). PMID: 21986093    Free PMC article.
Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.
Brian P Kelley, Vicente Valero, Min Yi, Steven J Kronowitz.
Plast Reconstr Surg, 2011 Oct 12; 129(2). PMID: 21987043    Free PMC article.
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?
R Leonard, R Ballinger, +13 authors, J M Bliss.
Br J Cancer, 2011 Oct 13; 105(9). PMID: 21989185    Free PMC article.
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Elizabeth A Mittendorf, Guy T Clifton, +8 authors, George E Peoples.
Cancer, 2011 Oct 13; 118(10). PMID: 21989902    Free PMC article.
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
Jacqueline A Shaw, Karen Page, +11 authors, R Charles Coombes.
Genome Res, 2011 Oct 13; 22(2). PMID: 21990379    Free PMC article.
Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
Rachel C Jankowitz, Kristine Cooper, +5 authors, Adam Brufsky.
Breast Cancer Res, 2011 Oct 18; 13(5). PMID: 21999244    Free PMC article.
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer.
Todd W Miller, Justin M Balko, Carlos L Arteaga.
J Clin Oncol, 2011 Oct 20; 29(33). PMID: 22010023    Free PMC article.
Highly Cited. Review.
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.
Eric A Ariazi, Heather E Cunliffe, +11 authors, V Craig Jordan.
Proc Natl Acad Sci U S A, 2011 Oct 21; 108(47). PMID: 22011582    Free PMC article.
The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
V Craig Jordan, Ifeyinwa Obiorah, +4 authors, Hiltrud Brauch.
Breast, 2011 Nov 02; 20 Suppl 3. PMID: 22015273    Free PMC article.
Modeling the impact of population screening on breast cancer mortality in the United States.
Jeanne S Mandelblatt, Kathleen A Cronin, +9 authors, Eric J Feuer.
Breast, 2011 Nov 02; 20 Suppl 3. PMID: 22015298    Free PMC article.
Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.
Gila Neta, William F Anderson, Ethel Gilbert, Amy Berrington.
Breast Cancer Res Treat, 2011 Oct 22; 131(3). PMID: 22015617    Free PMC article.
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.
Jennifer E Joh, Nicole N Esposito, +10 authors, Geza Acs.
Oncologist, 2011 Oct 22; 16(11). PMID: 22016474    Free PMC article.
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), S Darby, +13 authors, R Peto.
Lancet, 2011 Oct 25; 378(9804). PMID: 22019144    Free PMC article.
Highly Cited. Review.
G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.
Hao-Jun Luo, Ping Luo, +3 authors, Gang Tu.
J Breast Cancer, 2011 Oct 28; 14(3). PMID: 22031799    Free PMC article.
Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer.
Geumhee Gwak, Kyeongmee Park, +10 authors, Sung-Jin Park.
J Breast Cancer, 2011 Oct 28; 14(3). PMID: 22031805    Free PMC article.
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.
K B Lundin, M Henningson, +3 authors, H Jernström.
Br J Cancer, 2011 Oct 29; 105(11). PMID: 22033271    Free PMC article.
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.
Ubaldo E Martinez-Outschoorn, Allison Goldberg, +8 authors, Michael P Lisanti.
Cancer Biol Ther, 2011 Nov 02; 12(10). PMID: 22041887    Free PMC article.
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
Banu K Arun, Kapil Dhinghra, +16 authors, Gabriel N Hortobagyi.
Oncologist, 2011 Nov 02; 16(11). PMID: 22042783    Free PMC article.
Second malignancies among elderly survivors of cancer.
Ari M VanderWalde, Arti Hurria.
Oncologist, 2011 Nov 02; 16(11). PMID: 22042787    Free PMC article.
Review.
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
Jocelyne Jacquemier, Jean-Marie Boher, +12 authors, François Bertucci.
Breast Cancer Res, 2011 Nov 03; 13(6). PMID: 22044691    Free PMC article.
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Elisabeth Luporsi, Fabrice André, +22 authors, Jean-Pierre Bellocq.
Breast Cancer Res Treat, 2011 Nov 04; 132(3). PMID: 22048814    Free PMC article.
Highly Cited. Review.
How do I treat "triple-negative" disease.
Christos Vaklavas, Andres Forero-Torres.
Curr Treat Options Oncol, 2011 Nov 04; 12(4). PMID: 22048876
Optimal management of cancer treatment-induced bone loss: considerations for elderly patients.
Karen Tipples, Anne Robinson.
Drugs Aging, 2011 Nov 08; 28(11). PMID: 22054228
Review.
Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
Prashant Rajbhandari, Greg Finn, +9 authors, Elaine T Alarid.
Mol Cell Biol, 2011 Nov 09; 32(2). PMID: 22064478    Free PMC article.
Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy.
A Balakrishnan, D Ravichandran.
Br J Cancer, 2011 Nov 10; 105(12). PMID: 22068814    Free PMC article.
Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients.
Ying-Yi Qin, Hui Li, +8 authors, Jia He.
PLoS One, 2011 Nov 10; 6(11). PMID: 22069477    Free PMC article.
Systematic Review.
Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.
Muhammad Younus, Michelle Kissner, Lester Reich, Nicola Wallis.
Drug Saf, 2011 Nov 15; 34(12). PMID: 22077502
Systematic Review.
Genetics for the general internist.
Christina M Laukaitis.
Am J Med, 2011 Nov 15; 125(1). PMID: 22079017    Free PMC article.
Review.
Protein biomarkers for the early detection of breast cancer.
David E Misek, Evelyn H Kim.
Int J Proteomics, 2011 Nov 16; 2011. PMID: 22084684    Free PMC article.
Profile of V. Craig Jordan.
Sujata Gupta.
Proc Natl Acad Sci U S A, 2011 Nov 18; 108(47). PMID: 22089238    Free PMC article.
Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approval.
Martin H Cohen, John R Johnson, Robert Justice, Richard Pazdur.
Oncologist, 2011 Nov 18; 16(12). PMID: 22089970    Free PMC article.
Review.
Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer.
Andrei Dobrescu, Monique Chang, +3 authors, Alexander A Hindenburg.
ISRN Oncol, 2011 Nov 18; 2011. PMID: 22091428    Free PMC article.
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.
Todd W Miller, Brent N Rexer, Joan T Garrett, Carlos L Arteaga.
Breast Cancer Res, 2011 Nov 26; 13(6). PMID: 22114931    Free PMC article.
Highly Cited. Review.
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.
D J Brennan, D P O'Connor, +16 authors, W M Gallagher.
Oncogene, 2011 Dec 06; 31(30). PMID: 22139072    Free PMC article.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.
Adedayo A Onitilo, Suhail A R Doi, +3 authors, Richard Berg.
Thromb Res, 2011 Dec 14; 130(1). PMID: 22154240    Free PMC article.
BRCA mutation testing in determining breast cancer therapy.
Karen Lisa Smith, Claudine Isaacs.
Cancer J, 2011 Dec 14; 17(6). PMID: 22157293    Free PMC article.
Review.
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.
Christoph Thomssen, Anton Scharl, Nadia Harbeck.
Breast Care (Basel), 2011 Dec 14; 6(4). PMID: 22164127    Free PMC article.
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
Yun-Yong Park, Kyounghyun Kim, +11 authors, Ju-Seog Lee.
EMBO Mol Med, 2011 Dec 17; 4(1). PMID: 22174013    Free PMC article.
The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1.
L K Teh, N I Mohamed, +12 authors, J Din.
AAPS J, 2011 Dec 21; 14(1). PMID: 22183189    Free PMC article.
The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.
T Younis, D Rayson, C Skedgel.
Curr Oncol, 2011 Dec 21; 18(6). PMID: 22184496    Free PMC article.
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Laura J Esserman, Donald A Berry, +32 authors, I-SPY 1 TRIAL Investigators.
Breast Cancer Res Treat, 2011 Dec 27; 132(3). PMID: 22198468    Free PMC article.
Highly Cited.
Clinical and biomarker predictors of side effects from tamoxifen.
Wendy Lorizio, Alan H B Wu, +4 authors, Elad Ziv.
Breast Cancer Res Treat, 2011 Dec 31; 132(3). PMID: 22207277    Free PMC article.
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.
Willemien van de Water, Esther Bastiaannet, +8 authors, Cornelis J H van de Velde.
Oncologist, 2012 Jan 03; 17(1). PMID: 22210087    Free PMC article.
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
Caryn S Ross-Innes, Rory Stark, +12 authors, Jason S Carroll.
Nature, 2012 Jan 06; 481(7381). PMID: 22217937    Free PMC article.
Highly Cited.
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Pamela N Munster, Amy P Moore, +6 authors, Susan E Minton.
J Clin Oncol, 2012 Jan 11; 30(5). PMID: 22231041    Free PMC article.
Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, +5 authors, Sylvia K Plevritis.
J Clin Oncol, 2012 Jan 11; 30(5). PMID: 22231042    Free PMC article.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
George Fountzilas, Christos Valavanis, +18 authors, Petroula Arapantoni.
J Transl Med, 2012 Jan 14; 10. PMID: 22240029    Free PMC article.
Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast China.
Dalin Li, Qiujin Zhang, +4 authors, Da Pang.
Mol Cell Biochem, 2012 Jan 18; 364(1-2). PMID: 22249287
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.
Anupama Sharma, Ursula Koldovsky, +10 authors, Brian J Czerniecki.
Cancer, 2012 Jan 19; 118(17). PMID: 22252842    Free PMC article.
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
Esther M de Kruijf, Anita Sajet, +8 authors, Peter J K Kuppen.
BMC Cancer, 2012 Jan 20; 12. PMID: 22257486    Free PMC article.
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Szeman Ruby Chan, William Vermi, +10 authors, Robert D Schreiber.
Breast Cancer Res, 2012 Jan 24; 14(1). PMID: 22264274    Free PMC article.
Highly Cited.
Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.
Mengyuan Du, Xujuan Yang, +4 authors, William G Helferich.
Carcinogenesis, 2012 Jan 24; 33(4). PMID: 22266527    Free PMC article.
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
Robyn Macfarlane, Melanie Seal, +4 authors, Stephen K Chia.
Oncologist, 2012 Jan 24; 17(2). PMID: 22267852    Free PMC article.
Gene expression profiling: changing face of breast cancer classification and management.
Robert Wesolowski, Bhuvaneswari Ramaswamy.
Gene Expr, 2012 Jan 25; 15(3). PMID: 22268293    Free PMC article.
Review.
Emerging role of microRNAs in drug-resistant breast cancer.
Sarmila Majumder, Samson T Jacob.
Gene Expr, 2012 Jan 25; 15(3). PMID: 22268296    Free PMC article.
Review.
Impact of a reduced dose intensity of adjuvant anthracycline based chemotherapy in a population-based cohort of stage I-II breast cancers.
A V Tinker, C Speers, +2 authors, S Chia.
Ecancermedicalscience, 2008 Jan 01; 2. PMID: 22275960    Free PMC article.
Role of traditional and new biomarkers in breast carcinogenesis.
D Macis, M Cazzaniga, A De Censi, B Bonanni.
Ecancermedicalscience, 2009 Jan 01; 3. PMID: 22276018    Free PMC article.
Endocrine-responsive breast cancer: a 28-year Odyssey.
A West, Kp Friedman, F Muggia.
Ecancermedicalscience, 2012 Jan 26; 5. PMID: 22276069    Free PMC article.
Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.
Joseph Lipscomb, Theresa W Gillespie, +4 authors, Kevin C Ward.
Breast Cancer Res Treat, 2012 Jan 27; 133(1). PMID: 22278190    Free PMC article.
Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women.
Mg Mostafa, Mt Larsen, Rr Love.
J Bangladesh Coll Phys Surg, 2010 Jan 01; 28(3). PMID: 22279410    Free PMC article.
Ten-year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma.
José Luis Guinot, M Isabel Tortajada, +7 authors, Leoncio Arribas.
Clin Transl Oncol, 2012 Feb 04; 14(2). PMID: 22301399
Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.
Sarah C Baumgarten, Jonna Frasor.
Mol Endocrinol, 2012 Feb 04; 26(3). PMID: 22301780    Free PMC article.
Review.
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.
Dawn L Hershman, Elizabeth T Wilde, +4 authors, Alfred I Neugut.
J Clin Oncol, 2012 Feb 09; 30(8). PMID: 22312106    Free PMC article.
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.
Kathryn E Weaver, Fabian Camacho, +2 authors, Gretchen Kimmick.
Am J Clin Oncol, 2012 Feb 09; 36(2). PMID: 22314001    Free PMC article.
Clinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients.
Im-Kyung Kim, Seho Park, +4 authors, Byeong-Woo Park.
J Breast Cancer, 2012 Feb 11; 14(4). PMID: 22323919    Free PMC article.
Early breast cancer in the older woman.
Ari VanderWalde, Arti Hurria.
Clin Geriatr Med, 2012 Feb 14; 28(1). PMID: 22326036    Free PMC article.
Review.
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.
Farrokh Dehdashti, Richard Laforest, +7 authors, Michael J Welch.
J Nucl Med, 2012 Feb 15; 53(3). PMID: 22331216    Free PMC article.
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.
Thomas Delate, Erin J Aiello Bowles, +11 authors, Edward Wagner.
Cancer Epidemiol Biomarkers Prev, 2012 Feb 18; 21(4). PMID: 22337532    Free PMC article.
The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report.
Ipek Yonal, Fehmi Hindilerden, +2 authors, Melih Aktan.
J Med Case Rep, 2012 Feb 22; 6. PMID: 22339850    Free PMC article.
Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D.
Gerald F Riley, Joan L Warren, Linda C Harlan, Steven A Blackwell.
Medicare Medicaid Res Rev, 2012 Feb 22; 1(4). PMID: 22340780    Free PMC article.
Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.
Daichi Shigemizu, Zhenjun Hu, +3 authors, Charles DeLisi.
PLoS Comput Biol, 2012 Feb 22; 8(2). PMID: 22346740    Free PMC article.
Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it?
Ana Elisa Lohmann, Stephen Chia.
Curr Treat Options Oncol, 2012 Feb 22; 13(2). PMID: 22350496
Review.
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
Maggie C U Cheang, K David Voduc, +15 authors, Torsten O Nielsen.
Clin Cancer Res, 2012 Feb 22; 18(8). PMID: 22351696    Free PMC article.
Anthracycline regimen adherence in older patients with early breast cancer.
Carlos H Barcenas, Ning Zhang, +4 authors, Sharon H Giordano.
Oncologist, 2012 Mar 01; 17(3). PMID: 22371383    Free PMC article.
Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?
Atocha Romero, Trinidad Caldés, Eduardo Díaz-Rubio, Miguel Martín.
Clin Transl Oncol, 2012 Mar 01; 14(3). PMID: 22374418
Review.
FOXA1 represses the molecular phenotype of basal breast cancer cells.
G M Bernardo, G Bebek, +8 authors, R A Keri.
Oncogene, 2012 Mar 07; 32(5). PMID: 22391567    Free PMC article.
Breast cancer local therapy: what is its effect on mortality?
John R Benson, Katy A T Teo.
World J Surg, 2012 Mar 07; 36(7). PMID: 22392352
Review.
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, +9 authors, Norman Wolmark.
J Clin Oncol, 2012 Mar 07; 30(12). PMID: 22393101    Free PMC article.
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
James M Rae, Suzy Drury, +8 authors, ATAC trialists.
J Natl Cancer Inst, 2012 Mar 08; 104(6). PMID: 22395643    Free PMC article.
Highly Cited.
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
Meredith M Regan, Brian Leyland-Jones, +18 authors, Breast International Group (BIG) 1-98 Collaborative Group.
J Natl Cancer Inst, 2012 Mar 08; 104(6). PMID: 22395644    Free PMC article.
Highly Cited.
Breast cancer and fertility.
Jennifer K Litton.
Curr Treat Options Oncol, 2012 Mar 08; 13(2). PMID: 22396154
Review.
Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson.
Mol Oncol, 2012 Mar 13; 6(2). PMID: 22406404    Free PMC article.
Review.
Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.
David M Gershenson, Charlotte C Sun, +5 authors, Michael Deavers.
Gynecol Oncol, 2012 Mar 13; 125(3). PMID: 22406638    Free PMC article.
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.
C Krakstad, J Trovik, +9 authors, H B Salvesen.
Br J Cancer, 2012 Mar 15; 106(10). PMID: 22415229    Free PMC article.
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.
Shuzhen Liu, Jonathan Lachapelle, +3 authors, Torsten O Nielsen.
Breast Cancer Res, 2012 Mar 17; 14(2). PMID: 22420471    Free PMC article.
Highly Cited.
Patients with positive axillary lymph nodes: how to use genomic assays.
Ruta Rao.
Curr Treat Options Oncol, 2012 Mar 20; 13(2). PMID: 22426945
Current approaches to the management of Her2-negative metastatic breast cancer.
Keerthi Gogineni, Angela DeMichele.
Breast Cancer Res, 2012 Mar 21; 14(2). PMID: 22429313    Free PMC article.
Review.
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Andrea Malfettone, Concetta Saponaro, +2 authors, Annita Mangia.
BMC Cancer, 2012 Mar 24; 12. PMID: 22439624    Free PMC article.
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial.
Hiroyuki Konaka, Shin Egawa, +8 authors, Mikio Namiki.
BMC Cancer, 2012 Mar 24; 12. PMID: 22439742    Free PMC article.
Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.
Ewa Mrózek, Rachel Layman, +4 authors, Charles L Shapiro.
Clin Breast Cancer, 2012 Mar 27; 12(2). PMID: 22444722    Free PMC article.
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Alexey A Leontovich, Shuya Zhang, +8 authors, Antonino B D'Assoro.
Int J Oncol, 2012 Mar 27; 40(6). PMID: 22447278    Free PMC article.
Toward individualized breast cancer therapy: translating biological concepts to the bedside.
Gabriel N Hortobagyi.
Oncologist, 2012 Apr 05; 17(4). PMID: 22474069    Free PMC article.
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.
Alfred I Neugut, Grace Clarke Hillyer, +9 authors, Dawn L Hershman.
Breast J, 2012 Apr 11; 18(3). PMID: 22487337    Free PMC article.
Quality of breast cancer care: perception versus practice.
Nina A Bickell, Jennifer Neuman, +2 authors, Kathie-Ann Joseph.
J Clin Oncol, 2012 Apr 12; 30(15). PMID: 22493417    Free PMC article.
Circulating Tumor Cells Detected by RT-PCR for CK-20 before Surgery Indicate Worse Prognostic Impact in Triple-Negative and HER2 Subtype Breast Cancer.
Seong Bae Hwang, Jeoung Won Bae, Hye Yoon Lee, Hoon Yub Kim.
J Breast Cancer, 2012 Apr 12; 15(1). PMID: 22493626    Free PMC article.
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).
Alfred I Neugut, Grace Clarke Hillyer, +10 authors, Dawn L Hershman.
Breast Cancer Res Treat, 2012 Apr 25; 134(1). PMID: 22527111    Free PMC article.
Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer.
Ryung S Kim, Alvaro Avivar-Valderas, +4 authors, Jeffrey E Segall.
PLoS One, 2012 Apr 25; 7(4). PMID: 22530051    Free PMC article.
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer.
S Barton, L Zabaglo, +6 authors, M Dowsett.
Br J Cancer, 2012 Apr 26; 106(11). PMID: 22531639    Free PMC article.
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer.
Jessica Chubak, Onchee Yu, +6 authors, Diana S M Buist.
J Natl Cancer Inst, 2012 May 02; 104(12). PMID: 22547340    Free PMC article.
Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients group.
Beata Biesaga, Joanna Niemiec, Marek Ziobro.
Pathol Oncol Res, 2012 May 03; 18(4). PMID: 22549273    Free PMC article.
Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Xinyi Liu, Indira Jutooru, +5 authors, Stephen Safe.
Mol Cancer Ther, 2012 May 04; 11(7). PMID: 22553354    Free PMC article.
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
Michael J Hassett, Samuel M Silver, +12 authors, Jane C Weeks.
J Clin Oncol, 2012 May 16; 30(18). PMID: 22585699    Free PMC article.
Ductal Carcinoma in Situ: Clinical Perspective.
Thorsten Kühn.
Breast Care (Basel), 2010 Aug 01; 5(4). PMID: 22590442    Free PMC article.
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant Radiotherapy.
Christoph Thomssena, Nadia Harbeckb.
Breast Care (Basel), 2010 Aug 01; 5(4). PMID: 22590447    Free PMC article.
Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions.
Per E Lønning.
Ther Adv Med Oncol, 2012 May 17; 4(3). PMID: 22590486    Free PMC article.
Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells.
Paola Sánchez-Moreno, Houria Boulaiz, +2 authors, Antonia Aránega.
Int J Mol Sci, 2012 May 19; 13(4). PMID: 22606019    Free PMC article.
Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
Bruno Coudert, Bernard Asselain, +18 authors, UNICANCER Breast Group.
Oncologist, 2012 May 23; 17(7). PMID: 22610153    Free PMC article.
Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.
Jeanne S Mandelblatt, Leigh Anne Faul, +7 authors, Harvey J Cohen.
J Clin Oncol, 2012 May 23; 30(21). PMID: 22614985    Free PMC article.
Decline in the use of anthracyclines for breast cancer.
Sharon H Giordano, Yu-Li Lin, +2 authors, James S Goodwin.
J Clin Oncol, 2012 May 23; 30(18). PMID: 22614988    Free PMC article.
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
Wenbin Zhou, Qiang Ding, +4 authors, Shui Wang.
PLoS One, 2012 May 23; 7(5). PMID: 22615953    Free PMC article.
Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist?
Cordula Petersen, Florian Würschmidt.
Breast Care (Basel), 2012 May 24; 6(5). PMID: 22619647    Free PMC article.
Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.
Cong Xue, Xi Wang, +7 authors, Zhongyu Yuan.
Cancer Sci, 2012 May 26; 103(9). PMID: 22625227    Free PMC article.
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.
Laura J Esserman, Donald A Berry, +25 authors, Nola Hylton.
J Clin Oncol, 2012 Jun 01; 30(26). PMID: 22649152    Free PMC article.
Highly Cited.
Strategies for the discovery and development of therapies for metastatic breast cancer.
Bedrich L Eckhardt, Prudence A Francis, Belinda S Parker, Robin L Anderson.
Nat Rev Drug Discov, 2012 Jun 02; 11(6). PMID: 22653217
Highly Cited. Review.
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.
Zsuzsanna Varga, Joachim Diebold, +16 authors, Hans-Anton Lehr.
PLoS One, 2012 Jun 05; 7(5). PMID: 22662150    Free PMC article.
Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we?
Ariana E Huber-Wechselberger, Paul Niedetzky, Irene Aigner, Elisabeth Haschke-Becher.
Wien Med Wochenschr, 2012 Jun 13; 162(11-12). PMID: 22688624
Review.
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
Michael E Jones, Flora E van Leeuwen, +6 authors, Anthony J Swerdlow.
Breast Cancer Res, 2012 Jun 14; 14(3). PMID: 22691381    Free PMC article.
Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hassan A Hatoum, Faek R Jamali, +12 authors, Ali I Shamseddine.
Indian J Surg Oncol, 2010 Dec 01; 1(4). PMID: 22695879    Free PMC article.
Temporal trends in the surgical outcomes of patients with breast cancer.
Takeshi Hanagiri, Yoshika Nagata, +8 authors, Fumihiro Tanaka.
World J Surg Oncol, 2012 Jun 16; 10. PMID: 22697184    Free PMC article.
Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Todd P Knutson, Andrea R Daniel, +4 authors, Carol A Lange.
Breast Cancer Res, 2012 Jun 16; 14(3). PMID: 22697792    Free PMC article.
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
Line L Haugan Moi, Marianne Hauglid Flågeng, +5 authors, Gunnar Mellgren.
BMC Cancer, 2012 Jun 19; 12. PMID: 22703232    Free PMC article.
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
Alexander H G Paterson, Stewart J Anderson, +17 authors, Norman Wolmark.
Lancet Oncol, 2012 Jun 19; 13(7). PMID: 22704583    Free PMC article.
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.
Stephen K Chia, Vivien H Bramwell, +12 authors, Torsten O Nielsen.
Clin Cancer Res, 2012 Jun 20; 18(16). PMID: 22711706    Free PMC article.
Highly Cited.
Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers.
Erhan Bilal, Kristen Vassallo, +8 authors, Shridar Ganesan.
PLoS One, 2012 Jun 22; 7(6). PMID: 22719901    Free PMC article.
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
Jeffrey G Schneider, Danny N Khalil.
Breast Cancer Res Treat, 2012 Jun 23; 134(3). PMID: 22723033    Free PMC article.
Racial and ethnic differences in adjuvant hormonal therapy use.
Jennifer C Livaudais, Christopher Li, +7 authors, Gloria D Coronado.
J Womens Health (Larchmt), 2012 Jun 27; 21(9). PMID: 22731764    Free PMC article.
Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.
Jeffrey M Albert, Diane D Liu, +6 authors, Benjamin D Smith.
J Clin Oncol, 2012 Jun 27; 30(23). PMID: 22734034    Free PMC article.
Epithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).
Nitin Telang, Meena Katdare.
Oncol Lett, 2012 Jun 29; 3(4). PMID: 22740986    Free PMC article.
Risk of treatment-related esophageal cancer among breast cancer survivors.
L M Morton, E S Gilbert, +25 authors, B M P Aleman.
Ann Oncol, 2012 Jun 30; 23(12). PMID: 22745217    Free PMC article.
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.
Silvia Dellapasqua, Vincenzo Bagnardi, +9 authors, Marco Colleoni.
Breast, 2012 Jul 04; 21(5). PMID: 22749924    Free PMC article.
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
Foluso O Ademuyiwa, Wiam Bshara, +12 authors, Kunle Odunsi.
PLoS One, 2012 Jul 05; 7(6). PMID: 22761704    Free PMC article.
Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study.
Dong Hoe Koo, Cheol-Young Park, +2 authors, Sang Woo Oh.
PLoS One, 2012 Jul 05; 7(6). PMID: 22761921    Free PMC article.
Lipid profiles within the SABRE trial of anastrozole with and without risedronate.
Catherine Van Poznak, Andreas Makris, +2 authors, Richard Eastell.
Breast Cancer Res Treat, 2012 Jul 06; 134(3). PMID: 22763465    Free PMC article.
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
Paul Hodgkins, Monica Shaw, David Coghill, Lily Hechtman.
Eur Child Adolesc Psychiatry, 2012 Jul 06; 21(9). PMID: 22763750    Free PMC article.
Review.
Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer.
Rachel L Yung, Michael J Hassett, +6 authors, Deborah Schrag.
J Natl Cancer Inst, 2012 Jul 10; 104(14). PMID: 22773822    Free PMC article.
Recent advances in adjuvant systemic treatment for breast cancer: all systems go!
P N Fishman, S Verma.
Curr Oncol, 2006 Oct 01; 13(5). PMID: 22792012    Free PMC article.
High-risk estrogen-receptor-positive breast cancer: identification and implications for therapy.
Rosemary L Balleine, Nicholas R Wilcken.
Mol Diagn Ther, 2012 Jul 21; 16(4). PMID: 22812573
Review.
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.
Jan Budczies, Carsten Denkert, +12 authors, Oliver Fiehn.
BMC Genomics, 2012 Jul 25; 13. PMID: 22823888    Free PMC article.
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
Karin Beelen, Wilbert Zwart, Sabine C Linn.
Nat Rev Clin Oncol, 2012 Jul 25; 9(9). PMID: 22825374
Review.
Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data.
Kathryn J Huber-Keener, Xiuping Liu, +11 authors, Rongling Wu.
PLoS One, 2012 Jul 31; 7(7). PMID: 22844461    Free PMC article.
Clinicopathological features and treatment sensitivity of elderly Chinese breast cancer patients.
Jun-Jie Li, Ke-DA Yu, Gen-Hong DI, Zhi-Min Shao.
Oncol Lett, 2010 Nov 01; 1(6). PMID: 22870109    Free PMC article.
Is there a future for selective estrogen-receptor modulators in osteoporosis?
Roberto C Güerri-Fernández, Adolfo Diez-Perez.
Ther Adv Musculoskelet Dis, 2012 Aug 08; 4(2). PMID: 22870495    Free PMC article.
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Randi R Mathiesen, Elin Borgen, +10 authors, Bjørn Naume.
Breast Cancer Res, 2012 Aug 15; 14(4). PMID: 22889108    Free PMC article.
Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.
Jeffrey M Albert, I-Wen Pan, +4 authors, Benjamin D Smith.
Cancer, 2012 Aug 15; 118(19). PMID: 22890779    Free PMC article.
The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.
Sara J Schonfeld, Rochelle E Curtis, William F Anderson, Amy Berrington de González.
Cancer Causes Control, 2012 Aug 25; 23(10). PMID: 22918549    Free PMC article.
Breast cancer in South East Asia: comparison of presentation and outcome between a middle income and a high income country.
Nakul Saxena, Mikael Hartman, +7 authors, Helena M Verkooijen.
World J Surg, 2012 Aug 29; 36(12). PMID: 22926282
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Joseph A Sparano, Molin Wang, +10 authors, Nancy E Davidson.
Cancer, 2012 Aug 29; 118(23). PMID: 22926690    Free PMC article.
Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer.
Jean-Marc Nabholtz, Marie-Ange Mouret-Reynier, +4 authors, Philippe Chollet.
Indian J Surg Oncol, 2010 Jan 01; 1(1). PMID: 22930614    Free PMC article.
Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hassan A Hatoum, Faek R Jamali, +12 authors, Ali I Shamseddine.
Indian J Surg Oncol, 2010 Jan 01; 1(1). PMID: 22930621    Free PMC article.
Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator.
Shannon Wills, Anita Ravipati, +5 authors, David A Decker.
J Oncol Pract, 2012 Sep 04; 8(3). PMID: 22942807    Free PMC article.
Derailed estrogen signaling and breast cancer: an authentic couple.
Bramanandam Manavathi, Oindrilla Dey, +3 authors, Rakesh Kumar.
Endocr Rev, 2012 Sep 06; 34(1). PMID: 22947396    Free PMC article.
Review.
Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
Mohamed Elfagieh, Fathi Abdalla, +3 authors, Abdelbaset Buhmeida.
Tumour Biol, 2012 Sep 06; 33(6). PMID: 22948780
Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain.
R Font, J A Espinas, +9 authors, J M Borras.
Br J Cancer, 2012 Sep 08; 107(8). PMID: 22955858    Free PMC article.
A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model.
Jessica E Pritchard, Patrick M Dillon, +2 authors, Sarah J Parsons.
Oncology, 2012 Sep 12; 83(6). PMID: 22964943    Free PMC article.
High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.
Shinobu Umemura, Masatoshi Shirane, +3 authors, Robert Y Osamura.
Oncol Lett, 2010 Mar 01; 1(2). PMID: 22966291    Free PMC article.
Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study.
Vita Leonardi, Valentina Palmisano, +10 authors, Biagio Agostara.
Oncol Lett, 2010 Jul 01; 1(4). PMID: 22966374    Free PMC article.
Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients.
Erika A Waters, Ying Liu, Mario Schootman, Donna B Jeffe.
Ann Behav Med, 2012 Sep 18; 45(1). PMID: 22983622    Free PMC article.
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Oliver J Stoetzer, Debora M I Fersching, +9 authors, Stefan Holdenrieder.
Tumour Biol, 2012 Sep 18; 34(1). PMID: 22983919
Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Kuo Yao-Lung, Chen Dar-Ren, Chang Tsai-Wang.
BMC Med Inform Decis Mak, 2012 Sep 19; 12. PMID: 22985190    Free PMC article.
High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy.
Francesco Recchia, Giampiero Candeloro, +4 authors, Silvio Rea.
Exp Ther Med, 2010 Sep 01; 1(5). PMID: 22993611    Free PMC article.
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.
Scott D Ramsey, William E Barlow, +6 authors, Gabriel N Hortobagyi.
Contemp Clin Trials, 2012 Sep 25; 34(1). PMID: 23000081    Free PMC article.
Review.
Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study.
Alfred I Neugut, Grace Clarke Hillyer, +10 authors, Dawn L Hershman.
J Clin Oncol, 2012 Sep 26; 30(31). PMID: 23008305    Free PMC article.
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?
I Vaz-Luis, E P Winer, N U Lin.
Ann Oncol, 2012 Oct 02; 24(2). PMID: 23022997    Free PMC article.
Review.
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
P E Goss, J N Ingle, +11 authors, D Tu.
Ann Oncol, 2012 Oct 03; 24(2). PMID: 23028039    Free PMC article.
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.
Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric.
BMC Cancer, 2012 Oct 04; 12. PMID: 23031196    Free PMC article.
Obesity, energy balance, and cancer: new opportunities for prevention.
Stephen D Hursting, John Digiovanni, +6 authors, Nathan A Berger.
Cancer Prev Res (Phila), 2012 Oct 05; 5(11). PMID: 23034147    Free PMC article.
Review.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
P Dubsky, M Filipits, +17 authors, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Ann Oncol, 2012 Oct 05; 24(3). PMID: 23035151    Free PMC article.
Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
Stephen Hiscox, Bedanta Baruha, +7 authors, Julia Gee.
BMC Cancer, 2012 Oct 09; 12. PMID: 23039365    Free PMC article.
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.
H M Earl, L Hiller, +28 authors, NEAT Investigators and the SCTBG.
Br J Cancer, 2012 Oct 11; 107(8). PMID: 23047592    Free PMC article.
Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.
Maria E C Sandberg, Per Hall, +4 authors, Kamila Czene.
PLoS One, 2012 Oct 12; 7(10). PMID: 23056335    Free PMC article.
General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. V.
Mark Shilkrut, Felix Feng, Daniel A Hamstra.
Front Oncol, 2012 Oct 13; 2. PMID: 23061043    Free PMC article.
Risk of colorectal adenomas in women with prior breast cancer.
Ashish Shukla, Sandhya Shukla, +3 authors, Sushovan Guha.
Dig Dis Sci, 2012 Oct 16; 57(12). PMID: 23065089
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Amye J Tevaarwerk, Robert J Gray, +7 authors, Joseph A Sparano.
Cancer, 2012 Oct 16; 119(6). PMID: 23065954    Free PMC article.
Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment.
Pegdwende Olivia Dialla, Tienhan Sandrine Dabakuyo, +6 authors, Patrick Arveux.
BMC Cancer, 2012 Oct 17; 12. PMID: 23066863    Free PMC article.
Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns.
Julie A Margenthaler, Emad Allam, +4 authors, Frank E Johnson.
J Oncol Pract, 2012 Oct 19; 8(2). PMID: 23077433    Free PMC article.
Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.
L H Land, S O Dalton, M-B Jensen, M Ewertz.
Br J Cancer, 2012 Oct 20; 107(11). PMID: 23079577    Free PMC article.
Personalized medicine in breast cancer: a systematic review.
Sang-Hoon Cho, Jongsu Jeon, Seung Il Kim.
J Breast Cancer, 2012 Oct 24; 15(3). PMID: 23091538    Free PMC article.
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.
Li-Heng Yang, Hsin-Shun Tseng, +4 authors, Dar-Ren Chen.
J Breast Cancer, 2012 Oct 24; 15(3). PMID: 23091541    Free PMC article.
Adjuvant chemotherapy and survival of elderly korean patients with breast carcinoma.
Seung Pil Jung, Jeong Eon Lee, +9 authors, Seok Jin Nam.
J Breast Cancer, 2012 Oct 24; 15(3). PMID: 23091542    Free PMC article.
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative study.
Robin Urquhart, Cynthia Kendell, +5 authors, Geoffrey A Porter.
Implement Sci, 2012 Oct 27; 7. PMID: 23098262    Free PMC article.
Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.
Yaojen Chang, Clyde B Schechter, +6 authors, Jeanne S Mandelblatt.
Breast Cancer Res Treat, 2012 Oct 30; 136(3). PMID: 23104221    Free PMC article.
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.
Allison W Kurian, Daphne Y Lichtensztajn, +8 authors, Scarlett L Gomez.
Breast Cancer Res Treat, 2012 Nov 10; 137(1). PMID: 23139057    Free PMC article.
Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.
M B Hannouf, M Brackstone, B Xie, G S Zaric.
Curr Oncol, 2012 Nov 13; 19(5). PMID: 23144580    Free PMC article.
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.
Stacie B Dusetzina, G Caleb Alexander, +2 authors, Nancy L Keating.
Breast Cancer Res Treat, 2012 Nov 15; 137(1). PMID: 23149465    Free PMC article.
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid.
Rebecca Aft.
Int J Womens Health, 2012 Nov 16; 4. PMID: 23152708    Free PMC article.
The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors.
Kerry S Courneya, Jeff K Vallance, +9 authors, Christine M Friedenreich.
BMC Cancer, 2012 Nov 17; 12. PMID: 23153358    Free PMC article.
Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Young Ju Lee, A Jin Won, +4 authors, Hyung Sik Kim.
Int J Med Sci, 2012 Nov 17; 9(10). PMID: 23155362    Free PMC article.
miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status.
Zhenduo Lu, Yuping Ye, +3 authors, Zhenzhen Liu.
Oncol Lett, 2012 Nov 20; 4(5). PMID: 23162645    Free PMC article.
Preoperative delays in the US Medicare population with breast cancer.
Richard J Bleicher, Karen Ruth, +6 authors, Brian L Egleston.
J Clin Oncol, 2012 Nov 22; 30(36). PMID: 23169513    Free PMC article.
Accelerated partial breast irradiation for early-stage breast cancer: controversies and current indications for use.
Lisa C Klepczyk, Kimberly S Keene, Jennifer F De Los Santos.
Curr Treat Options Oncol, 2012 Nov 28; 14(1). PMID: 23179757
Review.
Weight-based chemotherapy dosing in obese patients with cancer: back to the future.
Gary H Lyman.
J Oncol Pract, 2012 Nov 28; 8(4). PMID: 23181001    Free PMC article.
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer.
Naoki Hayashi, Naoki Niikura, +2 authors, Naoto T Ueno.
Breast Cancer Res Treat, 2012 Nov 28; 137(2). PMID: 23184079    Free PMC article.
Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
Jessica E Cott Chubiz, Janie M Lee, +6 authors, G Scott Gazelle.
Cancer, 2012 Nov 28; 119(6). PMID: 23184400    Free PMC article.
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
Françoise Bonnet, Mickael Guedj, +14 authors, Michel Longy.
BMC Med Genomics, 2012 Nov 29; 5. PMID: 23186559    Free PMC article.
Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients.
Michael R Mallmann, Andrea Staratschek-Jox, +5 authors, Joachim L Schultze.
EPMA J, 2010 Sep 01; 1(3). PMID: 23199086    Free PMC article.
The role of microRNAs in breast cancer migration, invasion and metastasis.
Joy Tang, Aamir Ahmad, Fazlul H Sarkar.
Int J Mol Sci, 2012 Dec 04; 13(10). PMID: 23202960    Free PMC article.
Review.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, +36 authors, Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.
Lancet, 2012 Dec 12; 381(9869). PMID: 23219286    Free PMC article.
Highly Cited.
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients.
Ekaphop Sirachainan, Sureerat Jaruhathai, +6 authors, Chonlaphat Sukasem.
Pharmgenomics Pers Med, 2012 Dec 12; 5. PMID: 23226070    Free PMC article.
Optimal management of brain metastases from breast cancer. Issues and considerations.
Rupert Bartsch, Anna S Berghoff, Matthias Preusser.
CNS Drugs, 2012 Dec 15; 27(2). PMID: 23239265
Review.
The shifting landscape of metastatic breast cancer to the CNS.
Matthew R Quigley, Olivia Fukui, +2 authors, Steven Karlovits.
Neurosurg Rev, 2012 Dec 25; 36(3). PMID: 23262837
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.
Willemien van de Water, Caroline Seynaeve, +11 authors, Gerrit-Jan Liefers.
Oncologist, 2012 Dec 25; 18(1). PMID: 23263290    Free PMC article.
Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study.
Rachel C Shelton, Grace Clarke Hillyer, +8 authors, Alfred I Neugut.
Breast Cancer Res Treat, 2012 Dec 25; 137(3). PMID: 23263696    Free PMC article.
Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.
Yihang Liu, Jennifer L Malin, +2 authors, Rose C Maly.
Breast Cancer Res Treat, 2012 Dec 25; 137(3). PMID: 23263740    Free PMC article.
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.
Jonathan L Vandergrift, Joyce C Niland, +10 authors, Jane C Weeks.
J Natl Cancer Inst, 2012 Dec 25; 105(2). PMID: 23264681    Free PMC article.
Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.
Adnan Aydiner, Leyla Kilic, +6 authors, Abdullah Igci.
Med Oncol, 2013 Jan 01; 30(1). PMID: 23275115
Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
Jennifer C Livaudais, Andrea Lacroix, +7 authors, Gloria D Coronado.
Cancer Epidemiol Biomarkers Prev, 2013 Jan 01; 22(3). PMID: 23275187    Free PMC article.
Use of a urine anastrozole assay to determine treatment discontinuation among women with hormone-sensitive breast cancer: a pilot study.
Grace Clarke Hillyer, Alfred I Neugut, +5 authors, Dawn L Hershman.
J Oncol Pract, 2013 Jan 02; 8(5). PMID: 23277771    Free PMC article.
Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma.
M W Pitz, M Lipson, +7 authors, D D Eisenstat.
Curr Oncol, 2013 Jan 10; 19(6). PMID: 23300356    Free PMC article.
Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician's Choices.
Asim Jamal Shaikh, Shiyam Kumar, +2 authors, Osama Ishtiaq.
Int J Breast Cancer, 2013 Jan 11; 2012. PMID: 23304528    Free PMC article.
Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.
Elizabeth E Sweeney, Russell E McDaniel, +2 authors, V Craig Jordan.
Horm Mol Biol Clin Investig, 2013 Jan 12; 9(2). PMID: 23308083    Free PMC article.
How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?
Nadine Norton, Edith A Perez.
Breast Cancer Res, 2013 Jan 16; 15(1). PMID: 23316883    Free PMC article.
Sequential docetaxel as adjuvant chemotherapy for node-positive or/and T3 or T4 breast cancer: clinical outcome (Mansoura University).
H Sakr, R H Hamed, A H Anter, T Yossef.
Med Oncol, 2013 Jan 17; 30(1). PMID: 23322524
Engaging in health behaviors to lower risk for breast cancer recurrence.
Suzanne C O'Neill, Jessica T DeFrank, +4 authors, Noel T Brewer.
PLoS One, 2013 Jan 18; 8(1). PMID: 23326466    Free PMC article.
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.
Brian C Jensen, Howard L McLeod.
Pharmacogenomics, 2013 Jan 19; 14(2). PMID: 23327580    Free PMC article.
Review.
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer.
N Xenidis, M Perraki, +8 authors, V Georgoulias.
Br J Cancer, 2013 Jan 19; 108(3). PMID: 23329233    Free PMC article.
Survival probability and prognostic factors for breast cancer patients in Vietnam.
Nguyen H Lan, Wongsa Laohasiriwong, John F Stewart.
Glob Health Action, 2013 Jan 23; 6. PMID: 23336619    Free PMC article.
Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
Yadav Sapkota, Sunita Ghosh, +5 authors, Sambasivarao Damaraju.
PLoS One, 2013 Jan 24; 8(1). PMID: 23342018    Free PMC article.
Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer.
Rosane Vianna-Jorge, Juliana Simões Festa-Vasconcellos, Sheyla Maria Torres Goulart-Citrangulo, Marcelo Sobral Leite.
Front Genet, 2013 Jan 25; 3. PMID: 23346096    Free PMC article.
The mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell lines.
Marike Gabrielson, Elisabet Tina.
Oncol Rep, 2013 Jan 29; 29(4). PMID: 23354756    Free PMC article.
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
C A Drukker, J M Bueno-de-Mesquita, +10 authors, S C Linn.
Int J Cancer, 2013 Feb 02; 133(4). PMID: 23371464    Free PMC article.
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.
Vineetha Koroth Edavana, Ishwori B Dhakal, +4 authors, Susan Kadlubar.
Drug Metab Dispos, 2013 Feb 02; 41(4). PMID: 23371966    Free PMC article.
Translating metastasis-related biomarkers to the clinic--progress and pitfalls.
François-Clément Bidard, Jean-Yves Pierga, Jean-Charles Soria, Jean Paul Thiery.
Nat Rev Clin Oncol, 2013 Feb 06; 10(3). PMID: 23381003
Review.
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens.
John R Hawse, Malayannan Subramaniam, +9 authors, Thomas C Spelsberg.
PLoS One, 2013 Feb 06; 8(1). PMID: 23382923    Free PMC article.
The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
Chiara Lucchetti, Isabella Caligiuri, +2 authors, Flavio Rizzolio.
PLoS One, 2013 Feb 08; 8(2). PMID: 23390529    Free PMC article.
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
Leena Hilakivi-Clarke, Sonia de Assis, Anni Warri.
J Mammary Gland Biol Neoplasia, 2013 Feb 09; 18(1). PMID: 23392570    Free PMC article.
Review.
Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer.
Lisa Gallicchio, Ryan MacDonald, Kathy J Helzlsouer.
J Cancer Res Clin Oncol, 2013 Feb 15; 139(5). PMID: 23408333    Free PMC article.
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
Olga Golubnitschaja, Kristina Yeghiazaryan, +5 authors, Hans H Schild.
EPMA J, 2013 Feb 20; 4(1). PMID: 23418957    Free PMC article.
Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.
Matthias Kalder, Volker Ziller, +3 authors, Peyman Hadji.
J Cancer Res Clin Oncol, 2013 Feb 28; 139(6). PMID: 23443254
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
Diana Crivellari, Kathryn P Gray, +16 authors, Aron Goldhirsch.
Breast, 2013 Mar 05; 22(2). PMID: 23453899    Free PMC article.
Tualang honey promotes apoptotic cell death induced by tamoxifen in breast cancer cell lines.
Nik Soriani Yaacob, Agustine Nengsih, Mohd Nor Norazmi.
Evid Based Complement Alternat Med, 2013 Mar 12; 2013. PMID: 23476711    Free PMC article.
Clearing the air: a review of our current understanding of "chemo fog".
Erin O'Farrell, Joyce MacKenzie, Barbara Collins.
Curr Oncol Rep, 2013 Mar 14; 15(3). PMID: 23483375
Review.
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model.
Christian Franci, Jenny Zhou, +4 authors, Hosein Kouros-Mehr.
PLoS One, 2013 Mar 23; 8(3). PMID: 23520493    Free PMC article.
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.
Fabien Reyal, David Hajage, +14 authors, Xavier Sastre-Garau.
PLoS One, 2013 Mar 26; 8(3). PMID: 23526930    Free PMC article.
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Lois B Travis, Wendy Demark Wahnefried, +2 authors, Andrea K Ng.
Nat Rev Clin Oncol, 2013 Mar 27; 10(5). PMID: 23529000
Highly Cited. Review.
Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
Alan P Venook, Donna Niedzwiecki, +12 authors, Monica M Bertagnolli.
J Clin Oncol, 2013 Mar 27; 31(14). PMID: 23530100    Free PMC article.
False Positive 18F-FDG Uptake in Mediastinal Lymph Nodes Detected with Positron Emission Tomography in Breast Cancer: A Case Report.
Gamze Uğurluer, Mustafa Kibar, +2 authors, Meltem Serin.
Case Rep Med, 2013 Mar 28; 2013. PMID: 23533427    Free PMC article.
Pathways to breast cancer recurrence.
Aamir Ahmad.
ISRN Oncol, 2013 Mar 28; 2013. PMID: 23533807    Free PMC article.
Gene expression profile analysis of t1 and t2 breast cancer reveals different activation pathways.
Margit L H Riis, Xi Zhao, +6 authors, Vessela N Kristensen.
ISRN Oncol, 2013 Mar 28; 2013. PMID: 23533813    Free PMC article.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
George Fountzilas, Urania Dafni, +21 authors, Meletios A Dimopoulos.
BMC Cancer, 2013 Mar 30; 13. PMID: 23537287    Free PMC article.
Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.
P Rajbhandari, K A Schalper, +4 authors, E T Alarid.
Oncogene, 2013 Apr 02; 33(11). PMID: 23542176    Free PMC article.
Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.
Christopher R Friese, T May Pini, +8 authors, Jennifer J Griggs.
Breast Cancer Res Treat, 2013 Apr 02; 138(3). PMID: 23542957    Free PMC article.
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
Yan Ni Loh, Ellen L Hedditch, +3 authors, Caroline E Ford.
BMC Cancer, 2013 Apr 04; 13. PMID: 23547709    Free PMC article.
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy.
Mun Hui, Aurélie Cazet, +3 authors, Alexander Swarbrick.
Breast Cancer Res, 2013 Apr 04; 15(2). PMID: 23547970    Free PMC article.
Review.
STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro.
Xiaoyan Wang, Guozhu Wang, +5 authors, Shui Wang.
J Biomed Res, 2013 Apr 05; 26(5). PMID: 23554768    Free PMC article.
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.
Jennifer D Brooks, Sharon N Teraoka, +12 authors, Jane C Figueiredo.
Int J Mol Epidemiol Genet, 2013 Apr 09; 4(1). PMID: 23565321    Free PMC article.
Long-term efficacy and safety of exemestane in the treatment of breast cancer.
Ga Walker, M Xenophontos, Lc Chen, Kl Cheung.
Patient Prefer Adherence, 2013 Apr 10; 7. PMID: 23569364    Free PMC article.
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.
Vanessa B Sheppard, Claudine Isaacs, +10 authors, Jeanne S Mandelblatt.
Breast Cancer Res Treat, 2013 Apr 17; 139(1). PMID: 23588954    Free PMC article.
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
Alka Mukhopadhyay, Thaer Khoury, +2 authors, Ashwani K Sood.
Oncotarget, 2013 Apr 18; 4(4). PMID: 23592399    Free PMC article.
Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
Myles C Hodgson, Garrett Vanostran, +3 authors, Irina U Agoulnik.
PLoS One, 2013 Apr 18; 8(4). PMID: 23593223    Free PMC article.
Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer.
Francesco Recchia, Giampiero Candeloro, +4 authors, Silvio Rea.
Oncol Lett, 2013 Apr 20; 5(4). PMID: 23599749    Free PMC article.
Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.
Catherine M Kelly, Aman U Buzdar.
Drugs, 2013 Apr 23; 73(6). PMID: 23605692
Review.
Predictors of recovery of ovarian function during aromatase inhibitor therapy.
N L Henry, R Xia, +8 authors, D F Hayes.
Ann Oncol, 2013 Apr 25; 24(8). PMID: 23613476    Free PMC article.
Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention.
Jeanne Mandelblatt, Nicolien van Ravesteyn, +5 authors, Ahmedin Jemal.
Cancer, 2013 Apr 30; 119(14). PMID: 23625540    Free PMC article.
Current modalities of accelerated partial breast irradiation.
John A Cox, Todd A Swanson.
Nat Rev Clin Oncol, 2013 May 01; 10(6). PMID: 23629470
Review.
The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Soley Bayraktar, Patricia A Thompson, +5 authors, Abenaa M Brewster.
Oncologist, 2013 May 03; 18(5). PMID: 23635555    Free PMC article.
Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.
Grigorijs Plakhins, Arvids Irmejs, +7 authors, Janis Gardovskis.
Fam Cancer, 2013 May 04; 12(4). PMID: 23640109
Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER.
Véronique Gigoux, Daniel Fourmy.
Front Endocrinol (Lausanne), 2013 May 04; 4. PMID: 23641235    Free PMC article.
Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer.
Dong Hui Cho, Se Kyung Lee, +12 authors, Jung-Hyun Yang.
J Korean Surg Soc, 2013 May 07; 84(5). PMID: 23646312    Free PMC article.
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.
Nadiyah Kazmi, Diana C Márquez-Garbán, +4 authors, Richard J Pietras.
Lung Cancer Manag, 2013 May 08; 1(4). PMID: 23650476    Free PMC article.
What can be learnt about disease progression in breast cancer dormancy from relapse data?
Lisa Willis, Trevor A Graham, +3 authors, Karen M Page.
PLoS One, 2013 May 15; 8(5). PMID: 23671591    Free PMC article.
A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer.
Ava A John-Baptiste, Wei Wu, +2 authors, Chaim M Bell.
PLoS One, 2013 May 15; 8(5). PMID: 23671612    Free PMC article.
Systematic Review.
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
Julie C Friedland, Donald L Smith, +4 authors, David A Proia.
Invest New Drugs, 2013 May 21; 32(1). PMID: 23686707    Free PMC article.
Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels.
Kexin Meng, Wei Tian, +2 authors, Yongchuan Deng.
World J Surg Oncol, 2013 May 22; 11. PMID: 23688389    Free PMC article.
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.
Cathrin Brisken.
Nat Rev Cancer, 2013 May 25; 13(6). PMID: 23702927
Highly Cited. Review.
Tumour dormancy and clinical implications in breast cancer.
L Gelao, C Criscitiello, +6 authors, G Curigliano.
Ecancermedicalscience, 2013 May 30; 7. PMID: 23717341    Free PMC article.
The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence.
Sung Gwe Ahn, Hak Min Lee, +5 authors, Hy-De Lee.
PLoS One, 2013 May 30; 8(5). PMID: 23717438    Free PMC article.
Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer.
J Q Chen, Y Bao, +13 authors, L G Radvanyi.
Ann Oncol, 2013 Jun 05; 24(10). PMID: 23729783    Free PMC article.
Oophorectomy in breast cancer-controversies and current status.
Gurpreet Singh.
Indian J Surg, 2013 Jun 05; 74(3). PMID: 23730045    Free PMC article.
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment.
K Beelen, M Opdam, +8 authors, S C Linn.
Breast Cancer Res Treat, 2013 Jun 06; 139(3). PMID: 23736997    Free PMC article.
Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia.
A K Altwairgi, W M Hopman, M Mates.
Curr Oncol, 2013 Jun 06; 20(3). PMID: 23737687    Free PMC article.
The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, +3 authors, M Wilcox.
Br J Cancer, 2013 Jun 08; 108(11). PMID: 23744281    Free PMC article.
Highly Cited. Review.
Prognosis in women with breast cancer and private extra insurance coverage.
Juan J Grau, Gabriel Zanon, +4 authors, Albert Biete.
Ann Surg Oncol, 2013 Jun 12; 20(9). PMID: 23754547    Free PMC article.
Association of estrogen receptor, progesterone receptor and HER2 following neoadjuvant systemic treatment in breast cancer patients undergoing surgery.
Y-M Tsai, H-M Hsu, +5 authors, J-C Yu.
Ir J Med Sci, 2013 Jun 13; 183(1). PMID: 23757214
Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.
Tsuyoshi Shinohara, Makito Yasui, +2 authors, Kiyofumi Yamagishi.
Case Rep Oncol Med, 2013 Jun 14; 2013. PMID: 23762693    Free PMC article.
Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.
Hsin-Shun Tseng, Che Lin, +5 authors, Dar-Ren Chen.
World J Surg Oncol, 2013 Jun 19; 11. PMID: 23768133    Free PMC article.
Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.
Jennifer D Brooks, Sharon N Teraoka, +11 authors, Jane C Figueiredo.
Cancer Causes Control, 2013 Jun 19; 24(8). PMID: 23775025    Free PMC article.
Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study.
Imjai Chitapanarux, Ekkasit Tharavichitkul, +6 authors, Roy Vongtama.
J Radiat Res, 2013 Jun 22; 55(1). PMID: 23788495    Free PMC article.
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.
A Giordano, H Gao, +10 authors, J M Reuben.
Ann Oncol, 2013 Jun 27; 24(10). PMID: 23798614    Free PMC article.
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.
Dennis C Sgroi, Erin Carney, +16 authors, Paul E Goss.
J Natl Cancer Inst, 2013 Jul 03; 105(14). PMID: 23812955    Free PMC article.
Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.
K Stephen Suh, Sreeja Sarojini, +7 authors, Andre Goy.
J Oncol, 2013 Jul 03; 2013. PMID: 23818899    Free PMC article.
Hormonal therapies in young breast cancer patients: when, what and for how long?
Alexandre Christinat, Simona Di Lascio, Olivia Pagani.
J Thorac Dis, 2013 Jul 03; 5 Suppl 1. PMID: 23819026    Free PMC article.
Treatment of breast cancer in young women: do we need more aggressive therapies?
Giuseppe Cancello, Emilia Montagna.
J Thorac Dis, 2013 Jul 03; 5 Suppl 1. PMID: 23819027    Free PMC article.
How to improve breast cancer care measurement and reporting: suggestions from a complex urban hospital.
Ann Scheck McAlearney, Jill Wellner, Nina A Bickell.
J Healthc Manag, 2013 Jul 05; 58(3). PMID: 23821899    Free PMC article.
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response.
E H Lips, L Mulder, +5 authors, J Wesseling.
Breast Cancer Res Treat, 2013 Jul 06; 140(1). PMID: 23828499    Free PMC article.
HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.
Nilay Shah, Kideok Jin, +12 authors, Saraswati Sukumar.
Cancer Res, 2013 Jul 09; 73(17). PMID: 23832664    Free PMC article.
Efficacy of intraarterial chemoinfusion therapy for locally advanced breast cancer patients: a retrospective analysis of 28 cases.
Wei Zhang, Rong Liu, +4 authors, Hongwei Zhang.
Onco Targets Ther, 2013 Jul 10; 6. PMID: 23836989    Free PMC article.
Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity.
Rebecca Lamb, Sophie Lehn, +2 authors, Göran Landberg.
Cell Cycle, 2013 Jul 11; 12(15). PMID: 23839043    Free PMC article.
Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.
Guo-Shiou Liao, Maria Karmella Apaya, Lie-Fen Shyur.
Evid Based Complement Alternat Med, 2013 Jul 11; 2013. PMID: 23840256    Free PMC article.
Tamoxifen and ovarian function.
Martine Berliere, Francois P Duhoux, +6 authors, Jean-Pascal Machiels.
PLoS One, 2013 Jul 11; 8(6). PMID: 23840510    Free PMC article.
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
Deimante Tamkus, Alla Sikorskii, +6 authors, Nikolay V Dimitrov.
ISRN Oncol, 2013 Jul 12; 2013. PMID: 23844294    Free PMC article.
Chemotherapy dosing in overweight and obese patients with cancer.
Gary H Lyman, Alex Sparreboom.
Nat Rev Clin Oncol, 2013 Jul 17; 10(8). PMID: 23856744
Review.
Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial.
H Yang, X Zong, +17 authors, J Ni.
Br J Cancer, 2013 Jul 19; 109(3). PMID: 23860520    Free PMC article.
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
M Gnant, G Pfeiler, +12 authors, R Jakesz.
Br J Cancer, 2013 Jul 23; 109(3). PMID: 23868011    Free PMC article.
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
Henrik J Johansson, Betzabe C Sanchez, +15 authors, Janne Lehtiö.
Nat Commun, 2013 Jul 23; 4. PMID: 23868472    Free PMC article.
Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract.
Yukiko Nagashima, Noriko Maeda, +2 authors, Masaaki Oka.
Onco Targets Ther, 2013 Jul 23; 6. PMID: 23874107    Free PMC article.
Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study.
Maria E C Sandberg, Jingmei Li, +4 authors, Kamila Czene.
Breast Cancer Res, 2013 Jul 24; 15(4). PMID: 23876209    Free PMC article.
Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review).
Stefan Langhammer.
Oncol Rep, 2013 Jul 24; 30(4). PMID: 23877481    Free PMC article.
Review.
Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study.
Stanimira Krotneva, Kristen Reidel, +4 authors, Ari N Meguerditchian.
Breast Cancer Res Treat, 2013 Jul 25; 140(2). PMID: 23881523    Free PMC article.
EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor α.
Sunil Badve, I Tudor Vladislav, +6 authors, Therese Phillips.
J Clin Pathol, 2013 Jul 31; 66(12). PMID: 23894168    Free PMC article.
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
Otto Metzger-Filho, Zhuoxin Sun, +8 authors, Fatima Cardoso.
J Clin Oncol, 2013 Jul 31; 31(25). PMID: 23897954    Free PMC article.
Highly Cited.
Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis.
T Qin, Z Y Yuan, +6 authors, S S Wang.
Curr Oncol, 2013 Aug 02; 20(4). PMID: 23904760    Free PMC article.
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
Alexandra Schönherr, Viktoria Aivazova-Fuchs, +14 authors, Brigitte Rack.
Breast Care (Basel), 2013 Aug 02; 7(4). PMID: 23904831    Free PMC article.
Using Simulation Modeling to Inform Strategies to Reduce Breast Cancer Mortality in Black Women in the District of Columbia.
Aimee M Near, Jeanne S Mandelblatt, Clyde B Schechter, Michael A Stoto.
Epidemiol Res Int, 2012 Apr 26; 2012(2012). PMID: 23914301    Free PMC article.
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.
Ifeyinwa Obiorah, V Craig Jordan.
Menopause, 2013 Aug 08; 20(4). PMID: 23921472    Free PMC article.
Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.
Xue Qin Yu, Mark Clements, Dianne O'Connell.
J Cancer Surviv, 2013 Aug 08; 7(4). PMID: 23921991
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
George Pentheroudakis, Vassiliki Kotoula, +19 authors, George Fountzilas.
PLoS One, 2013 Aug 08; 8(7). PMID: 23923010    Free PMC article.
Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.
Lorena Rocha Ayres, André de Oliveira Baldoni, Anna Paula de Sá Borges, Leonardo Régis Leira Pereira.
Int J Clin Pharm, 2013 Aug 13; 36(1). PMID: 23934310
Review.
Internal Mammary Sentinel Node Biopsy in Breast Cancer. Is it Indicated?
R Maráz, G Boross, +3 authors, G Cserni.
Pathol Oncol Res, 2013 Aug 13; 20(1). PMID: 23934505
Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR.
Jeon-Hor Chen, Wei-Fan Pan, +9 authors, Min-Ying Su.
NMR Biomed, 2013 Aug 14; 26(12). PMID: 23940080    Free PMC article.
Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells.
Hae Won Kim, Jung Eun Kim, +5 authors, Byeong-Cheol Ahn.
PLoS One, 2013 Aug 14; 8(8). PMID: 23940545    Free PMC article.
Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).
Guohua Rong, Hua Kang, +2 authors, Haichen Sun.
PLoS One, 2013 Aug 21; 8(8). PMID: 23951052    Free PMC article.
Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
Aleksandra Markiewicz, Marzena Wełnicka-Jaśkiewicz, +4 authors, Anna J Zaczek.
PLoS One, 2013 Aug 21; 8(8). PMID: 23951298    Free PMC article.
The role of antioxidants in the era of cardio‑oncology.
Duncan T Vincent, Yasmine F Ibrahim, Michael Graham Espey, Yuichiro J Suzuki.
Cancer Chemother Pharmacol, 2013 Aug 21; 72(6). PMID: 23959462    Free PMC article.
Review.
Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens.
Yasser Abdel Kader, Tamer El-Nahas, Amr Sakr.
Onco Targets Ther, 2013 Aug 24; 6. PMID: 23966793    Free PMC article.
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Richard A Anderson, Mikkel Rosendahl, Thomas W Kelsey, David A Cameron.
Eur J Cancer, 2013 Aug 24; 49(16). PMID: 23968732    Free PMC article.
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
Josh J Carlson, Joshua A Roth.
Breast Cancer Res Treat, 2013 Aug 27; 141(1). PMID: 23974828    Free PMC article.
Highly Cited. Systematic Review.
SEOM clinical guidelines for the systemic treatment of early breast cancer 2013.
S Del Barco, E Ciruelos, +3 authors, SEOM.
Clin Transl Oncol, 2013 Aug 28; 15(12). PMID: 23979909
Review.
The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.
Janna Sand-Dejmek, Roy Ehrnström, +2 authors, Lisa Ryden.
PLoS One, 2013 Aug 31; 8(8). PMID: 23990917    Free PMC article.
Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.
Xi Zhang, Xin Mu, +4 authors, Kunwei Shen.
PLoS One, 2013 Aug 31; 8(8). PMID: 23991038    Free PMC article.
Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer.
Min Ying, Yingjian He, +7 authors, Tao Ouyang.
Chin J Cancer Res, 2013 Sep 03; 25(4). PMID: 23997526    Free PMC article.
A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer.
T I Barron, C Cahir, L Sharp, K Bennett.
Br J Cancer, 2013 Sep 05; 109(6). PMID: 24002590    Free PMC article.
Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen.
Insee Sensorn, Ekaphop Sirachainan, +5 authors, Darawan Pinthong.
Pharmgenomics Pers Med, 2013 Sep 11; 6. PMID: 24019753    Free PMC article.
Do community-based patient assistance programs affect the treatment and well-being of patients with breast cancer?
Nina A Bickell, Andrea N Geduld, +8 authors, Howard Leventhal.
J Oncol Pract, 2013 Sep 12; 10(1). PMID: 24023271    Free PMC article.
Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer.
Hiltrud Brauch, Matthias Schwab.
Br J Clin Pharmacol, 2013 Sep 17; 77(4). PMID: 24033728    Free PMC article.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Dennis C Sgroi, Ivana Sestak, +9 authors, Mitch Dowsett.
Lancet Oncol, 2013 Sep 17; 14(11). PMID: 24035531    Free PMC article.
Highly Cited.
Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.
S R Chan, C G Rickert, +11 authors, R D Schreiber.
Cell Death Differ, 2013 Sep 17; 21(2). PMID: 24037089    Free PMC article.
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.
Marcelo Madeira, André Mattar, +2 authors, Luiz Henrique Gebrim.
BMC Cancer, 2013 Sep 21; 13. PMID: 24047421    Free PMC article.
Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.
Adriana Lasa, Arnal Garcia, +5 authors, Agusti Barnadas.
PLoS One, 2013 Sep 24; 8(9). PMID: 24058517    Free PMC article.
Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients.
Anna Babayan, Juliane Hannemann, +3 authors, Simon A Joosse.
PLoS One, 2013 Sep 24; 8(9). PMID: 24058649    Free PMC article.
Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo.
Kathleen A O'Leary, Fatou Jallow, +4 authors, Linda A Schuler.
Endocrinology, 2013 Sep 26; 154(12). PMID: 24064365    Free PMC article.
Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.
Mario Niepel, Marc Hafner, +5 authors, Peter K Sorger.
Sci Signal, 2013 Sep 26; 6(294). PMID: 24065145    Free PMC article.
Breast cancer management in the elderly.
M Luque, F Arranz, +9 authors, Y Fernández.
Clin Transl Oncol, 2013 Oct 03; 16(4). PMID: 24085574
Review.
Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.
Allison W Kurian, Aya Mitani, +14 authors, Amar K Das.
Cancer, 2013 Oct 09; 120(1). PMID: 24101577    Free PMC article.
A robust prognostic signature for hormone-positive node-negative breast cancer.
Obi L Griffith, François Pepin, +4 authors, Joe W Gray.
Genome Med, 2013 Oct 12; 5(10). PMID: 24112773    Free PMC article.
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion.
N Falkenberg, N Anastasov, +9 authors, M Aubele.
Br J Cancer, 2013 Oct 17; 109(10). PMID: 24129242    Free PMC article.
Tamoxifen resistance in breast cancer.
Minsun Chang.
Biomol Ther (Seoul), 2012 May 01; 20(3). PMID: 24130921    Free PMC article.
Review.
Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review).
Jichun Zhou, Rongyue Teng, +7 authors, Shuduo Xie.
Oncol Lett, 2013 Oct 19; 6(2). PMID: 24137320    Free PMC article.
COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.
Lacey M Litchfield, Savitri N Appana, Susmita Datta, Carolyn M Klinge.
Mol Cell Endocrinol, 2013 Oct 22; 382(1). PMID: 24141032    Free PMC article.
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.
Kenji Taketani, Eriko Tokunaga, +10 authors, Yoshihiko Maehara.
Surg Today, 2013 Oct 22; 44(10). PMID: 24142101    Free PMC article.
Benefit risk assessment and update on the use of docetaxel in the management of breast cancer.
Scheryll Alken, Catherine M Kelly.
Cancer Manag Res, 2013 Oct 22; 5. PMID: 24143122    Free PMC article.
Review.
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
P Dubsky, J C Brase, +18 authors, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Br J Cancer, 2013 Oct 26; 109(12). PMID: 24157828    Free PMC article.
Highly Cited.
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
Weiyi Toy, Yang Shen, +15 authors, Sarat Chandarlapaty.
Nat Genet, 2013 Nov 05; 45(12). PMID: 24185512    Free PMC article.
Highly Cited.
Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancer.
Hamid Reza Mirzaei, Parisa Sabet Rasekh, +5 authors, Parastoo Hajian.
Int J Breast Cancer, 2013 Nov 05; 2013. PMID: 24187626    Free PMC article.
Breast cancer-initiating cells: insights into novel treatment strategies.
Guido Santilli, Mara Binda, Nadia Zaffaroni, Maria Grazia Daidone.
Cancers (Basel), 2011 Jan 01; 3(1). PMID: 24212666    Free PMC article.
Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast Cancer.
Ashish B Rajput, Nianping Hu, +8 authors, Harriet E Feilotter.
Cancers (Basel), 2011 Jan 01; 3(4). PMID: 24213134    Free PMC article.
Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer.
Aleksandra Markiewicz, Magdalena Książkiewicz, +4 authors, Anna J Zaczek.
Cancers (Basel), 2013 Nov 13; 5(4). PMID: 24217115    Free PMC article.
The global challenge of reducing breast cancer mortality.
Robert Burton, Robin Bell.
Oncologist, 2013 Nov 13; 18(11). PMID: 24218000    Free PMC article.
High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.
Kristin E Williams, Douglas L Anderton, +2 authors, Kathleen F Arcaro.
Epigenetics, 2013 Nov 15; 9(2). PMID: 24225485    Free PMC article.
'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention.
Manuel Debald, Kristina Yeghiazaryan, +3 authors, Olga Golubnitschaja.
EPMA J, 2013 Nov 16; 4(1). PMID: 24228816    Free PMC article.
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis.
Rahber Thariani, Norah Lynn Henry, +4 authors, David L Veenstra.
J Comp Eff Res, 2013 Nov 19; 2(3). PMID: 24236631    Free PMC article.
Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups.
Shengfan Zhang, Julie S Ivy, +2 authors, Bonnie C Yankaskas.
Health Care Manag Sci, 2013 Nov 19; 17(3). PMID: 24242701
Molecular profiling for breast cancer: a comprehensive review.
Muaiad Kittaneh, Alberto J Montero, Stefan Glück.
Biomark Cancer, 2013 Nov 20; 5. PMID: 24250234    Free PMC article.
Review.
Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study.
Heidi D Klepin, Ann M Geiger, +6 authors, Mark A Espeland.
Cancer Prev Res (Phila), 2013 Nov 21; 7(1). PMID: 24253314    Free PMC article.
Two-gene expression ratio as predictor for breast cancer treated with tamoxifen: evidence from meta-analysis.
Lin Zhao, Shimiao Zhu, Ying Gao, Yaogang Wang.
Tumour Biol, 2013 Nov 23; 35(4). PMID: 24264313
Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial.
Michaela Bossart, Peyman Hadji, +2 authors, Annette Hasenburg.
J Cancer Res Clin Oncol, 2013 Nov 26; 140(1). PMID: 24271056
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl, Lisa Rydén.
BMC Cancer, 2013 Nov 28; 13. PMID: 24274821    Free PMC article.
Metastasis dormancy in estrogen receptor-positive breast cancer.
Xiang H-F Zhang, Mario Giuliano, +2 authors, C Kent Osborne.
Clin Cancer Res, 2013 Dec 04; 19(23). PMID: 24298069    Free PMC article.
Highly Cited. Review.
Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score.
Sung Gwe Ahn, Hak Min Lee, +5 authors, In-Sun Chu.
Int J Mol Sci, 2013 Dec 07; 14(12). PMID: 24304542    Free PMC article.
Irradiation after surgery for breast cancer patients with primary tumours and one to three positive axillary lymph nodes: yes or no?
C Lu, H Xu, +3 authors, Y Jia.
Curr Oncol, 2013 Dec 07; 20(6). PMID: 24311960    Free PMC article.
Post-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes: a meta-analysis.
Yaming Li, Meena S Moran, +2 authors, Bruce G Haffty.
PLoS One, 2013 Dec 07; 8(12). PMID: 24312582    Free PMC article.
Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.
Louis A Penner, Susan Eggly, +3 authors, Terrance L Albrecht.
J Soc Issues, 2012 Jun 25; 68(2). PMID: 24319297    Free PMC article.
The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis.
Qing Qu, Yan Mao, Xiao-chun Fei, Kun-wei Shen.
PLoS One, 2013 Dec 11; 8(12). PMID: 24324816    Free PMC article.
CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.
Sung-Hsin Kuo, Shi-Yi Yang, +6 authors, Chiun-Sheng Huang.
Biomed Res Int, 2013 Dec 11; 2013. PMID: 24324964    Free PMC article.
Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.
Deirdre P Cronin-Fenton, Per Damkier, Timothy L Lash.
Future Oncol, 2013 Dec 18; 10(1). PMID: 24328412    Free PMC article.
Review.
How do I recommend extended adjuvant hormonal therapy?
Amitkumar Mehta, John T Carpenter.
Curr Treat Options Oncol, 2013 Dec 18; 15(1). PMID: 24338340
Review.
Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital.
Meaghan M Crowley, Molly E McCoy, +5 authors, Tracy A Battaglia.
J Oncol Pract, 2013 Dec 19; 10(2). PMID: 24345397    Free PMC article.
New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.
Iain Rj Macpherson, Tr Jeffry Evans.
Breast Cancer (Dove Med Press), 2009 Jan 01; 1. PMID: 24367159    Free PMC article.
Review.
Adjuvant treatment of breast cancer in postmenopausal women: role of exemestane.
Iain Rj Macpherson, Colin Lindsay, Peter Canney.
Breast Cancer (Dove Med Press), 2010 Jan 01; 2. PMID: 24367167    Free PMC article.
Review.
Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update.
Reva Schneider, Ayman Barakat, John Pippen, Cynthia Osborne.
Breast Cancer (Dove Med Press), 2011 Jan 01; 3. PMID: 24367181    Free PMC article.
Review.
Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective.
Marcio Machado, Thomas R Einarson.
Breast Cancer (Dove Med Press), 2012 Jan 01; 4. PMID: 24367204    Free PMC article.
Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.
Laetitia Huiart, Anne-Deborah Bouhnik, +6 authors, Roch Giorgi.
PLoS One, 2013 Dec 25; 8(12). PMID: 24367488    Free PMC article.
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites.
Nynke G L Jager, Rutger H T Koornstra, +6 authors, Jos H Beijnen.
BMC Cancer, 2014 Jan 01; 13. PMID: 24373320    Free PMC article.
Breast cancer in the elderly-Should it be treated differently?
Petra Tesarova.
Rep Pract Oncol Radiother, 2012 Jan 01; 18(1). PMID: 24381744    Free PMC article.
Review.
Toremifene and tamoxifen have similar efficacy in the treatment of patients with breast cancer: a meta-analysis of randomized trials.
Qian-Ling Ye, Zhi-Min Zhai.
Mol Biol Rep, 2014 Jan 07; 41(2). PMID: 24390230
The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?
Stephen R D Johnston, Belinda Yeo.
Curr Oncol Rep, 2014 Jan 07; 16(1). PMID: 24390724
Review.
Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).
Tadahiko Shien, Hiroji Iwata, +7 authors, Haruhiko Fukuda.
Int J Clin Oncol, 2014 Jan 08; 19(6). PMID: 24395447
Managing the changing burden of cancer in Asia.
Rengaswamy Sankaranarayanan, Kunnambath Ramadas, You-lin Qiao.
BMC Med, 2014 Jan 10; 12. PMID: 24400922    Free PMC article.
Review.
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer.
David M Marcus, Jeffrey M Switchenko, +5 authors, Mylin A Torres.
Front Oncol, 2014 Jan 11; 3. PMID: 24409418    Free PMC article.
Breast cancer: the menacing face of Janus kinase.
C J Watson, K Hughes.
Cell Death Differ, 2014 Jan 15; 21(2). PMID: 24413196    Free PMC article.
Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway.
Shira Peleg Hasson, Tami Rubinek, Larysa Ryvo, Ido Wolf.
Breast Care (Basel), 2014 Jan 15; 8(4). PMID: 24415977    Free PMC article.
Review.
Evaluation of the progesterone receptor status in breast cancer using three different antibodies: a comparison by Allred score system.
Renata Dalmaschio Daltoé, Klesia Pirola Madeira, +3 authors, Leticia Batista Azevedo Rangel.
Int J Clin Exp Pathol, 2014 Jan 16; 7(1). PMID: 24427354    Free PMC article.
Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics.
E Colzani, A L V Johansson, +5 authors, K Czene.
Br J Cancer, 2014 Jan 18; 110(5). PMID: 24434426    Free PMC article.
The role and clinical relevance of disseminated tumor cells in breast cancer.
Malgorzata Banys, Natalia Krawczyk, Tanja Fehm.
Cancers (Basel), 2014 Jan 18; 6(1). PMID: 24434543    Free PMC article.
The application of Oncotype DX in early-stage lymph-node-positive disease.
Sarika Jain, William J Gradishar.
Curr Oncol Rep, 2014 Jan 21; 16(1). PMID: 24442572
Review.
Long-term impact of the 70-gene signature on breast cancer outcome.
C A Drukker, H van Tinteren, +4 authors, L J Van't Veer.
Breast Cancer Res Treat, 2014 Jan 22; 143(3). PMID: 24445566    Free PMC article.
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Karin Beelen, Mark Opdam, +8 authors, Sabine C Linn.
Breast Cancer Res, 2014 Jan 23; 16(1). PMID: 24447434    Free PMC article.
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
Vivien H C Bramwell, Alan B Tuck, +9 authors, Ann F Chambers.
Breast Cancer Res, 2014 Jan 24; 16(1). PMID: 24451146    Free PMC article.
Physicians' influence on breast cancer patient compliance.
Karel Kostev, Lilia Waehlert, +2 authors, Peyman Hadji.
Ger Med Sci, 2014 Jan 24; 12. PMID: 24454275    Free PMC article.
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer.
Sei Hyun Ahn, Hwa Jung Kim, +6 authors, Jong Won Lee.
J Breast Cancer, 2014 Jan 24; 16(4). PMID: 24454460    Free PMC article.
Crowdsourcing awareness: exploration of the ovarian cancer knowledge gap through Amazon Mechanical Turk.
Rebecca R Carter, Analisa DiFeo, +2 authors, Jiayang Sun.
PLoS One, 2014 Jan 28; 9(1). PMID: 24465580    Free PMC article.
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
Karin Beelen, Mark Opdam, +8 authors, Sabine C Linn.
Breast Cancer Res, 2014 Jan 29; 16(1). PMID: 24467828    Free PMC article.
Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.
A R Daniel, A L Gaviglio, +7 authors, C A Lange.
Oncogene, 2014 Jan 29; 34(4). PMID: 24469035    Free PMC article.
Highly Cited.
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Debora de Melo Gagliato, Ana M Gonzalez-Angulo, +5 authors, Mariana Chavez-Macgregor.
J Clin Oncol, 2014 Jan 29; 32(8). PMID: 24470007    Free PMC article.
Managing breast cancer in the older patient.
Tracey O'Connor, Arvind Shinde, +2 authors, Arti Hurria.
Clin Adv Hematol Oncol, 2014 Jan 30; 11(6). PMID: 24472802    Free PMC article.
Review.
Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis.
Ferrán Catalá-López, Adolfo Alonso-Arroyo, +2 authors, David Moher.
BMC Med, 2014 Jan 31; 12. PMID: 24476131    Free PMC article.
Review.
Bilateral breast cancers.
Steven A Narod.
Nat Rev Clin Oncol, 2014 Feb 05; 11(3). PMID: 24492834
Review.
Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Feng-yan Li, San-gang Wu, +5 authors, Zhen-yu He.
PLoS One, 2014 Feb 06; 9(2). PMID: 24498305    Free PMC article.
Tumor bed volumetric changes during breast irradiation for the patients with breast cancer.
Mi Joo Chung, Young Jin Suh, +4 authors, Jong Hoon Lee.
Radiat Oncol J, 2014 Feb 07; 31(4). PMID: 24501711    Free PMC article.
Detection of cancer DNA in plasma of patients with early-stage breast cancer.
Julia A Beaver, Danijela Jelovac, +26 authors, Ben H Park.
Clin Cancer Res, 2014 Feb 08; 20(10). PMID: 24504125    Free PMC article.
Highly Cited.
Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells.
Kumiko Oida, Akira Matsuda, +9 authors, Akane Tanaka.
Sci Rep, 2014 Feb 18; 4. PMID: 24531845    Free PMC article.
Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer.
J A Pérez-Fidalgo, B Bermejo, +7 authors, A Lluch.
Clin Transl Oncol, 2014 Feb 18; 16(9). PMID: 24532305    Free PMC article.
Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor-and HER2-Positive Metastatic Breast Cancer.
Thomas E Delea, Carol Hawkes, +2 authors, Stephen R D Johnston.
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550751    Free PMC article.
Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications.
Huali Wang, Haijing Liu, +10 authors, Bo Zhang.
BMC Cancer, 2014 Feb 25; 14. PMID: 24559156    Free PMC article.
Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance.
Sanaz Tabarestani, Sayyed Mohammad Hossein Ghaderian, Hamid Rezvani, Reza Mirfakhraie.
Med Oncol, 2014 Feb 25; 31(4). PMID: 24563328
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.
Jyothi S Prabhu, Aruna Korlimarla, +12 authors, T S Sridhar.
J Cancer, 2014 Feb 25; 5(2). PMID: 24563670    Free PMC article.
Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.
Sanaz Tabarestani, Sayyed Mohammad Hossein Ghaderian, +9 authors, Eznollah Azargashb.
Cell Oncol (Dordr), 2014 Feb 28; 37(2). PMID: 24573687
Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.
L M Boerman, A J Berendsen, +3 authors, G H de Bock.
Support Care Cancer, 2014 Mar 04; 22(7). PMID: 24584711
Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women--an Asian population-based study.
Kun-Pin Hsieh, Li-Chia Chen, +2 authors, Yi-Hsin Yang.
PLoS One, 2014 Mar 04; 9(2). PMID: 24586261    Free PMC article.
Pregnancy associated breast cancer and pregnancy after breast cancer treatment.
Emek Doğer, Eray Calışkan, Peter Mallmann.
J Turk Ger Gynecol Assoc, 2011 Jan 01; 12(4). PMID: 24592003    Free PMC article.
Review.
A novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cells.
Yuefeng Sun, Ravi Kasiappan, +4 authors, Wenlong Bai.
J Biol Chem, 2014 Mar 13; 289(18). PMID: 24619425    Free PMC article.
CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance.
Tian Gao, Yong Han, +3 authors, Jiafu Ji.
PLoS One, 2014 Mar 14; 9(3). PMID: 24622579    Free PMC article.
Promoting quality and evidence-based care in early-stage breast cancer follow-up.
N Lynn Henry, Lynn N Henry, +4 authors, Julie R Gralow.
J Natl Cancer Inst, 2014 Mar 15; 106(4). PMID: 24627271    Free PMC article.
Review.
Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
Marcelo Sobral Leite, Letícia Carlos Giacomin, +6 authors, Rosane Vianna-Jorge.
BMC Cancer, 2014 Mar 19; 14. PMID: 24629097    Free PMC article.
Tamoxifen for women at high risk of breast cancer.
Safia A Nazarali, Steven A Narod.
Breast Cancer (Dove Med Press), 2014 Mar 22; 6. PMID: 24648767    Free PMC article.
Review.
Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.
Katsunori Tozuka, Jun Horiguchi, +7 authors, Izumi Takeyoshi.
Mol Clin Oncol, 2013 Jan 01; 1(1). PMID: 24649129    Free PMC article.
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more.
Keiichi Kontani, Shin-Ichiro Hashimoto, +7 authors, Hiroyasu Yokomise.
Mol Clin Oncol, 2014 Mar 22; 1(2). PMID: 24649151    Free PMC article.
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX®, clinicopathological markers and tumor cell dissemination in the blood and bone marrow.
Bahriye Aktas, Agnes Bankfalvi, +2 authors, Sabine Kasimir-Bauer.
Mol Clin Oncol, 2014 Mar 22; 1(6). PMID: 24649291    Free PMC article.
Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells.
Rodrigo B Interiano, Jun Yang, Adrian L Harris, Andrew M Davidoff.
J Surg Res, 2014 Mar 25; 190(1). PMID: 24656476    Free PMC article.
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.
V Craig Jordan.
Endocr Relat Cancer, 2014 Mar 25; 21(3). PMID: 24659478    Free PMC article.
Review.
Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.
P-P Wong, C C Yeoh, +5 authors, H C Hurst.
Oncogene, 2014 Mar 26; 33(37). PMID: 24662835    Free PMC article.
Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer.
Arturo Loaiza-Bonilla, Francisco Socola, Stefan Glück.
Clin Med Insights Womens Health, 2013 Jan 01; 6. PMID: 24665209    Free PMC article.
Review.
Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.
J Wason, A Marshall, +2 authors, N Stallard.
Br J Cancer, 2014 Mar 29; 110(8). PMID: 24667651    Free PMC article.
Survival of women with inflammatory breast cancer: a large population-based study.
S Dawood, X Lei, +6 authors, A M Gonzalez-Angulo.
Ann Oncol, 2014 Mar 29; 25(6). PMID: 24669011    Free PMC article.
The effect of local therapy on breast cancer mortality: is there an age-interaction?
Ismail Jatoi.
Indian J Surg Oncol, 2014 Mar 29; 5(1). PMID: 24669159    Free PMC article.
Screening mammography in older women: a review.
Louise C Walter, Mara A Schonberg.
JAMA, 2014 Apr 03; 311(13). PMID: 24691609    Free PMC article.
Highly Cited. Review.
An approach to evaluating and comparing biomarkers for patient treatment selection.
Holly Janes, Marshall D Brown, Ying Huang, Margaret S Pepe.
Int J Biostat, 2014 Apr 04; 10(1). PMID: 24695044    Free PMC article.
Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance.
Maiko Takahashi, Tetsu Hayashida, +3 authors, Yuko Kitagawa.
Cancer Sci, 2014 Apr 05; 105(6). PMID: 24698107    Free PMC article.
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance.
Charlotte K Y Ng, Britta Weigelt, +5 authors, Jorge S Reis-Filho.
Cancer Res, 2014 Apr 08; 74(11). PMID: 24706696    Free PMC article.
Radiotherapy issues in elderly breast cancer patients.
Ian Kunkler.
Breast Care (Basel), 2012 Dec 01; 7(6). PMID: 24715826    Free PMC article.
Review.
HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.
Beyhan Ataseven, Daniela Gologan, +4 authors, Wolfgang Eiermann.
Breast Care (Basel), 2012 Dec 01; 7(6). PMID: 24715828    Free PMC article.
Review.
Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer.
Mattea Reinisch, Gunter von Minckwitz, +6 authors, Sibylle Loibl.
Breast Care (Basel), 2014 Apr 10; 8(1). PMID: 24715845    Free PMC article.
The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer.
Qing Qu, Yu Zong, +4 authors, Kun-wei Shen.
World J Surg Oncol, 2014 Apr 12; 12. PMID: 24721777    Free PMC article.
Outcomes of ethnic minority groups with node-positive, non-metastatic breast cancer in two tertiary referral centers in Sydney, Australia.
Stephanie H Lim, Geoff P Delaney, +3 authors, Paul de Souza.
PLoS One, 2014 Apr 23; 9(4). PMID: 24752636    Free PMC article.
Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.
Esther M de Kruijf, Esther Bastiaannet, +5 authors, Gerrit Jan Liefers.
Mol Oncol, 2014 Apr 29; 8(5). PMID: 24767310    Free PMC article.
Oral health-related complications of breast cancer treatment: assessing dental hygienists' knowledge and professional practice.
L Susan Taichman, Grace Gomez, Marita Rohr Inglehart.
J Dent Hyg, 2014 Apr 29; 88(2). PMID: 24771774    Free PMC article.
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.
R Kreienberg, U-S Albert, +3 authors, A Wöckel.
Geburtshilfe Frauenheilkd, 2014 Apr 29; 73(6). PMID: 24771925    Free PMC article.
Second malignancies after breast cancer: The impact of adjuvant therapy.
Chunhui Dong, Ling Chen.
Mol Clin Oncol, 2014 Apr 29; 2(3). PMID: 24772296    Free PMC article.
Review.
Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer.
Francesco Recchia, Giampiero Candeloro, +6 authors, Silvio Rea.
Mol Clin Oncol, 2014 Apr 29; 2(3). PMID: 24772320    Free PMC article.
Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.
Katherine E Reeder-Hayes, Anne Marie Meyer, +2 authors, Stephanie B Wheeler.
Breast Cancer Res Treat, 2014 May 03; 145(3). PMID: 24789443    Free PMC article.
Oligometastatic breast cancer: a shift from palliative to potentially curative treatment?
Simona Di Lascio, Olivia Pagani.
Breast Care (Basel), 2014 May 08; 9(1). PMID: 24803881    Free PMC article.
Review.
Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer.
Sarah E Holton, Anna Bergamaschi, Benita S Katzenellenbogen, Rohit Bhargava.
PLoS One, 2014 May 13; 9(5). PMID: 24816718    Free PMC article.
Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.
Rebecca A Shelby, Sara N Edmond, +5 authors, Gretchen G Kimmick.
Support Care Cancer, 2014 May 14; 22(10). PMID: 24821365
Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer.
Jessica S Wells, Ora L Strickland, Jo Ann Dalton, Sarah Freeman.
Cancer Nurs, 2014 May 17; 38(2). PMID: 24831041    Free PMC article.
Breast cancer and aging: results of the U13 conference breast cancer panel.
M F Barginear, H Muss, +5 authors, A Hurria.
Breast Cancer Res Treat, 2014 May 23; 146(1). PMID: 24847891    Free PMC article.
Review.
Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.
Adam M Brufsky.
Am J Clin Oncol, 2014 May 24; 37(4). PMID: 24853663    Free PMC article.
Systematic Review.
Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims.
Bih-Ru Wang, Yuh-Lih Chang, +5 authors, Yueh-Ching Chou.
Patient Prefer Adherence, 2014 May 24; 8. PMID: 24855343    Free PMC article.
Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.
Rachel Webber-Foster, Giorgi Kvizhinadze, Gareth Rivalland, Tony Blakely.
Pharmacoeconomics, 2014 May 27; 32(7). PMID: 24859241
Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.
Elgene Lim, Min Ni, +3 authors, Myles Brown.
Curr Breast Cancer Rep, 2014 May 27; 6(2). PMID: 24860642    Free PMC article.
Relationship between chemotherapy and prognosis in different subtypes of node-negative breast cancer.
Xia Liu, Yong Guan, +5 authors, Yun Niu.
Tumour Biol, 2014 May 28; 35(9). PMID: 24863944
The clinical significance of PR, ER, NF- κ B, and TNF- α in breast cancer.
Xian-Long Zhou, Wei Fan, Gui Yang, Ming-Xia Yu.
Dis Markers, 2014 May 28; 2014. PMID: 24864130    Free PMC article.
Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors.
Stephanie Brooke Wheeler, Racquel Elizabeth Kohler, +6 authors, Hyman Bernard Muss.
J Cancer Surviv, 2014 May 29; 8(4). PMID: 24866922    Free PMC article.
Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.
Carlos H Barcenas, Jiangong Niu, +6 authors, Sharon H Giordano.
J Clin Oncol, 2014 May 29; 32(19). PMID: 24868022    Free PMC article.
ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116.
Anton G T Terwisscha van Scheltinga, Marjolijn N Lub-de Hooge, +8 authors, Elisabeth G E de Vries.
MAbs, 2014 May 30; 6(4). PMID: 24870719    Free PMC article.
Testing the treatment effect on competing causes of death in oncology clinical trials.
Federico Rotolo, Stefan Michiels.
BMC Med Res Methodol, 2014 Jun 03; 14. PMID: 24884550    Free PMC article.
Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial.
Nan Peng, Yi Zhang, +5 authors, Xiao-Min Wang.
Trials, 2014 Jun 03; 15. PMID: 24885324    Free PMC article.
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
Marieke A Vollebergh, Esther H Lips, +9 authors, Sabine C Linn.
Breast Cancer Res, 2014 Jun 03; 16(3). PMID: 24887359    Free PMC article.
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
Ines Vaz-Luis, Rebecca A Ottesen, +10 authors, Nancy U Lin.
J Clin Oncol, 2014 Jun 04; 32(20). PMID: 24888816    Free PMC article.
Adherence to hormone therapy among women with breast cancer.
Claudia Brito, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos.
BMC Cancer, 2014 Jun 05; 14. PMID: 24893670    Free PMC article.
Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
Xiao-Yan Zhao, Shen Yang, +3 authors, Jie Zhang.
PLoS One, 2014 Jun 06; 9(6). PMID: 24901647    Free PMC article.
Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer.
Alfred I Neugut, Grace Clarke Hillyer, +6 authors, Dawn L Hershman.
Breast Cancer, 2014 Jun 07; 21(6). PMID: 24902664    Free PMC article.
Drug resistance to targeted therapies: déjà vu all over again.
Floris H Groenendijk, René Bernards.
Mol Oncol, 2014 Jun 10; 8(6). PMID: 24910388    Free PMC article.
Highly Cited. Review.
B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells.
Qiang Wu, Xue Liu, +11 authors, Zheng-Sheng Wu.
BMC Cancer, 2014 Jun 12; 14. PMID: 24917186    Free PMC article.
Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer.
David R Lairson, Rohan C Parikh, +2 authors, Xianglin L Du.
Pharmacoeconomics, 2014 Jun 13; 32(10). PMID: 24920195
Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.
Ping Fan, V Craig Jordan.
Steroids, 2014 Jun 17; 90. PMID: 24930824    Free PMC article.
Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
Chang Xia, Mary C Schroeder, +2 authors, Alexandra Thomas.
Ann Surg Oncol, 2014 Jun 18; 21(13). PMID: 24934585    Free PMC article.